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ABSTRACT 
Ligand Diffusion Pathways and Mechanisms for Regulating 0 2 Affinity in Two 
Model Invertebrate Globins: The E7 Gate and Apolar Tunnel 
By 
Mallory D. Salter 
The major pathway for 02 binding to mammalian myoglobins (Mbs) and 
hemoglobins (Hbs) involves transient outward movements of the distal histidine (HisE7), 
which allows ligand migration into the distal portion of the heme pocket. This E7 gate 
pathway appears dominant in vertebrate Hbs and Mbs. However, a number of 
invertebrate globins, including the dimeric hemoglobin from the blood clam Scapharca 
inaequivalvis (ScHbl), have an inverted quaternary structure in which an EF:FE dimer 
interface appears to block the HisE7 gate. Another set of globins, including the mini-
hemoglobin from the Nemertean sea worm Cerebratulus lacteus (CerHb), are missing the 
N-terminal A-helix, which results in an internal tunnel between theE- and H-helices. 
This apolar channel has been suggested to represent an alternative to the HisE7 gate 
pathway. To determine the roles of the E7 gate and alternative pathways, we have 
systematically examined the effects of mutations at the E7 position in ScHbl and CerHb 
and at 21 other positions along the polar channel in CerHb. 
As was observed for SwMb and HbA, there is a progressive decrease in the 
bimolecular rate constants for 0 2 binding to ScHbl as the size of the amino acid at 
position E7 is increased from Ala to Trp. This pattern is unaffected when ScHbl is 
completely converted to the R- or high affinity quaternary state by the F97Y mutation or 
when the dimer interface is completely disrupted by the K30D mutation. In contrast, E7 
mutations have little affect on the rates of ligand entry and escape in CerHb. Instead, 
ligands diffuse through the apolar channel between the E- and H-helices as judged by 
decreases in both overall association and dissociation rate constants and increases in the 
extent of geminate recombination when the channel is blocked by small to large amino 
acid mutations. In SwMb, these trends are only observed when the small to large 
mutations are constructed at or near the E7 gate or directly in the distal pocket where 
ligands are captured. Thus, it is clear that globins have evolved more than one pathway 
for rapid 0 2 uptake and release. 
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Chapter 1: Introduction and Background 
1.1 General introduction - Mammalian myoglobin (Mb) and hemoglobin (Hb) 
are well-known 02 storage and delivery heme proteins (1 -3) and have been the topic of 
much research since Perutz and Kendrew first reported their three-dimensional structures 
over 45 years ago ( 4, 5). In the last twenty years, globins have been discovered in all 
kingdoms of life, expanding this family of proteins from the previously known vertebrate 
a- and f3- globins of human Hb, mammalian Mbs, invertebrate Hbs, and the symbiotic 
leghemoglobins found in leguminous plants (Lbas) (6). For instance, nonsymbiotic Hbs 
(NsHbs) have been found in all plants (7-9) and chimeric flavohemoglobins {FHbs) have 
been found in bacteria and fungi. These FHbs are examples of newly defined 
multidomain globins within the Hb superfamily composed of anN-terminal globin 
domain linked to an FAD reductase domain and a C-terminal domain resembling simple 
bacterial Hbs (10). Two additional globins discovered within the animal kingdom are 
cytoglobin (Cygb) and neuroglobin (Ng) that appear to be ubiquitous among all 
vertebrates even though their functions are still under debate ( 11). 
Most of these single and multidomain globins belong to the 3/3 a-helical fold 
family (Fig l.lA). This structure consists of seven to eight a-helices (designated A 
through H) in which two sets of three a-helices (BEF/AGH) wrap around a heme 
prosthetic group {Fig l.IB). A newer family of globins referred to as truncated 
hemoglobins {TrHbs) have a 2/2 a-helical fold {Fig. I. I C) in which two sets oftwo a-
helices (BE/GH) wrap around a heme prosthetic group ( 12). TrHbs are typically 20-40 
residues shorter than most mammalian Hbs (1 2), and have been found in green algae 
( 13), plants ( 14), protozoa ( 15) and bacteria ( 16). 
A. B. C. 
0 OH 
Figure 1.1 Structural variation among the globin superfamily. A, Model of a 3/3 a-helical fold illustrated by sperm whale myoglobin (PDB ID: 
2mgm). B, Fe (II) protoporphyrin IX (heme b). C, Model of a 2/2 a-helical fold illustrated by Bacillus subtilis hemoglobin (PDB ID: 1 ux8) . The globin 
backbones are designated by gray cartoon, the E7 and F8 positions highlighted by cyan sticks, the heme groups by blue sticks, and bound oxygen and 
cyanide by red sticks in A and C, respectively. The protein structures were generated in MacPyMol and heme bin ChemDraw. 
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The discovery of globins in all kingdoms of life and animal subphyla led to the 
recognition of a variety of globin primary and quaternary structures. For example, just 
among invertebrate globins, the quaternary state can range from single domain/ 
monomeric globins, exemplified by the mini-hemoglobin from Cerebratulus lacteus (I 09 
amino acids), to> 3 million Dalton (Da) aggregates of dodecameric globins, exemplified 
by Lumbricus terrestris hemoglobin (Fig. 1.2). In general, monomeric Hbs include the 
single domain globins (SDGs) of approximately 17 kDa molecular weight with either the 
traditional 3/3 a-helical fold or the 2/2 a-helical fold. 
The specific structural features observed in each globin family finely tune the 
physiological role of the individual globin. The main functions of most animal muscle 
and blood cell hemoglobins involve 02 storage and transport. Recently, a number of 
researchers have shown that NO dioxygenation (the conversion of nitric oxide to nitrate 
by Mb02 or Hb02; Fig. 1.3) is an important secondary physiological function in both 
these globins (17-21). Since nitric oxide can irreversibly disrupt the Fe/S center in 
aconitase (22) and bind to cytochrome c oxidase with high affinity (18), NO is highly 
toxic to both neuronal and striated muscle cells because it inhibits mitochondrial 
respiration. Once the NO radical is captured in the distal pocket1 of globins, it reacts 
immediately with bound dioxygen, which resembles superoxide having a partial negative 
charge. As a result, the rate of NO dioxygenation in myocytes and red cells is directly 
related to the rate at which NO enters the reactive Fe center of the heme prosthetic group 
(Fig. 1.3). 
1 The distal pocket refers to the cavity surrounding the bound ligand. The distal pocket is opposite the 
proximal pocket which contains the His(F8) residue that forms the only covalent bond to the heme 
prosthetic group. 
4 
Figure 1.2. Structural representation of the dodecameric hemoglobin unit from Lumbricus terrestris 
(PDB ID: lx9f). The globin backbone is represented by gray cartoon and each heme group is designated by 
blue sticks. The protein structure was generated in MacPyMol. 
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Highly toxic: 
Inhibits aconitase Leu(B 1 0) His(E7~) Phe(CD4) (TCA cycle) and 
cytochrome c oxidase ~ r=( 
(electron transport to 
0 2) Non-covalent 0( +) -
l ligand pocket N H"N V N 0 
ll ~ -......0 11''"'"1 1: 
•N--0 0?' \ ........................ (·) N 
,........ o" '~o lie or ~- o'' 
Nitrate: non-
toxic 
( Leu(G8) 1 (-) 
Mb02 -"--"'------- S5~== -= --...==:~-:§~e;~Q~II!J::.I)-:=:!.::::::z~~~~~~ ___.....,;...---,.----...-. aquometMb 
(+) I 
N'l 
His(F8) ~N,H 
1/2 NADH 
Figure 1.3. Nitric oxide dioxygenation by oxymyoglobin. NO dioxygenation to oxymyoglobin occurs by 
temporary disruption of the hydrogen bond between the distal histidine (HisE7) and bound oxygen 
followed by rapid reaction with coordinated oxygen. Nitric oxide, a highly toxic molecule, is thus 
converted to nitrate, a non-toxic product. This figure was taken from the proposed scheme based on work 
from (20, 21, 23-25). 
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Additional functions ofHbs include: 0 2 sensing in globin coupled sensors (GCS) 
such as the heme-based aerotactic transducers (HemATs) found in Archaea and Bacteria 
(26); 02 scavenging or sequestering in anaerobic organisms including parasitic 
roundworms and bacteria having anaerobic growth cycles; and dehaloperoxidase activity 
in certain sea worms ((27, 28); see review by (29)). 
1.1 Ligand binding mechanism in myoglobin: the baseball glove model-
Following determinations of the initial three-dimensional structures of sperm whale Mb 
(SwMb) and horse heart Hb, Perutz and Matthews proposed that ligands enter globins 
through a short channel, which is gated by the distal E72 histidine and connects the 
reactive Fe center of the heme prosthetic group to the solvent phase surrounding the 
protein (30). This short channel is now referred to as the E7 gate pathway. In the view of 
most experimentalists, ligand binding toMb is well understood ((1, 31-37) and references 
therein) and consists of four major steps (Fig. 1.4). (1) Weakly bound water is displaced 
to create a vacant distal pocket above the heme Fe atom. (2) Ligands migrate into the 
protein through a short channel that is created when the distal histidine (His64) 
transiently rotates upward and then are captured in the interior pocket of the active site. 
This non-covalent intermediate is often called the B state because it can also be generated 
by photolysis of the equilibrium bound or A state. (3) Covalent bond formation between 
the internal ligand and the Fe atom ofthe heme group then competes with ligand escape 
back out through the HisE7 gate. (4) The bound ligand can be further stabilized by 
electrostatic interactions with surrounding polar amino acid side chains (Fig. 1.4). 
2 Amino acids have been identified with their topological site numbers and/or helical position as defined in 
the conventional globin fold, i.e. His64(E7) refers to the histidine at residue 64, which is located at the 7th 
position of the E-helix. 
deoxyMb(H20) Mb---X MbX5 
KH20 
Mb MbX 
Figure 1.4. Ligand binding mechanism for sperm whale myoglobin as a model system for mammalian Mbs and Hbs. In deoxyMb (PDB ID : 
1 a6n), a noncovalently bound water (blue sphere) is located within the ligand-binding pocket and is displaced in the first step of binding. Residues E7, 
BIO, Ell and G8 surround the distal pocket and HisF8 designates the proximal histidine. In the second step, the ligand (CO, in this example, designated 
by red and white spheres) enters the "empty" binding pocket (PDB ID: labs). In the third step, a covalent bond is fmmed between the ligand (02, in this 
example, designated by red spheres) and Fe2+ (PDB ID: 2mgm). In the last step, a hydrogen bond (cyan dashed line) forms between the HisE7 and the 
ligand to stabilize the bound ligand. Figure taken from (33, 38) . The protein structures were generated in MacPyMol. 
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In this model, the distal pocket ofthe globin is compared to the pocket of a 
baseball glove. In order to 'catch' an incoming ligand, the thumb of the glove (HisE7) 
must swing open momentarily to allow entry of the ligand into the pocket (space between 
IleB9, LeuBlO, ValEll, and IleG8). Following capture in the distal pocket, the histidine 
"thumb" rotates downward toward the heme trapping the ligand close to the reactive Fe 
center of the heme prosthetic group. Then a covalent bond is formed between the Fe and 
ligand, and finally a hydrogen bond is formed between the HisE7 and the bound ligand. 
Despite all the experimental evidence supporting ligand movement into Mb through this 
E7 pathway, most theoretical simulations suggest that multiple alternative routes are used 
more frequently (39). These theoretical simulations are further described in the 
introduction of Chapter 7. 
1.3 Focus of thesis research- In order to gain a greater understanding ofligand 
diffusion pathways in globins from subphyla other than Vertebrata, the dimeric 
hemoglobin from the mollusk Scapharca inaequivalvis (ScHbl) was first explored. ScHbi 
has been studied for many years, and Royer et al .. (40, 41) have suggested that the 
specific quaternary structure in this globin might hinder or block the E7 gate pathway. 
Secondly, I wanted to explore a globin whose tertiary structure suggested an alternate 
pathway through a putative apolar tunnel ( 42, 43). In this case, I chose the mini-
hemoglobin from a Nemertean sea worm, Cerebratulus lacteus (CerHb ). Our goal was to 
test whether or not these two invertebrate hemoglobins employ the E7 gate pathway for 
ligand diffusion. If not, then a rational mutagenesis study would be used in order to map 
any novel pathways. In the end, the comparison between the ligand diffusion pathways in 
these two invertebrate hemoglobins and in SwMb has yielded a more general 
understanding of ligand diffusion pathways for all globins and the selective pressures 
involved in the evolution of alternative pathways. 
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1.4 Structure of Scapharca inaequivalvis hemoglobin (ScHbl) - ScHbl is an 
invertebrate globin from the blood clam Scapharca inaequivalvis and has a distal pocket 
composition very similar to that of vertebrate hemoglobins, containing MetBIO, PheCDI, 
HisE7 and LeuE II (Fig. 1.5). This mollusk protein has an "inverted" dimeric quaternary 
structure compared to adult human hemoglobin A (HbA) and the E7 gate pathway in 
ScHbl appears to be blocked by the highly polar EF:FE dimer interface (40, 41) (Fig. 
1.6A). This dimer interface is a common characteristic ofmultimeric invertebrate globins 
with "normal" HisE7 containing active sites but with inverted quaternary structures 
compared to vertebrate Hbs ( 44, 45). ScHbl was selected not only for this unique 
structural arrangement, but also because an expression system had been established ( 46), 
multiple crystal structures had been determined (47, 48), and extensive kinetic studies 
had already been published for both wild type (wt) ScHbl and a few mutants (47, 49-51). 
In addition, ScHbl dimer can be locked into a completely R, high affinity state 
(51). In wt ScHbl, the F97 residue packs next to the proximal histidine hindering, the Fe 
from moving into the heme plane due to a more eclipsed heme Fe orientation (Fig. 1.7A). 
Upon ligand binding, F97 rotates towards the dimer interface disrupting a well-ordered 
cluster of water molecules, and the plane of the imidazole ring becomes more staggered 
in relation to the pyrrole nitrogen atoms, and, as a result, the Fe atom can readily move 
into the heme plane (Fig. 1.7B). These structural changes do not occur when Tyr is 
present at the 97(F4) position because the additional phenol hydroxyl 0 atom prevents 
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Figure 1.5. Distal pocket structure of Scapharca inaequivalvis oxyhemoglobin (PDB ID: lhbl). The 
globin backbone is represented by gray spheres and key active site residues, MetB 10, PheCD 1, LeuCD4, 
HisE7, and LeuE11, are depicted in sticks. The perspective of this representation is across the dimer 
interface. One subunit has been removed and part of the protein matrix has been slabbed away to provide 
an unhindered view of the active site. The protein structure was generated in MacPyMol. 
B. 
Figure 1.6. Quaternary structural representation of Scapharca inaequivalvis oxyhemoglobin (ScHbl) (PDB ID: lhbl) and human hemoglobin A 
(HbA) (PDB ID: 2dnl). A, Dimeric structure of ScHbi. B, Tetrameric structure of HbA. In each, the globin backbone is represented as gray helices 
while the heme prosthetic group, HisE7, and HisF8 are depicted as sticks. In ScHbi, the HisE7 gates open towards the dimer interface as illustrated by 
the cyan arrows. In HbA, the HisE7 gates open towards the solvent as depicted by the cyan arrows. The protein structures were generated in MacPymol. 
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WT T-state 
Eclipsed 
F97Y 
R-state 
B. 
D. 
WT R-state 
Staggered 
F97Y R-state 
Staggered 
Figure. 1.7. Heme Fe orientation and proximal His geometry ofT- and R-state ScHbl and F97Y ScHbl protein structure. A, In the 
unliganded or T- quaternary state, the plane of the imidazole ring is hindered from moving into the plane of the heme due to an eclipsed geometry 
(PDB ID: lnwi). B, In the liganded orR- quaternary state, the plane of the imidazole ring is readily available to move into the plane of the heme 
due to a more staggered geometry (PDB ID: lhbi). Thus, the reactivity of the Fe and the affinity for ligand increases in the R-state. C, Structural 
representation of the Phe97(F4)Tyr ScHbi mutant. The globin backbone is represented by gray cartoon, the heme group is designated by red sticks, 
the HisE7 residue by cyan sticks and the F97Y mutation by blue sticks. D, In the F97Y ScHbi mutant, the plane of the imidazole ring is readily 
available to move into the plane of the heme due to a constantly staggered geometry (PDB ID: 2aup). The protein structures were generated in 
MacPyMol. 
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the side chain from packing underneath the heme in the T, low affinity state, and the 
dimer is locked into the R state even when no ligands are bound (Fig. I. 7C). Thus, in the 
Tyr97(F4) mutant, the Fe is held in the more reactive, high affinity state, and, as a result, 
the route of entry in ScHbl can be focused on without having to analyze the complex 
kinetics associated with cooperative ligand binding. 
1.5 Structure ofCerebratulus lacteus mini-hemoglobin (CerHb)- In contrast to 
animal Hbs, the pathways for ligand binding in trHbs appear to be distinct from the E7 
gate found in most classic 3/3 a-helical globins (1 5, 52-54). These bacterial and plant 
Hbs display truncation of elements found in the classic globin fold, including almost 
complete loss of the A-helix, significant shortening ofthe CD-D helical region, and 
reduction of the F -helix to an extended polypeptide loop ( 12, 15, 54). The resulting 
tertiary structure has the appearance of a 2/2 a-helical fold (Fig. 1.1 C). The abbreviated 
CD-E region results in the pulling of theE-helix closer to the heme distal pocket, which 
may preclude the use of the E7 residue as a gate for ligand entry and exit. The crystal 
structures of M tuberculosis trHb (TrHbN and TrHbO) and other trHbs display the 
presence of a tunnel through the protein matrix between theE- and H- helices that is large 
enough for ligand diffusion to the heme distal pocket from external regions near the EF 
corner and the C-terminus ofthe protein (12, 16, 54-57). However, very little 
experimental work has been done to map these alternative pathways in trHbN (58) or 
trHbO (59). 
A very similar protein matrix tunnel is found in the neuronal mini-Hb of the 
Nemertean sea worm, Cerebratulus lacteus (Fig. 1.8A and B), which is the smallest 
A. 
CerHb 
side view 
C. 
SwMb 
side view 
CerHb 
back view 
D. 
SwMb 
back view 
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Figure 1.8. Structural representation of Cerebratulus lacteus mini-hemoglobin (PDB ID: lkr7) and 
sperm whale myoglobin (PDB ID: 2mgm) from side and back perspectives. A, CerHb side view. B, 
CerHb back view. C, SwMb side view. D, SwMb back view. In each panel, the globin backbone is, 
represented as gray cylinders, the heme prosthetic group by blue sticks and E7 and F8 residues as sticks. 
TheN-terminus is noted in each panel to emphasize the loss of the A-helix in CerHb. The protein structures 
were generated in MacPymol. 
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known globin with only 109 amino acids (42, 43, 60). Although CerHb is genetically 
distinct from the trHbs, it is also missing an A-helix and has marked shortening of the B-
and H-helices. CerHb also has a distal pocket very similar to some truncated, microbial, 
and invertebrate Hbs that have TyrBlO and GlnE7 in their active sites (42, 43). These two 
polar residues normally donate strong hydrogen bonds to bound ligands that typically 
cause an extremely high oxygen affinity ( 60, 61). However, CerHb contains a Thr at the 
E 11 position, and the Thr48(E 11) 13 hydroxy 1 0 atom pulls the TyrB I 0 phenol H atom 
away from the bound ligand. As a result, the non-bonding electrons on the TyrB 10 0 
atom point toward the bound ligand, and this negative electrostatic field decreases the 
oxygen affinity of wt CerHb almost 1,000-fold to a value, K02= 1.3 J!M-1, similar to 
vertebrate myoglobins (K02= 1.1 JlM-1) ((61, 62); See Chapter 4). As a result, this CerHb 
has a Mb-like Oz affinity and serves an Oz storage function in the axons and brains of the 
organism. Pesce et al. (62) suggested that the naturally occurring ThrEll in CerHb 
represents an example of convergent evolution from a high to low affinity hemoglobin to 
provide 0 2 delivery to brain and neuronal tissue. 
Despite its moderate oxygen affinity, CerHb displays very rapid rates of 
association (k'02= 240 J1M-1s-1) 3 and dissociation (k02= 180 s-1). These large rate 
constants seem surprising considering the crowded active site and multiple hydrogen 
bonding interactions that appear to "tie" down the amide side chain of GlnE7, which 
forms the E7 gate for CerHb. Bolognesi and coworkers (42, 53, 62) suggested that the 
large apolar channel created by the absence of anN-terminal A-helix and the reduction of 
the H-helix to 8 amino acids may be the pathway for ligand movement into the distal 
3 The term k'!i=d is used to describe the association rate constant of a ligand, which is defined in the 
subscript. Likewise, kligand refers to the dissociation rate constant. 
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pocket and account for the high rates of ligand binding and release. CerHb was selected 
for detailed study because of these unique properties, and because an efficient expression 
system had already been established ( 43), crystal structures had been determined (12, 42, 
60, 62), and initial kinetic studies ofwt and mutants had been published (62). 
1. 6 Thesis objectives - In this thesis work, ligand diffusion pathways were 
investigated in both ScHbi and CerHb. ScHbi represents a model for a 3/3 invertebrate 
globin with a putative E7 gate despite its inverted quaternary structure, while CerHb 
represents a model for a 2/2 invertebrate globin with an alternate, apolar tunnel pathway. 
In addition to determining if the apolar tunnel in CerHb serves as the ligand diffusion 
pathway, I also carried out a more detailed comparison map with SwMb by expanding 
the existing library of SwMb mutants to helical positions that are important in CerHb. 
This expansion allowed more specific comparisons between mutations in the pathways 
for ligand migration in both SwMb and CerHb. Our goals were to determine: (1) if the 
presence of His at E7 is an indicator of the E7 gate pathway in subphyla other than 
Vertebrata, despite variation in quaternary structure, and (2) ifthe TyrB10/GlnE7 motif is 
an indicator of a hindered E7 gate which led to the evolution of alternative pathways to 
maintain high rates of uptake and release. 
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Chapter 2: Materials and Methods 
2.1 Materials - All eDNA primers were purchased from Sigma-Aldrich (St. 
Louis, MO); Quikchange mutagenesis kits were purchased from Stratagene (La Jolla, 
CA); the QIAprep Spin Miniprep kits were purchased from QIAGEN (Valencia, CA); all 
XL1-Blue, BL21(DE3), and BL21(DE3)pLysS competent cells were purchased from 
Stratagene (La Jolla, CA). W311 0/aclq L8 ( 63) competent cells were a gift from the 
Royer group (U Mass Med Center). Isopropyl-1-thio-~-D-galactopyranoside (IPTG) was 
purchased from Gold BioTechnology, Inc. (St. Louis, MO); b---aminolevulinic acid (&-
ALA) was purchased from Sigma-Aldrich (St. Louis, MO); hemin was purchased from 
either Porphyrin Products (Logan, UT) or Sigma-Aldrich (St. Louis, MO); and cylinders 
of02, CO, and NO were purchased from Matheson Tri-gas (Parsippany, NJ) in ultra high 
purity form. 
2.2 ScHbl sample preparation -Wild type ScHbi was originally isolated as 
described in Chiancone et a/. ( 64) and the plasmids were expressed in E. coli 
W311 0/aclq L8 using the scheme to express recombinant wt ScHbi as described by 
Summerford eta/. (46). I am grateful for the wt, F97Y, and K30D plasmids, which I 
received from the Royer group upon initiation of this study (46, 49, 65). Further 
construction of recombinant mutant ScHbis at Rice University began using the 
QuickChange site-directed mutagenesis kit in one of three genetic backgrounds: WT, 
F97Y (high affinity or completely R-state), or K30D (monomeric). Recombinant 
expression plasmids containing the ScHbi genes were transformed into E. coli 
BL21 (DE3) or W311 0/aclq L8 cells. All cells were grown in Luria broth (LB; 10 g of 
tryptone, 5 g ofyeast extract, and 10 g ofNaCl per liter) containing 100 mg/mL 
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ampicillin. A 20 L Biostat C fermentor was used to express the cells in LB media 
containing 38 mM &-ALA. After 4-6 hours of growth at 37 °C, the cells were induced 
with IPTG, and the temperature was dropped to 28 oc for the remainder of the expression 
cycle. The fermentor regulated air, pH, and other growth conditions. After an expression 
period of approximately 15 hours, the cells were harvested by centrifugation and 
resuspended with lysis buffer (50 mM Tris, pH 8.0, 1 mM ethylenediaminetetraacetic 
acid (EDTA), 0.5 mM dithiothreitol (DTT), 100 mM NaCl, 5% glycerol, and 1 mM 
phenylmethanesulfonylfluoride (PMFS)). This modified protocol is based on the method 
reported by Summerford et al. ( 46). 
The harvested cell paste was lysed by three freeze thaw cycles, sonication, and 
passage through a cell breaker two times to disrupt all the cell membranes. MgCh, DNase 
I, and RNase A were then added to the liquefied cell paste, and cell debris was separated 
from the soluble proteins by centrifugation at 30,000 X g (14,000 rpm) for 30 minutes. 
The supernatant was subjected to two ammonium sulfate precipitations (45% and 95%). 
The protein in the second precipitate was resuspended and dialyzed overnight against 40 
mM 2-(N-cyclohexylamino)ethane sulfonic acid (CHES) buffer, pH 9.0. The isolated 
protein was then purified by anion exchange chromatography by a fast flow 
diethylaminoethyl cellulose (DEAE) column at pH 9.0. The purified protein was then 
concentrated and dialyzed overnight in 40 mM 4-(2-Hydroxyethyl)piperazine-1-
ethanesulfonic acid (HEPES), pH 7.0 and passed through a Carboxymethyl (CM) 
Sepharose size-exclusion column. The purity of the eluted protein by molecular weight 
was checked by SDS-PAGE, and the spectral characteristics ofwt ScHbl are shown in 
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Figure 2.1. Visible spectra for the recombinant Scapharca inaequivalvis Hbl (ScHbl) 
expressed and purified at Rice University. A, The soret peak for met-ScHbi, ScHbi-02, and 
ScHbi-CO are located at 413 nm, 417, and 421 nm, respectively. B, the a and ~ bands of each 
protein are labeled accordingly. The absorbance change of each spectrum has been normalized. 
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Figure 2.2. Visible spectra for the recombinant Cerebratulus lacteus Hb (CerHb) expressed 
and purified at Rice University. A, The soret peak for met-CerHb, CerHb-02, and CerHb-CO are 
located at 406 run, 413 , and 419 nm, respectively. B, the a and~ bands of each protein are labeled 
accordingly. The absorbance change of each spectrum has been normalized. 
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Fig. 2.1. All of the above procedures were conducted using buffers equilibrated with 1 
atm CO in order to maintain the stability of the protein. The final purified ScHbl was 
concentrated to 1 mM, flash frozen, and stored in liquid nitrogen. 
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Most of the purified recombinant ScHbiCO samples were used directly. All 
experiments were carried out in 0.1 M phosphate buffer, pH 7.0, 1.0 mM EDTA, 20 °C. 
When necessary, ScHbi02 protein samples were prepared by equilibration with 1 atm 0 2 
under an intense light to remove the bound CO. When necessary, the unstable mutants 
were pre-reduced with dithionite and then quickly passed through a G25 column, and 
eluted with buffer equilibrated with 1 atm of CO. As noted below, 0 2 binding kinetics 
were often measured in samples containing mixtures of CO and 0 2. For those 
experiments, the starting ScHbl sample was in the reduced CO form, which is extremely 
stable. 
2.3 CerHb sample preparation -Wild type and mutant recombinant CerHb 
cDNAs were constructed as described previously by the Moen and Dewilde group at the 
University of Antwerp, using a synthetic gene with codon usage optimized for expression 
in E. coli ( 66-68). Mutants of wt CerHb were then constructed using a QuickChange 
mutagenesis kit to create a large library of variants. Expression plasmids were 
transformed into the E. coli BL21(DE3)pLysS expression strain. All cells were grown in 
terrific broth (TB) (12 g oftryptone, 24 g of yeast extract, 1 mL glycerol, 2.3 g KH2P04, 
and 12.5 g K2HP04 per liter) containing 34 J.tg/mL chloramphenicol, 100 J.tg/mL 
ampicillin, and 1 mM ~-ALA. Four IL cultures were induced with 0.5 mM IPTG, 
expressed overnight at 28 °C, and pelleted by centrifugation at 4 °C. Pellets were 
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resuspended in lysis buffer (0.05 M Tris-HCl, pH 8.0, 1 mM EDTA, pH 8.0, 5 mM DTT) 
and passed through 3 freeze-thaw cycles ( 67). 
Purification began with sonication of the total cell lysate and was followed by two 
ammonium sulfate precipitations ( 40% and 90% ). The protein was isolated in the last 
precipitate and was resuspended in and dialyzed against 15 mM Tris-HCl, pH 8.5. The 
resultant sample was passed through a fast flow DEAE column at low ionic strength and 
then CerHb was eluted with NaCI. The purified CerHbs were then further purified by 1 or 
2 passages through a Sephac:ryl S200 column (67). The purity of the eluted protein was 
checked by SDS-PAGE, and spectral characterization ofwt CerHb is shown in Fig. 2.2. 
The final purified CerHb was concentrated to 1 mM and stored in liquid nitrogen. 
Recombinant CerHb samples were isolated in the reduced oxygenated state and 
used directly. All experiments were carried out in 0.1 M phosphate buffer, pH 7.0, 1.0 
mM EDTA, 20 °C. CerHbCO and CerHb02 protein samples were prepared by 
equilibration with 1 atm CO and 1 atm 0 2, respectively. When necessary, the unstable 
mutants were pre-reduced with dithionite and then quickly passed through a G25 column, 
and eluted with buffer equilibrated with 1 atm of CO. As noted below, 0 2 binding 
kinetics were often measured in samples containing mixtures of CO and 0 2• For those 
experiments, the starting CerHb sample was in the reduced CO form to prevent 
autooxidation. 
2.4 SwMb sample preparation- The wild type SwMb gene (in pMb413) was 
originally constructed as described in Springer and Sligar ( 69). Wt SwMb was then 
altered using a QuickChange site-directed mutagenesis kit to create a number of new 
single amino acid mutations. Recombinant expression plasmids were transformed into the 
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E. coli BL21(DE3) expression strain. All cells were grown in LB containing 200 mg!L 
ampicillin. A 14 L LB culture containing 100-200 J.tM FeS04 was expressed overnight at 
37 oc with 50%02 tension at pH 7.0. 700 mL of20% glucose was added throughout the 
expression cycle. The cells were pelleted by centrifugation at 4 °C, and the paste was 
frozen and stored at -20 oc ( 69, 70). 
Purification began with lysis of the total cell paste by the addition oflysis buffer 
(0.5 mM DTT, 1 mM toluene sulfonyl chloride, 40 U/ml DNAse I, 3 U/ml RNAse A, 2 
mg/mllysozyme at pH 6.0), and then incubation overnight at 4 °C. The lysis suspension 
was pelleted by centrifugation, and subjected to two ammonium sulfate cuts (50% and 
90%). The last pellet was resuspended in and dialyzed against high pH buffer (20 mM 
Tris, 1 mM EDTA, pH 8.0) overnight and passed through an anion exchange column, 
DEAE 52. The pH was then lowered to 6.0 with 50% acetic acid and the protein was 
passed over a CM Sepharose size-exclusion column {20 mM NaPi, pH 6.0) and eluted 
with a pH gradient from 6.0 to 9.5 (69, 70). The purity of the eluted protein was checked 
by SDS-PAGE. Final purified SwMb was concentrated to 1 mM and stored in liquid 
nitrogen. 
Recombinant SwMb samples were isolated in the reduced CO bound state and 
used directly. All experiments were carried out in 0.1 M phosphate buffer, pH 7.0, 1.0 
mM EDTA, 20 °C. SwMbCO and SwMb02 protein samples were prepared by 
equilibration with 1 atm CO and 1 atm 0 2, respectively. Again, 02 binding kinetics were 
often measured in samples containing mixtures of CO and 02. 
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2.5 Measurement of overall rates of ligand association and dissociation - CO 
association time courses were measured after complete laser photolysis of 50 J.lM 
CerHbCO, MbCO, and ScHbiCO samples containing various free [CO] under pseudo 
first order conditions. A~ 500-ns excitation pulse from a Phase-R model2IOOB dye laser 
was used (71, 72) and transmittance changes were recorded with a Tektronix TDS220 
digitizing oscilloscope. In most cases, the time courses were fitted to a simple 
exponential expression, and k'co was calculated as kobsi[CO] or from the slope of plots of 
kobs versus [CO]. 
0 2 association and dissociation time courses were determined after complete laser 
photolysis of 50 J.lM Hb or Mb samples in mixtures of 02 and CO using the 500-ns dye 
laser (71, 73-75). In these reactions, various HbCO and MbCO samples are prepared in 
buffer containing~ 50 J.lM CO and 1250 J.lM 0 2,750 J.lM CO and 250 J.lM 02,500 J.lM 
CO and 500 J.lM 0 2, and 250 J.lM CO and 750 J.lM 02. The laser pulse photolyzes the 
Fe(II)CO complex, generating deoxyHb or deoxyMb, which can then rapidly react with 
either ligand. The initial rapid bimolecular rebinding phase is monitored by a large 
decrease in absorbance of the unliganded Hb or Mb at 436 nm, which is dominated by 02 
rebinding because of its larger association rate constant (Fig. 2.3). The pseudo first order 
rate for this fast phase, kfast, is given by: 
kfast = k~2[02 ] + k02 + k~0 [CO] (Eq. 2.1) 
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Figure 2.3. Overall ligand binding fast phase time course of CerHb A55W in a 75% CO/ 25% 0 2 
mixture. The laser excitation pulse photodissociates bound CO causing an almost instantaneous increase in 
absorbance to form deoxyHb. This rapid increase is followed by a decrease in absorbance at 436 run, which 
tracks the fast bimolecular binding of 0 2 to the deoxygenated Hb sample. 
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In this fast phase, CO dissociation can be neglected because the absolute value of kco is 
on the order of 0.01 s·1, whereas under the conditions of the laser experiments, kfast is on 
the order of 10,000 to 300,000 s·1• In most cases, the 0 2 dissociation rates, k02, for the wt 
and mutant Hb02 samples of all three proteins (0.2 to -10,000 s·1) also make only a small 
contribution to the observed rate coefficients in the fast phase but were considered in the 
analysis. 
The slow phase observed after photolysis of HbCO or MbCO in mixtures of CO 
and 02 represents displacement of the transiently bound 0 2 by CO, which, although 
kinetically less reactive, has a higher affinity for the heme Fe atom (71, 73-75). The time 
course for this replacement reaction is best monitored by the large increase in absorbance 
ofHbCO or MbCO at 425 nm (Fig. 2.4). The rate of this slower process, ks1ow, is given 
by: 
(Eq. 2.2) 
An iterative, non-linear, least squares fitting routine (Solver in Microsoft Excel) 
was used to optimize the values ofk'02, k02, and k'co to give the best fit to the kfast and 
ksiow values at the different [02]/[CO] ratios including conditions where [02] = 0, and 
where [CO]~ 0 (71). In previous work, it has been shown that this method ofusing 
photolysis and 0 2/CO mixtures gives results identical to those obtained in more 
conventional rapid mixing and photolysis experiments, and eliminates problems due to 
autooxidation ofunstable mutants and low Hb02 quantum yields (73-75). 
In the case of ScHbi samples, partial photolysis time courses were also measured 
at 436 nm to measure the binding of the second ligand molecule to Hb2X dimeric 
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Figure 2.4. Slow 0 2 displacement time course of CerHb A55W in a 75o/o CO/ 25% 0 2 mixture. 
Following photolysis and rapid binding of 0 2 to the deoxygenated sample (a small absorbance decrease at 
425 run), transiently bound 0 2 is displaced by CO causing a slow absorbance increase at 425 run. 
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intermediates. In partial photolysis experiments, the intensity of the exciting light was 
reduced so that only 10 % of the bound ligands were photolyzed. As a result, the Hb2X 
molecules partially switch to the more relaxed, R-state containing one bound ligand, but 
unfortunately the observed k'02, k02, and k'co rate constants still contained a significant 
contribution from the T state. Thus in most cases the full and partial photolysis time 
courses showed similar bimolecular rate constants (see Chapter 3). Again, rate constants 
for 02 and CO binding to ScHbl were obtained by fitting the krast and kslow values to the 
expressions in Equations 2.1 and 2.2 as was done for CerHb. 
The association rate constants for NO binding to deoxy-Hb or deoxy-Mb were 
measured using a flow-flash multi-mixing apparatus and the 500 ns dye laser. An 
anaerobic sample ofHbCO or MbCO containing little or no free ligand was mixed with 
3/4, 1/2, 1/4, and 1/10 atm NO (1500, 1000, 500, and 200 JlM, respectively). Immediately 
after mixing, the HbCO or MbCO complex was photolyzed, and the complete absorbance 
change for NO binding to the newly generated deoxyHb or deoxyMb was followed at 436 
nm. This approach avoids the difficulty of photolyzing the Fe(II)NO complexes, which 
have an extremely small quantum yield. The observed rate is equal to k'No[NO] + 
k'co[CO]. Since both k'co and [CO] << k'No and [NO], respectively, this equation reduces 
to kobs ~ k'No[NO]. The value ofk'No was determined from the slope ofkobs versus [NO]. 
CO dissociation time courses were determined by stopped-flow analysis in which 
the heme bound CO was displaced by a high concentration of the higher affinity NO 
ligand. In these experiments, 5-10 JlM HbCO or MbCO was mixed with 1 atm NO (2000 
JlM) and the decrease in [HbCO] or [MbCO] was monitored as an absorbance decrease at 
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420 run (72, 76). Under these conditions, the observed first order rate constant is directly 
equal to kco because k'No[NO] >>k'co[CO]. 
2.6 Measurement of rates of geminate recombination- Time courses for internal 
ligand rebinding (geminate recombination 4) from within the Hbs and Mbs were measured 
at 436 run after excitation with a 9-ns excitation pulse from a Lumonics Y A G-laser 
system. Transmittance changes were recorded on a Tektronix TDS3052 digitizing 
oscilloscope on nanosecond time scales. The geminate rebinding time courses were fitted 
to one or two exponential expressions with an offset reflecting the amount of escape to 
solvent and the fitted exponent equals the rate of geminate recombination, kgem (Fig. 
2.5;(36)). For a simple exponential internal rebinding process, the fraction of geminate 
recombination, Fgem, was calculated as Fgem= (AAgem/AAgem+YO), where AAgem represents 
the absorbance change associated with internal geminate rebinding (one or two phases). 
The offset, YO, is the difference between the absorbance after complete geminate 
recombination and the absorbance of the original ground state, which is observed either 
prior to photolysis or at long times after bimolecular rebinding from solvent is complete 
(i.e. fully liganded HbCO or Hb02) (Fig. 2.5). 
2. 7 Fourier Transform Infrared (FTIR) spectroscopy- Wild type and mutant 
HbCO or MbCO samples were exchanged into 100 mM KPi, pH 7.0 buffer and 
concentrated to ~ 1 mM. 20 ~L protein and 200 mM sodium dithionite were added to a 
CO purged Eppendorftube, vortexed, and allowed to equilibrate for;:::: 20 minutes. Each 
20 ~L protein sample was loaded into a BioCell fit with two dry CaF2 windows. The 
4 Geminate recombination refers to the intramolecular rebinding of a ligand to the heme following 
photodissociation, but not dissociation from the protein. 
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spectra were collected using a Nicolet spectrometer with an MCT detector (purged with 
nitrogen 
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Figure 2.5. Geminate recombination time course of CerHb A55W-CO. Following the 9-ns excitation 
pulse, a decrease in absorbance is observed at 436 run. In this example, the amplitude of geminate 
recombination is 0.209 and the offset is 0.261. Therefore, Fgem is 0.44 (Fgem = AI A+ YO). The exponent, K2, 
is equal to kgem· 
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2:: 18 hours) and OMNIC software. The protein spectrum was collected between 1800 and 
2400 cm-1 and subtracted from a background buffer spectrum containing water vapor 
peaks. Fig. 2.6 displays the spectra generated by the OMNIC software. The process of 
baseline correction and peak identification was achieved with a program written by 
George Blouin in Microsoft Excel (77). In this program, data between 1900 and 2300 
cm-1 are used to establish a baseline, and peak integration is achieved to identifY major 
and minor C-0 stretching frequencies. Fig. 2.6 provides an example of original corrected 
spectra generated by this program. Expanded and normalized spectra are given in Fig. 3.3 
in Chapter 3. Additional background on FTIR is given in Chapter 4. 
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Figure 2.6 FTIR Spectra of heme-bound CO generated with an MCT detector and OMNIC software. 
The colored lines represent IR absorption spectra (raw data) collected using a Nicolet spectrometer with an 
MCT detector (purged with nitrogen:::=: 18 hours) and OMNIC software. The CO heme-protein spectra are 
collected between 1800 and 2400 cm·1 and subtracted from a background buffer spectrum containing water 
vapor peaks. Final normalized spectra can be found in Fig. 3.3 in Chapter 3. 
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Chapter 3: Studies of 02 and CO Binding to Scapharca inaequivalvis Hb (ScHbl): 
Implications for Quaternary Structure 
3.1 Introduction -The overall bimolecular rate at which a small molecule such as 
CO, 02 or NO reacts with the Fe of the heme prosthetic group in a globin is governed by 
the rates at which the ligand enters the protein matrix, moves to the active site, and forms 
a bond with the heme Fe atom. Thus, it is important to determine the route of ligand 
migration and the hindrances placed along this pathway. Recently, the ligand diffusion 
pathways in SwMb and HbA have been examined in detail and, even though changes in 
quaternary structure do occur upon binding in human hemoglobin, the gated HisE7 
pathway first determined for Mb also occurs in both subunits oftetrameric Hb (36, 73, 
78, 79). 
In human HbA, intersubunit contacts are located far away from the solvent 
exposed edge of the heme group and do not provide any impediment to the outward and 
upward movement of the distal histidine side chain (Fig. 1.6B). Thus, dissociation of the 
HbA tetramer into dimers does not affect the accessibility of the E7 channel to solvent in 
the a and j3 subunits because the heme propionates and the distal histidine are located far 
away from either subunit interface. In contrast, many invertebrate hemoglobins, which 
also cooperatively bind 0 2, have a dimeric structure in which the heme propionates are 
part of the intersubunit contact, and the HisE7 gates appear to be partially blocked by this 
interface. The best studied example is the dimeric Hbi from the blood clam, Scapharca 
inaequivalvis ( 44, 45). In this structure, the intersubunit contacts occur between residues 
on theE- and F-helices creating an EF:FE dimer interface. This interface appears to have 
evolved to allow cooperativity in a simple dimer by a direct steric interconnection 
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between the proximal regions of the heme groups (51). The interface between the ScHbi 
subunits is inverted with respect to the alpha I beta I interface in HbA, which involves the 
G and H helices of both subunits. In adition, the EF:EF interface appears to close the E7 
gate pathway in which outward movement of the HisE7 side chains would be directed 
into the dimer interface (Figs. 1.6A, 1.7C, 3.1). As a result, this EF:FE dimer interface 
could potentially inhibit ligand migration through the HisE7 gates. 
Thus, the inverted dimeric hemoglobin I from Scapharca inaequivalvis (ScHbi) 
was chosen as a model for studying a 'closed' E7 gate pathway. However, one key 
problem is that ligand binding to wt ScHbi is highly cooperative and exists in two 
conformations, designated R for high 0 2 affinity and T for low affinity. This situation 
complicates kinetic analyses. For example, after complete photolysis, the ScHbi relaxes 
to the T state in which binding is slower for the first bimolecular association rate constant 
(i.e. ~ + X - Hb2X), whereas CO displacement from the fully oxygenated complex 
represents ligand dissociation for the fully saturated normally, R state conformation (i.e. 
Hb2X2 - Hb2X + X). Even after ~ 10-15 % partial photolysis to ensure that only Hb2X 
molecules are rebinding ligands, the fraction ofR state conformers is small. Thus, in our 
initial screen of ScHbi His69(E7) variants, the association rate constants represent ligand 
binding toT-like conformations and the dissociation rate constants represent more R-like 
conformations. In addition, the apparent equilibrium association or affinity constants, 
defined experimentally as k'oik02, represent hybrid values between the affinities for the 
R and T states. Thus, it is possible that distal histidine mutations could affect both the 
quaternary transition and the pathway for ligand binding, resulting in complex changes in 
the observed rate constants. Despite these complications, the initial screen of the 
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Figure 3.1. Structure of Scapharca inaequivalvis hemoglobin indicating the K30:D89 salt bridge and 
Xe binding sites (PDB ID: 3g46). The K30 and D89 residues (blue sticks) form a key salt bridge in the 
dimeric ScHbl. The K30D mutation places two negatively charged amino acids, D30 and D89, next to each 
other, and the charge repulsion causes dissociation into identical monomers. Xe binding sites are 
designated as green spheres, HisE7 and the heme group are designated as sticks colored by element, and the 
carbon backbone by gray cartoon. The protein structure was generated in MacPyMol. 
His69(E7) mutants still provides key insights into the role of the E7 gate in regulating 
ligand binding. 
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However, to avoid the complications due to alternative quaternary conformations, 
distal histidine mutations in the ScHbi variant with the Phe97(F4)-Tyr mutation were 
also examined. Normally, PheF4 packs under the heme pocket in T state deoxy ScHbi 
dimers, and reduces ligand affinity by inhibiting in-plane movement of the heme Fe atom 
(Figs. 1.7C and 3.2; (51)). Insertion ofthe "extra" hydroxyl group in Tyr97 prevents this 
packing, and the F4 phenol side chain moves out into the dimer interface, locking the 
protein in the high affinity, R quaternary state. Thus, when additional mutations are made 
in the F97Y background, any observed effects are due to changes in the restrictions along 
the ligand migration pathway in the R state and not changes in the quaternary R to T 
transition. 
Despite the dimer interface, the HisE7 gate appeared to us to be the most 
plausible ligand migration pathway in ScHbi. However, as in other globins, molecular 
dynamics (MD) simulations suggest that ligands diffuse away from the heme Fe toward a 
space defined by residues Ile114, Proll7, Ilell8 and Trp135 and then escape from the 
protein by multiple routes which do not include the HisE7 gate because of the dimer 
interface (80). Recently, Knapp et al. (81) carried out experiments in the presence of high 
pressures ofXe gas and showed, by crystallography, that the noble gas occupies some of 
the cavities suggested by the MD simulations (Fig. 3.1 ). However, there was little or no 
effect of high pressures ofXe on ligand binding, suggesting that although internal 
cavities are able to accommodate Xe, their presence does not affect ligand migration into 
and out of the active site. 
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Figure 3.2. Dimer interface structure of Scapharca inaequivalvis oxyhemoglobin (PDB ID: lhbn. The 
globin backbone of one subunit is represented by yellow spheres and the other subunit by gray cartoon. 
The key active site residues, MetBlO, PheCDl , ArgCD3 , HisE7, and LeuEll , are depicted in sticks, and 
are labeled for the yellow subunit. The Phe97 residue for the yellow subunit is designated by cyan sticks. 
The perspective of this representation is across the dimer interface where the heme group of the gray 
subunit is also depicted in sticks. The protein structure was generated in MacPyMol. 
To resolve this discrepancy between MD simulations and the Xe-binding 
experiments and to explore the E7 channel, the distal histidine in ScHbi was mutated 
systematically to small, intermediate, and large apolar amino acids. These same HisE7 
mutations were also constructed in the Phe97(F4)~Tyr genetic background to ensure 
examination of only the R quaternary structure. Then, as a further control, the 
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Lys30~ Asp mutation was also made. This replacement has been shown previously to 
disrupt the dimer interface causing the formation of monomeric ScHbi (Fig. 3.1;(49)). 
For each series of variants, overall 0 2 and CO binding parameters were measured using 
flash photolysis and rapid-mixing techniques. 
3.2 Effects of E7 mutations on FTIR spectra - When HisE7 is replaced by an 
apolar amino acid, there is a shift in Vc-o from 1945 cm-1 in wt ScHbi to~ 1970 cm-1 in 
the Ala, Val, Leu, and PheE7 series (Fig. 3.3, Table 3.1). As discussed further in Section 
4.2, there is an inverse relationship between Vc-o and the electrostatic field surrounding 
the bound ligand. Therefore, the shift of~ 30 cm-1 to a higher frequency correlates with a 
loss of favorable hydrogen bond donation to the bound ligand. When HisE7 is mutated to 
Gln, a minimal increase in vc-o (~ 5 cm-1) is observed as the amide NH2 atoms of the Gin 
side chain can still donate a hydrogen bond to the bound ligand. When HisE7 is mutated 
to Trp, two Vc-o peaks are observed. In this case, the indole side chain appears to have 
two orientations, a major one with hydrogen bond donation to the bound ligand (low 
frequency peak) and one with an apolar active site. Two peaks were also reported for 
TrpE7 SwMbCO ( 82) but only one apolar peak is observed for the TrpE7 mutants of a 
and 13 HbA subunits (73). 
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Figure 3.3. FTIR spectra ofwt, F97Y, and E7 mutants of ScHbl. These spectra were generated with an 
MCT detector and OMNIC software followed by baseline correction and peak integration. Wt ScHbl and 
F97Y ScHbl (dashed) display Vc.o peaks at~ 1945 cm·1• HisE7 mutations are notated on the right y-axis. As 
the peak frequency increases from 1945 cm·1 to ~1975 cm·1, there is a decrease in hydrogen bond donors 
surrounding the bound CO (Chapter 4). 
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Table 3.1. Rate and equilibrium constants for 0 2 and CO binding and FTIR stretching frequencies to 
A, J:!OSition His69(E!} mutants of ScBbl at 2B 7.0, 20° C. 
WT k'02 ko2 Ko2 k'co kco Kco Background vc-o J!M-1s-1 s-1 J!M-1 J!M-1s-1 s-1 JJ,M-1 cm-1 
Mutants 
Gly69 110 1600 0.017 16 0.060 270 1968 
Ala69 63 1900 0.033 13 0.068 190 1969 
Val69 73 5300 0.014 27 0.025 1100 1974 
Leu69 85 3600 0.024 23 0.017 1350 1972 
His69(E7) 14 130 0.111 0.15 0.005 30 1945 
WT 0.24 48 
Gln69 27 2200 0.012 0.97 0.019 50 1952 
Phe69 33 32000 0.001 1.6 0.062 26 1972 
Trp69 8 210 0.038 1 0.018 56 1947, 
1972 
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Figure 3.4. Time courses for 0 2 binding to wt and HisE7 mutants of ScHbl at pH 7, 20 °C. A, bimolecular 0 2 rebinding measured at 436 nm after photolysis 
of 50 11M ScHbl at -1250 11M 0 2 and B, Slow 0 2 displacement phase measured at 425 nm after photolysis of a mixture of 50 11M ScHbiCO, -500 11M CO and 
-500 11M Oz. 
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A hydrogen bond between the pyrrole NH atoms of the indole ring in TrpE7 and 
the bound ligand in ScHbiCO could account for the vc-o peak at 1947 em-\ but it is also 
possible that a water molecule donates a proton when the indole side chain is in a 
conformation that just blocks but does not enter the E7 channel. The second vc-o peak for 
TrpE7 at 1972 cm-1 suggests that the phenyl portion of the indole side chain is directed 
toward the bound ligand maintaining an apolar active site (Table 3.1 ). Such an orientation 
is observed in the Trp64(E7) SwMbCO crystal structure (PDB ID: 3NML; (78)). 
Unfortunately, a crystal structure ofTrpE7 ScHbl was not determined so these 
interpretations are speculative. 
3.3 Effects of E7 mutations on rates of ligand binding to wt ScHbl- When 
HisE7 is replaced by a small apolar amino acid such as Gly, Ala, Val, or Leu, a 4- 8-fold 
increase in the bimolecular rate constant for 0 2 association occurs (k' 02= 63-110 J..LM-1s-1 
versus k'02 = 14 J..LM-1s-1 for wt ScHbl, Table 3.1). Large increases ink' 02 are most 
readily attributed to a decrease in the energy barrier to ligand entry resulting from 
replacement of the large imidazole gate with smaller amino acids leaving the E7 channel 
open. In addition, when an apolar amino acid replaces HisE7, distal pocket water is no 
longer present in the deoxy form and there is no requirement for its displacement prior to 
ligand binding (KH2o; Fig. 1.4). Both effects will increase the rate constant for 
bimolecular 02 binding. The importance of the loss of distal pocket water is illustrated by 
the larger k' 02 for the PheE7 variant, 33 J..LM-1s-1 versus 14 J..LM-1s-1 for wt ScHbl, where 
the imidazole side chain in deoxy wt hydrogen bonds to an internal water molecule thus 
offering more resistance to 02 binding than the larger benzyl side chain which has no 
water attached (Table 3.1). 
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The dependence ofthe 02 association rate constant on the size of the E7 amino 
acid is best examined using apolar mutations in the active site to avoid complications of 
water binding all together; in this case, any effect is due to steric hindrance alone. The 
value ofk'02 for ScHbl decreases -14-fold from 110 JlM-1s-1 to- 8 JlM-1s-1 for the series 
Gly, Ala, Val, Leu, Phe, and TrpE7 (Table 3.1, Fig. 3.4). The large, but invariant 
association rate constant for the Ala, Val, Leu series was verified by examining the 
GlyE7 mutant. Further decreasing the size of the amino acid to Gly resulted in only a 
20% increase in k'02. The same general increase ink' 02 with decreasing size at the E7 
position is observed for a and~ chains ofHbA and Mb, supporting the view that the E7 
gate pathway occurs in all four proteins (Table 3.2, (73)). 
Upon replacement of the native HisE7 hydrogen bond donor with an apolar amino 
acid, the 02 dissociation rate constant also increases due to loss of stabilization of the 
bound ligand (i.e. Kstabilzation in Fig. 1.4 decreases to 0; Table 3.1). When comparing ko2 
between the largest and smallest apolar replacements, there is an- 20-fold decrease from 
-4000 s-1 for GlyE7 and AlaE7 to 200 s-1 in TrpE7 (Table 3.1). However, for this 
parameter, the dependence on size is complex and probably does not correlate directly 
with rates ofligand migration out of the protein. For example, replacement ofHisE7 with 
Phe produces a dramatic increase in the 0 2 dissociation rate constant to 32,000 s-1, which 
is 10-fold higher than any of the other apolar mutants. Birukou eta/. (73) observed a 
similar effect for PheE7 in the a and ~ subunits of HbA. In all three cases, ko2 for the 
PheE7 mutant is much greater than either AlaE7 or TrpE7 (Tables 3.1 and 3.2). The 
markedly high dissociation rate constant for PheE7 variants suggest that the benzyl side 
chain is driven into the distal pocket by a strong hydrophobic effect and sterically hinders 
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Table 3.2. Rate constants for bimolecular 0 2 binding in isolated, monomeric a and p chain mutants 
at position HisE7 in HbA at pH 7.0, 20° C. Data taken from Birukou et al. (73). 
Subunit k'02 ko2 Ko2 Subunit k'02 ko2 Ko2 M-1 -1 s-1 M-1 M-1 -1 s-1 /;!M-1 !:! s !:! !:! s 
a Gly(E7) 250 540 0.45 ~ Gly(E7) 160 680 0.24 
a Ala(E7) 160 880 0.18 ~ Ala(E7) 120 860 0.14 
a Leu(E7) 91 450 0.2 ~ Leu(E7) 110 4600 0.18 
(40%) 
630 
(60%) 
a HisWT 40 16 2.5 ~ HisWT 52 14 3.7 
aPhe(E7) 51 9800 0.0052 ~ Phe(E7) 25 2400 0.01 
a Trp(E7) 0.5 450 0.47 ~ Trp(E7) 1.7 190 0.009 
the bound ligand, causing an increase in the rate of thermal bond disruption (k..bond for 
step 3 in Fig. 1.4). 
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In contrast to PheE7, the TrpE7 indole ring is almost certainly too big to enter the 
distal pocket when a ligand is bound and thus probably does not affect the initial ligand 
dissociation step. However, the TrpE7 indole ring can still occupy a conformation in 
which it blocks the route of ligand escape following photolysis. This latter interpretation 
is supported by the decrease in ko2 from~ 4000 s-1 in the Gly, Ala, Val, LeuE7 series to 
200 s-1 in TrpE7 (Table 3.1). This idea is supported by crystal structures ofTrpE7 f3CO 
HbA and TrpE7 MbCO, where the indole side chain is found outside of the distal pocket 
but blocking the E7 channel ( 83). 
3.4 Effects of E7 mutations on rates of ligand binding to F97Y ScHbl- Analysis 
of the kinetic properties of ScHbl variants is complicated by the R to T allosteric 
transition, which makes it difficult to compare effects of mutations on ligand entry versus 
changes in quaternary structure. To verify the trends observed for mutants in the wt 
background, the same HisE7 substitutions were constructed in the R-state (F97Y) genetic 
background. 
As mentioned in Sections 1.5 and 3.1, the larger Tyr97 side chain cannot be 
accommodated under the heme pocket next to the proximal histidine and is oriented 
outward toward the dimer interface (Fig. 3.2). As a result, the coordinated HisF8 side 
chain can adopt a staggered orientation with respect to the pyrrole N atoms of the heme 
ring, allowing more rapid in-plane movement of the Fe atom during ligand binding (Fig. 
1.7D; (51)). In globins with an eclipsed orientation of the proximal imidazole ring such as 
SwMb (61), the iron atom is much less reactive because ofthe steric hindrance to in-
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plane movement of the iron atom during ligand binding. Thus, the Fe atom in the F97Y 
ScHbl mutant is more reactive and its 02 affinity is 40- 160-fold higher than in wt ScHbl. 
Since the dimer is locked in the high affinity R state, cooperative ligand binding is 
eliminated (51). 
In our control experiments with the single F97Y mutant containing the native 
HisE7 side chain, two 02 and CO association and dissociation rates were observed. 
However, in all cases ligand binding is still very rapid, and the affinities are higher than 
wt ScHbl. When the distal histidine is mutated within the F97Y genetic background, this 
kinetic heterogeneity is relieved and simple monophasic time courses for ligand binding 
and dissociation are observed. For example, upon replacement of His by Val, k' 02 
increases 2-fold and ko2 increases 30-fold, and only single phases are observed (Fig. 3.5, 
Table 3.3). The key observation among the HisE7 mutations in the F97Y background is 
that, as in wt ScHbl, small apolar E7 mutations result in significant increases in k' o2 from 
-40 J.1M-1s-1 in F97Y to 93 J.1M-1s-1 in F97Y/AlaE7 (Table 3.3). When large apolar 
mutations are constructed as in F97Y/TrpE7, k' o2 decreases- 6-fold from 93 J.1M-1s-1 in 
F97Y/AlaE7 to 15 J.1M-1s-1 in F97Y/TrpE7 (Fig. 3.5). The inverse correlation between the 
size of the E7 amino acid and the bimolecular rate constant for 02 still holds, verifying 
the results for the mutants in the wt background and supporting the E7 channel as the 
major pathway for ligand entry. 
Dramatic increases in ko2 also occur when HisE7 is replaced with apolar amino 
acids, and, again, the largest value ofk02 is observed for the HisE7-+Phe replacement 
(3500 s-1 for F97Y/PheE7) in comparison to both F97Y (12 s-1) and the mutants 
containing small apolar amino acids(- 275 s-1). Again, this marked increase in ko2 for the 
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Table 3.3. Rate and equilibrium constants for 0 2 and CO binding to position His69(E7) mutants in 
the R-state background of ScHbl at pH 7.0, 20° C. 
R-State (97Y) k'02 ko2 Ko2 k'co kco Kco Vc-o Background J..LM-Is-1 s-1 J..LM-1 J..LM-1s-I s-1 J..LM-1 cm-1 
Mutants 
Ala69 93 125 0.74 33 0.004 8,300 
Val69 92 390 0.24 42 0.003 14,000 1974 
His69(E7) 45 12 3.75 2 0.005 330 97Y 33 2 16.5 15 0.001 1,200 1945 
Gln69 66 63 1.05 20 0.003 6,700 1954 
Phe69 56 3500 0.02 11 0.027 400 1970 0.0001 110,000 
Trp69 15 57 0.26 2.4 0.007 340 
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Figure 3.5. Time courses for 0 1 binding to 97Y/HisE7 mutants of ScHbl at pH 7.0, 20° C. 
Bimolecular 0 2 rebinding measured at 436 nm after photolysis of 50 j.IM ScHbiCO at - 500 j.IM Oz 
and - 500 !lM CO. 
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Table 3.4. Rate and equilibrium constants for 0 2 and CO binding to position His69(E7) mutants in 
the monomeric background of ScHbl at eH 7.0, 20° C. 
ScHbl k'02 koz Koz k'co kco Kco vc-o J.1M-1s-1 s-1 J.lM-1 J.1M-1s-1 s-1 J.lM-1 cm-1 
WT 14 130 0.111 0.15 0.005 30 1945 
0.24 48 
Trp69 8 210 0.038 1.0 0.018 56 
F97Y 45 12 3.75 2.0 0.005 330 1945 
33 2 16.5 15 0.001 1,200 
F97Y/Trp69 15 57 0.26 2.4 0.007 340 
K30D 43 110 0.41 1.0 0.007 140 1945 
K30D/Trp69 13 747 0.02 0.79 0.019 42 
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F97Y /PheE7 double mutant is almost certainly due to direct steric hindrance of the bound 
ligand. 
3.5 Kinetics of ligand binding to K30D ScHbl- The results described in the 
previous sections suggest strongly that the HisE7 residue still functions as a gate for 
ligand migration in the dimeric ScHbi, despite the presence of the polar interface near the 
N-terminal region of theE- helix. To test more directly whether or not the dimer interface 
does retard opening and closing of the E7 gate and ligand migration from the solvent 
through it, the K30D mutation in ScHbi was constructed which Chiancone eta/. ( 49) 
showed causes dissociation into functional monomers. The Lys30(B3) to Asp mutation 
places a negative charge next to Asp89 at the EF comer of the adjacent subunit in the 
dimer, which causes complete disruption ofthe interface (see Fig. 3.1). In these K30D 
monomers, the HisE7 side chain should be able to rotate more freely into the solvent 
phase and open the E7 channel ( 49). In addition, this protein should show no cooperative 
binding, display no apparent kinetic heterogeneity, and be in the high affinity R state. 
The single K30D mutation does cause an increase ink' 02 from 14 ~M-1 s-1 to 44 
~M-1 s- 1for wt ScHbi (Table 3.4), which could be due to the loss of steric hindrance 
imposed upon the ligand diffusion pathway by the interface or an increase in Fe reactivity 
due to the switch to a more high affinity state or both. It appears that the effect of the 
interface on 0 2 binding is negligible when comparing the 0 2 binding rates of K30D to 
F97Y ScHbi. The k' 02 values are roughly the same ( 43 ~M-1 s- 1 for K30D versus 45 
~M-1 s- 1 for F97Y ScHbi) for both variants, presumably because they are both in the R 
state (Table 3.4). In both cases, mutation ofHisE7 to Trp causes an identical3-fold 
decrease in k'02 to~ 13 ~M-1 s- 1 for K30D/TrpE7 and 15 ~M-1s-1 for F97Y/TrpE7 (Table 
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Figure 3.6 Dependence of k' 02 on the size of the E7 amino acid side chain for HbA a and 13 chains, 
SwMb, and ScHbl E7 mutants in the wt and F97Y genetic backgrounds. There is an inverse correlation 
between rate of 0 2 association and the size of the E7 amino acid side chain for all E7 gate globin models. 
Previous data for SwMb was taken from (36) and all data for HbA was taken from (73) . 
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3.4). If the interrace had an effect on 0 2 binding, one would expect that the 0 2 
association rates would increase for both K30D and K30D/TrpE7 variants. Thus it seems 
clear that the dimer interrace is not impeding ligand movement through the E7 gate in 
ScHbl. 
3.6 Conclusions- Despite the inverted EF:FE dimer interrace in ScHbi, there is 
still a strong inverse correlation between the size of the amino acid at the E7 position and 
the bimolecular rate of02 association with the protein (Fig. 3.6). Increases in 0 2 binding 
occur upon mutation of the HisE7 to smaller apolar amino acids in both wt and the R 
state, F97Y genetic background mutations, and a 3-fold decrease in k'02 was observed 
when HisE7 was replaced with Trp in either wt type dimeric or K30D monomeric ScHbl. 
As shown in Fig. 3.6, effects of amino acid size at the E7 position in the two dimeric 
forms of ScHbi are almost identical to those observed previously for the a and ~ subunits 
of human HbA tetramers or monomers (73, 78) and the SwMb monomer (36, 79, 84). 
Thus, the inverted dimer interrace does not appear to change the pathway for ligand entry 
in ScHbi and probably not in any of the other invertebrate Hbs with this quaternary 
structure and a distal histidine. To find an alternative pathway for ligand entry, I had to 
turn to another invertebrate globin with a significantly different active site and globin 
fold, and the search for that alternative pathway is described in the next two chapters. 
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Chapter 4: Initial Studies of02 and CO Binding to Cerebratulus lacteus Hb (CerHb) 
4.1 Introduction- As described in Chapters 1 and 3, the distal histidine found in 
HbA, ScHbi, and SwMb form part of the E7 gate, which can swing open to allow entry of 
ligands into an interior distal pocket cavity that is circumscribed by the BlO, Ell and G8 
amino acid side chains. A key question is whether or not alternative pathways occur in 
other hemoglobins, particularly those without a HisE7 and the classic 3/3 a-helical globin 
fold. The mini-Hb from Cerebratulus lacteus (CerHb) was chosen as a good model 
system, which has a TyrB10/GlnE7 (YQ) active site motif, an approximate 2/2 a-helical 
globin fold, and a long apolar tunnel running between the E- and H- helices ( 60). 
However, I first needed to understand quantitatively how its novel active site affects 0 2 
and CO binding, regardless of the pathway for entry and exit. 
The YQ active site motif is common to both microbial and invertebrate globins (6, 
15) and characteristically results in an ultra high 0 2 affinity. This class ofYQ globins is 
exemplified by Ascaris suum hemoglobin, in which TyrB 10 and GlnE7 donate two strong 
hydrogen bonds to bound 0 2 resulting in an ultra high affinity (Ko2 = 575 J.LM-1) (Fig. 
4.1 ). In contrast, CerHb demonstrates a moderate 0 2 affinity (Ko2 = 1.3 J.LM-1), which is 
almost identical to that of SwMb (Ko2 = 1.1 J.LM-1) (Fig. 4.2A). As opposed to Ascaris 
suum hemoglobin where the E 11 amino acid is an apolar Ile, the E 11 position in the distal 
pocket of CerHb is occupied by a third polar amino acid, Thr. Therefore, rather than two 
hydrogen bonds between the bound ligand and TyrB 10 and GlnE7, additional polar 
interactions can occur in CerHb between the bound ligand and all three neighboring 
amino acid side chains (Fig. 4.2B). Surprisingly, the added polarity of the ThrEll side 
chain in CerHb reduces 0 2 affinity markedly rather than enhancing it, making CerHb an 
Tyr('BlO) 
Gln(E7) 
K02 = 5 75 J,.LM-1 
k' 02 = 2.3 f..l.M -1s·1 
k02 = 0.004 s 1 
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Phe(G8) 
Figure 4.1. Structural representation of Ascaris hemoglobin (PDB ID: lash) active site. Key amino 
acids BlO, E7, and Ell , the heme prosthetic group, and the proximal histidine are depicted in sticks. C 
atoms are gray, N atoms are blue, and 0 atoms are red. The two strong hydrogen bonds are depicted by 
blue dashed lines with the approximate distances (in A) labeled. The figure was generated in MacPyMol. 
A. 
His{E7) 
2.72 •• Vai(Ell) 
K02 = 1.1 !lM-1 
k' 02 = 16 !lM-1s 1 
k02 : 14 s-1 
B. 
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Tyr(BlO) 
K02 = 1.3 llM-1 
k' 02 : 230 !lM·1s·1 
k02 = 190 s-1 
Thr(Ell) 
Figure 4.2. Structural representation of A, SwMb (PDB ID: 2mgm) and B, CerHb (PDB ID: lkr7) 
active sites. Key amino acids BlO, E7, and Ell, the heme prosthetic group, and the proximal histidine are 
depicted in sticks. C atoms are gray, N atoms are blue, and 0 atoms are red. In each panel, the relevant 
hydrogen bonds are depicted by blue dashed lines with the approximate distances (in A) labeled. The figure 
was generated in MacPyMol. 
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unusual YQ Hb with a moderate Oz affinity. A structural explanation of this moderate 
affinity was obtained by a combination of mutagenic, crystallographic, and rapid kinetic 
measurements (See Section 4.6; (42, 60, 62)). 
The effects of polarity in the active site in CerHb are unique among YQ motif 
containing globins. (I) The favorable electrostatic interactions between ThrEll and 
TyrB 10 and GlnE7 in CerHb led to an unfavorable interaction with bound 0 2 and a 
marked decrease in affinity. (2) The amide side chain ofGlnE7 in CerHb is "tied" down 
by 3- 4 hydrogen bonds to amino acids surrounding the heme-binding site, perhaps 
inhibiting entry and exit through the E7 gate. 
4.2 Correlations between v c-o, electrostatic field, kco and k02 in SwMb - The 
peak frequency for C-0 bond stretches, Vc-o, is directly related to bond order. A higher 
bond order results in a higher stretching frequency peak (vco ~ 2150 cm-1 for a triple 
bond) and a lower bond order results in a smaller frequency peak (vco ~ 1650 cm-1 for a 
double bond). The same principles apply when the CO molecule is bound to the heme Fe 
atom. When CO is bound to Hb or Mb, it exhibits a bond order of 2.5-2.8 which leads to 
strong absorption of IR light in a region distinct from the rest of the protein matrix and 
water, -1900 to 2000 cm-1 (85). The precise bond order is dependent upon the 
surrounding electrostatic field, which is determined by the amino acid side chains and 
their orientation in the distal portion of the heme pocket. Thus, residues B 1 0, E7, and E 11 
can affect bond order that, in turn, determines the peak stretching frequencies in the IR 
absorption spectrum. As a result, FTIR measurements of iron carbonyl complexes have 
been used as an empirical predictor of the electrostatic potential field surrounding bound 
ligands in Mbs, Hbs, and other heme-containing proteins ( 86-88). 
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In the case of Mb, a hydrogen bond exists between the bound CO and the amide 
NE-H atoms ofHisE7; the C-0 bond order is~ 2.6; and the peak vc.o is located at 1945 
cm-1 (Fig. 4.3B). Increasing the positive field adjacent to the bound ligand causes the C-0 
bond order to decrease and the Fe-C bond order to increase due to stabilization of the 
more carbonyl like resonance structure (i.e. Fe=C=O) with more non-bonded electron 
density on the 0 atom and greater back bonding by the Fe atom (Fig. 4.3A). Removal of 
positive field or hydrogen bond donation to create an apolar active site increases the C-0 
bond order, and addition of negative field from Lewis bases (electron donors, normally 
non-bonded electrons on 0 or N atoms) cause even further increases due to stabilization 
of the Fe6--C=06+ resonance form (Fig. 4.3C; (85)). In the latter cases, vc-o increases and 
VFe-c decreases. The net result is an inverse relationship exists between the electrostatic 
field near the bound ligand and the peak C-0 stretching frequency, Vco (33, 85). 
Even though the electrostatic environment surrounding bound CO does affect the 
C-0 and Fe-C bond orders, the magnitudes of these effects are small in terms of changes 
in the CO dissociation rate and association equilibrium constants because the Fe-CO 
complex is apolar with little or no net displacement of charge from the Fe atom. In 
contrast, the Fe-02 complex is highly polarizable and resembles a ferric-superoxide 
complex, i.e. Fe(III)-02·-, with a partial charge of -0.8 on the 0 atoms (85). As a result, 
hydrogen bond donation or an adjacent partial positive charge from a Lewis acid can 
stabilize bound 0 2, decreasing the rate of dissociation several orders of magnitude ( 85, 
89). Thus, a strong linear correlation is expected between the C-0 stretching frequency of 
bound CO, which measures the electrostatic field, and the logarithm of the Oz 
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Figure 4.3. Proposed models for electrostatic interactions in the active site of SwMb. A, Val68(E11)Asn demonstrates a positive electrostatic field with two 
hydrogen bond donors surrounding the bound CO. The Fe=C=O resonance form dominates and a low Vc.o of 1916 cm"1 is observed. B, Wt SwMb demonstrates a 
more neutral electrostatic field with one hydrogen bond donor surrounding the bound CO. As a result, a resonance form where the C-0 bond order is ~2.6 
dominates and a vc.o of 1945 cm·1 is observed. C, His64(E7)VaUVal68(Ell)Thr SwMb demonstrates a negative electrostatic field where both hydrogen bond 
donors have been removed. The non-bonded electrons of Thr68(E11) are directed towards the bound CO. The Fe-·c"'o+ resonance form dominates and a higher 
vc.o of 1984 cm"1 is observed (62). Structures generated with ChemDraw. Figure taken from (85). 
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dissociation rate constant from the same globin. 
As shown in Fig. 4.45, this correlation has been established unambiguously using 
02 dissociation rate constants and C-0 stretching frequencies from a large library of 
SwMb variants (33, 82). This correlation is demonstrated most dramatically by 
comparing wt SwMb (1945 cm-1) to both the single mutant Val68(Ell)Asn and the 
double mutant His64(E7)Va1Nal68(Ell)Thr (Table 4.1A, Fig. 4.3). As described by 
Phillips (85), mutation ofValEll- Asn in the single mutant provides additional 
hydrogen bonding to the bound ligand resulting in a more positive electrostatic field 
surrounding the bound ligand (Fig. 4.3A). On the other hand, mutation ofHisE7-Val 
and ValEll-Thr results in the non-bonded electrons ofthe ThrEll hydroxyl 0 atom 
being directed towards the bound CO atom yielding a more negative electrostatic field 
(Fig. 4.3C). In the case of the single ValEllAsn replacement, the neutral Fe=C=O 
resonance form is more favored by the "extra" hydrogen bond and a lower Vc-o of 1916 
cm-1 is exhibited in comparison to 1945 cm-1 in wt SwMb. In the case of the double 
mutant, the Fe--C=O+ resonance form is favored and a higher Vc-o of 1984 cm-1 is 
exhibited ((85), Fig. 4.3, Table 4.1A). 
4.3 Construction of SwMb vs CerHb single and multiple mutants - In order to 
gain a better understanding of the electrostatic environment generated by the B 10, E7, 
and Ell side chains that surround bound ligands in both proteins, SwMb mutants that 
mimic the distal pocket of CerHb and CerHb mutants that mimic SwMb were constructed 
and analyzed. The single SwMb mutants HisE7Gln and ValEll Thr, the double 
5 Data from a and ~ subunits of HbA (73) and F97Y mutants of ScHbl (Chapter 3) have also been included 
in this data set to demonstrate the more general correlation between vc-o and log(koz) among 3/3 a-helical 
globins with a distal histidine. 
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Table 4.1. CO stretching frequency, 0 2 dissociation rate, and 0 2 affinity of A, key SwMb 
mutants and wt Ascaris suum Hb, and B, key CerHb mutants. Data taken from (36, 61, 85, 89-
91). 
A. SwMb Mutants Vc.o koz logkoz Ko2 (cm-1) (s-1) (JlM-1) 
WT 1945 15 1.2 1.1 
Single 
Leu29(B10) 
Phe29 1932 1.4 0.15 15 
His64(E7) 
Leu64 1965 4100 3.6 0.02 
Gln64 1945 130 2.1 0.01 
Va168(Ell) 
Asn68 1916 0.54 -0.3 3.5 
Thr68 1958 39 1.6 0.08 
Mu1ti:ele 
Leu29(B 1 O)Tyr/ 1934 1.6 0.2 1.8 
His64(E7)Gln 
His64(E7) Val/ 1984 4000 3.6 0.025 
Val68(E 11 )Thr 
Leu29(B 1 O)Tyr/ 1938, 7.4 0.9 0.06 
His64(E7)G ln/ 1953 
Va168(E11)Thr 
Ascaris suum Hb D 1 1912 0.004 -2.4 370 
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Table 4.1 (cont'd). CO stretching frequency, 0 1 dissociation rate, and 0 1 affinity of A, key 
SwMb mutants and wt Ascaris suum Hb2 and B2 kei CerHb mutants. 
B. CerHb Mutants Vc-O km log km Ko2 (cm-1) (s-I) (JJM-I) 
WT 1979 190±25 2.3 1.3 
Single 
Val7(B6) 
Ala7 1981 270 2.4 0.93 
Ttp7 1974 14 1.1 2.4 
PhelO(B9) 
AlalO 1971 40 1.6 1.8 
Tyrll(BlO) 
Alall 1976 400 2.6 0.30 
Phell 1969 460 2.7 0.30 
Gln44(E7) 
Leu44 1993 96 2.0 1.9 
Phe44 1987 170 2.2 0.12 
His44 1962 81 1.9 1.0 
Lys47(E10) 
Ttp47 1983 180 2.3 1.0 
Thr48(Ell) 
Ala48 1934 0.26 -0.59 160 
Val48 1940 0.025 -1.6 170 
Ala82(G8) 
Leu82 1980 56 1.7 0.88 
Phe82 1965 18 1.3 13 
Ttp82 1960 11 1.0 5.7 
Leu86(Gl2) 
Ttp86 1980 60 1.8 1.6 
Multi£le 
YllF/Q44L" 1972 490 2.7 0.60 
YllF/Q44H 1941 16 1.2 0.88 
YllF/T48V 1951 62 1.8 3.7 
Q44L/T48V 1940 4.2 0.62 13 
YllF/Q44L/T48V 1968 270 2.4 1.6 
YllF/Q44H/T48V 1935 2.9 0.46 10 
• This group of mutants follows the conventional single letter mutation nomenclature where 
Y11F means mutation of Tyr to Phe at the 11th amino acid from theN-terminus. 
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Figure 4.4. Correlations between the C-0 stretching frequency (v c.o) and 0 2 dissociation rate 
constants (k02) in SwMb, HbA, and ScHbl. A direct relationship exits between vc-o and log(k02) for 
SwMb(92, 93), HbA (73) and ScHbl F97Y mutants (Chapter 3). SwMb single mutants are represented by 
open squares and CerHb mimics of SwMb are represented by filled squares. HbA a subunit mutants are 
represented by open circles, and HbA !3 subunit mutants are represented by filled circles. ScHbl F97Y 
mutants are represented by filled triangles. Data for wt ScHbl were not included because the ko2 values 
represent a mixture of R and T values and do not correspond directly to a single quaternary state. The 
straight line fit has an R-square value= 0.78756. 
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mutant LeuB 1 0Tyr/HisE7Gln, and the triple mutant LeuB 1 OTyr/HisE7Gln/V alE 11 Thr 
had been constructed previously, and I fully characterized the FTIR spectra of all four 
variants (Table 4.1). The CerHb single mutants, GlnE7His and ThrEllVal had also been 
constructed previously. To complete the direct comparison between CerHb and SwMb, 
the multiple CerHb mutants GlnE7His/ThrE11Val and TyrB10Phe/GlnE7His/ThrE11Val 
were generated. 
4.4 Measurement of01 binding for active site mutants in SwMb- The effects 
on 02 and CO binding in some of the SwMb mutants that mimic the distal pocket of 
CerHb have been reported previously (53, 61, 62, 85, 90). Mutation of the HisE7 to Gin 
in SwMb causes an~ 10-fold increase in k02 and a 6-fold decrease in Ko2 (Table 4.1) due 
to weakening the hydrogen bond between the E7 side chain and bound 02. Relative to the 
single GlnE7 SwMb mutant, the double SwMb mutant LeuB 1 OTyr/HisE7Gln restores k02 
and Ko2 to wt SwMb values due to an additional hydrogen bond between the TyrB 10 
hydroxyl group and bound 02. As part of her Master's Thesis, Angela Hale created the 
triple SwMb mutant, LeuB10Tyr/HisE7Gln/ValE11 Thr, which mimics the CerHb distal 
pocket. She found that the addition ofThrE11 yields an increase in ko2 and a decrease in 
Ko2 in relation to the double TyrB 1 O/GlnE7 SwMb mutant. Thus, as in wt CerHb, the 
ThrEll hydroxyl atom in the SwMb triple mutant pulls the proton on the TyrBIO 
hydroxyl away from bound 02 destabilizing it, verifYing our previous interpretations 
((62, 90), Table 4.1). 
4.5 Measurement of 0 1 binding and affinity for active site mutants in CerHb -
Pesce et al. (62) constructed the GlnE7-+ His CerHb mutant and reported decreases in 
both k' 02 and ko2 and a small increase in Ko2 in comparison to wt CerHb, the latter being 
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Table 4.2. 0 1 association and dissociation rate constants, 0 1 affinity, and CO dissociation rate 
constants of A, ~ey SwMb mutants andB, key CerHb mutants. Data taken from i(85), ii(70), iii(61), iv 
(90}, v {62}, and Vl {53}. 
A. SwMb Mutant k'02 ko2 Ko2 kco (f:!M-ls-1} (s-1} (f:!M-1} (s-1} 
WT 17 15 1.1 0.019 
His(E7)Glni 23 130 0.18 0.012 
Leu(B 1 O)Pheii 21 1.4 15 0.006 
Val(E 11 )Thri 2.8 39 0.072 0.079 
Leu(B 1 O)TY.!/ 2.8 1.6 1.8 0.019 
His(E7)Gln111 
Leu(B 1 O)Tyr/His(E7)Glnl 0.45 7.4 0.061 0.021 
Val(E11}Thrv 
B. CerHb Mutant k'02 ko2 Ko2 kco (f:!M-ls-1) (s-1) (~M-1) (s-1} 
WT 230 190 1.2 0.054 
Gln(E7)His 130v 65v 1.9v O.Ollvi 
Tyr(B10)Phe 140 460 0.30 0.0081 
Thr(Ell)Valv 30 0.18 170 0.0070 
Gln(E7)His/ 120 11 11 0.010 
Thr(E11)Val 
Tyr(B 1 O)Phe/Gln(E7)His/ 29 2.9 10 0.036, 
Thr(E11}Val 0.0050 
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due to a slightly stronger hydrogen bond between the HisE7 side chain and bound 0 2 
(Table 4.2) . To expand the comparison between the SwMb and CerHb active sites the 
' 
double CerHb mutant GlnE7His/ThrE11 Val was constructed. By replacing the ThrE11 
with Val, a strong hydrogen bond can now form between TyrB 10 and bound 0 2 as 
observed for the single ValE 11 mutant, but the effect in the presence of HisE7 is much 
smaller, suggesting competition between HisE7 and TyrB 10 for favorable interactions 
with the bound ligand. A similar competition occurs in the single TyrB 10 SwMb mutant 
where HisE7 is present naturally (61). Replacing TyrB10 with Phe in HisE7NalE11 
CerHb leads to smaller rates of 02 binding and release with little change in affinity 
(Table 4.2). The 02 affinity and rate constants of this PheB10/HisE7NalE11 CerHb triple 
mutant are roughly equal to those of the PheB 10 single SwMb mutant, demonstrating that 
site directed mutagenesis in CerHb can produce a mutant that mimics the corresponding 
variant in myoglobin. 
4.6 Electrostatic stabilization in CerHb- In the case ofwt CerHb, the non-bonded 
electrons of the TyrB10 hydroxyl 0 atom point toward the bound CO stabilizing the Fe--
C=O+ resonance form (Fig. 4.5A), an effect similar to that observed for the double 
HisE7ValNalE11 Thr mutation in SwMb (Fig. 4.3C). As a result, there is a negative 
electrostatic field surrounding the bound ligand; a high Ye-o peak occurs at 1979 cm-1, 
and rapid rates of02 dissociation are observed for wt CerHb (Table 4.1B). By mutating 
the CerHb polar active site residue ThrE 11 to a Val, the TyrB 10 phenol H atom rotates 
toward the bound 0 2, stabilizing the F e=C=O resonance structure, an effect similar to that 
observed in wt and Val(E11)Asn SwMb mutant (Fig. 4.3B). As a result, the CO 
stretching frequency decreases dramatically from 1979 cm-1 in wt CerHb to 1940 cm-1 in 
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the ValEll CerHb mutant and a dramatic 1000-fold decrease in k02 is observed (Tables 
4.1 and 4.2). As a result, there is a 140-fold increase in 0 2 affinity (Ko2 increases from 
1.2 J.LM-1 in wt CerHb to 170 J.LM-1 in ValEll CerHb (62)). Thus, this isosteric 
replacement of Thr by Val markedly alters the hydrogen bond network between ThrE 11, 
TyrBIO, and GlnE7, and allows strong hydrogen bonds to form between the bound 0 2 
atoms and the side chains ofTyrBIO and GlnE7. These strong hydrogen bonds lead to the 
high Koz, which is characteristic of other invertebrate hemoglobins with the YQ active 
site motif (Fig. 4.5B, Table 4.1B, ( 6, 15), ( 62). 
When all three active site residues in CerHb are mutated to apolar amino acids in 
the TyrllBIOPhe/Gln44E7Leu/Thr48Ell Val CerHb mutant, the electrostatic field 
becomes zero and a decrease in C-0 stretching frequency is observed, from 1979 cm-1 in 
wt CerHb with a negative field from TyrBIO to 1968 cm-1 in the completely apolar 
CerHb triple mutant (Table 4.1 C). The neutral electrostatic field in the 
Tyr liB I 0Phe/Gln44E7Leu/Thr48E 11 Val CerHb mutant resembles that in the HisE7Leu 
SwMb mutant, which shows a similar Vc-o peak at 1967 cm-1 (Table 4.1A). When the 
BIO and Ell active site residues are apolar, but the E7 residue is mutated to His as in the 
Tyr11B10Phe/Gln44E7His/Thr48E11Val CerHb mutant, the positive increase in 
electrostatic field causes a decrease in vco to 1935 cm-1, a stretching frequency which is 
nearly equal to that observed in the PheBIO SwMb mutant (1932 cm-1) (Table 4.1C). This 
~ 35 cm-1 decrease in vc-o for the triple Tyr11B10Phe/Gln44E7His/Thr48E11Val CerHb 
mutant in comparison to wt CerHb is accompanied by a marked 65-fold decrease in koz 
(Table 4.1 and Fig. 4.6). Fig. 4.6 demonstrates that correlations between vc-o and koz also 
occur for the library of CerHb mutants and related globins, and further verifies using 
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Figure 4.5. Proposed models for electrostatic interactions in the active site of CerHb. A, Wt CerHb 
demonstrates a negative electrostatic field surrounding the bound CO as a result of the TyrBlO non-bonded 
electrons directed towards the bound CO. The Fe-·c .. o+ resonance form dominates and a high vc.o of 1979 
cm·1 is observed. B, Thr48(Ell)Val CerHb demonstrates a positive electrostatic field surrounding the 
bound CO. As a result, the Fe=C=O resonance form dominates and a lower Vc.o of 1940 cm·1 is observed 
( 62). Structures generated in ChemDraw. 
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Figure 4.6. Correlation between the C-0 stretching frequency (Vc..o) and 02 dissociation rate 
constants (ko2) in CerHb. A direct relationship exits between vc.o and log(k02) for CerHb mutants (Data 
from Table 4.2). CerHb single mutants are represented by open squares, CerHb multiple mutants are 
represented by filled squares, and SwMb mimics of CerHb are represented by filled triangles. Ascaris suum 
Hb D1 is found at 1912 cm"1 represented by a filled circle (94, 95). The straight line fit has an R-squared 
value= 0.63886. 
the bound CO stretching frequency as a general empirical predictor of relative oxygen 
dissociation rate constants for all globins, regardless of the active site amino acid 
composition (85). 
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4. 7 Conclusions - Despite their similar 0 2 affinities, it is clear from the FTIR and 
mutagenesis data in this chapter that the electrostatic environments surrounding the 
bound ligand in wt CerHb and SwMb are markedly different. In wt SwMb, there is a 
strong positive electrostatic field adjacent to bound ligands as measured by the low vco 
peak at -1941 cm-I, whereas in wt CerHb there is a negative electrostatic field 
surrounding the bound CO resulting in a vco peak at 1979 cm-1• The new data for our 
library of CerHb mutants supports the two key relationships that had previously been 
established for Mb and Hb: (1) a strong inverse correlation between the vc-o peak and the 
electrostatic field adjacent to bound CO, and (2) a strong direct correlation between Vc-o 
and log(k02). This comparison provides a clear picture of how CerHb achieved an oxygen 
affmity similar to that of mammalian Mb when starting from a high affinity protein with 
two strong hydrogen bonds between TyrB 10 and GlnE7 and bound 0 2• The addition of 
ThrE 11 to the YQ active site motif causes the TyrB 10 hydroxyl to rotate away from the 
bound ligand due to interactions with the E 11 hydroxyl group. This orientation causes the 
non-bonded electrons on the TyrB 10 0 atom to destabilize bound 0 2, which partially 
accounts for the high 0 2 dissociation rate constant of native CerHb. 
However, these electrostatic effects cannot explain why the absolute values ofk'02 
and ko2 are both 10-fold higher than those ofwt SwMb. The reason for the higher rates of 
binding in wt CerHb must be due to a different pathway or kinetic mechanism for ligand 
binding than in SwMb. These differences and the importance of understanding ligand 
migration pathways in globins are explored quantitatively in the next three chapters. 
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Chapter 5: Entry and Exit in CerHb: Mutations at the E7 and E18 Helical Positions 
*Much of the prose, figures, and references that appear in this chapter were taken from 
Salter eta!. {2008) (74). The use of quotation marks has been omitted from this section to 
avoid redundancy. 
5.1 Introduction -As in Mb and HbA, the shortest route to solvent from the heme 
Fe is through the E7 gate, which in CerHb, would involve outward and upward 
movement of the Gln44(E7) side chain away from the heme plane. The proposed 
alternative pathway in CerHb involves movement in the opposite direction through an 
apolar tunnel between theE- and H- helices, which is bounded by Val7(B6), Ala82(G8), 
Leu86(Gl2), Leu98(H9), and Ala55{El8) {Fig. 5.1). To examine which pathway is 
applicable in CerHb, I systematically changed the sizes of the key amino acids at the 
exit/entry point of the E7 gate (Gln44) and entrance to the apolar channel (Ala55). 
Gln44(E7) was mutated to Ala, Val, Leu, His, Phe, and Trp, and Ala55{El8) was mutated 
to Val, Leu, Phe, and Trp. The effects of these mutations on overall bimolecular and 
internal geminate rates of 0 2 and CO binding were measured. 
The results for the GlnE7 mutations are complex, indicating that this amino acid 
affects the extent of steric hindrance and electrostatic stabilization of the bound ligand, 
but, at the same time, these data do not provide any compelling evidence that ligands 
enter and exit through the shorter E7 gate pathway. In contrast, the results for the AlaE18 
mutants indicate strongly that this amino acid forms part of the opening for ligand entry 
and exit in CerHb. Based on these results, key mutants were sent to Martino Bolognesi, 
Marco Nardini (University of Milan), and Alessandra Pesce (University of Genova) who 
crystallized and determined the structures ofthe Phe55{El8) and Trp55{El8) CerHb 
WT CerHb "Back View" 
Figure 5.1. Structure of wt CerHbOz (PDB: lkr7) showing side and back views of the molecule. Gln44(E7) is shown in cyan and located directly 
above the heme propionates. Ala55(El8) is shown in green and located at the end of the E-helix forming part of the open entrance to the apolar tunnel 
between theE- and H- helices (74) . 
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mutants. The structural models showed that these replacements only caused blockage of 
the entrance to the apolar channel and not marked alterations in the active site. The 
combined structural and kinetic data suggest strongly that the apolar channel in CerHb is 
probably the major route for ligand entry and exit. The detailed experimental results 
supporting this conclusion are provided in this chapter. 
5.2 Effects of position 44(E7) CerHb mutants on overall 0 1 and CO binding-
Bimolecular association (k') and unimolecular dissociation (k) rate constants for ligand 
binding to Gln44(E7) mutants ofCerHb are listed in Table 5.1A. Some ofthese rate 
parameters were reported on in previous work performed by Angela Hale as part of her 
M.A. thesis (53, 62). Va1E7 and PheE7 mutants were constructed to complete the series 
of size variants at the E7 gate position and the 0 2 and CO binding parameters for all six 
variants were re-measured to allow a more direct comparison with the same replacements 
in SwMb, which uses the E7 gate for ligand entry and exit (Table 5.1 and Fig. 5.2). 
In general, replacement ofHisE7 with smaller apolar amino acids (A,V, L) in 
SwMb results in dramatic increases in both k'02 and ko2 (Table 5.1B). In the case of 
ligand association, the 5 to 10-fold increases are due to loss of non-covalently bound 
water (KH2o) and opening of the E7 channel (Fig. 1.4), both ofwhich increase the rate of 
ligand binding in SwMb. In the case of ligand dissocia~ion, the larger 100 to 1000-fold 
increases in ko2 are due to loss of hydrogen bonding to bound 02 (Fig. 1.4, Kstabilization) 
and greater rates of thermal Fe-02 bond breakage (k..bond). The increases in ko2 dominate, 
resulting in large~ 100-fold decreases in 0 2 affinity for the apolar E7 mutants ofMb 
(Ko2 values in Table 5.1B and Fig. 5.2C). 
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Table 5.1. Rate and equilibrium constants for 0 2 and CO binding to A, position 44(E7) mutants of 
CerHb and B, position 64(E7) mutants of SwMb at pH 7 .0, 20 °C. Two phases for 0 2 association and 
dissociation were observed for Trp44 CerHb; roughly 50% of the observed absorbance changes were 
observed with the fast phase and 50% with the slow phase. 
A. CerHb k'o2 koz Koz k'co kco Kco M 
Mutants JlM-1s·1 s-1 JlM-1 JlM-1s-1 s-1 J.LM-1 (Kco/Koz) 
Ala44 160 33 4.9 41 0.05, 0.0004 820,10000 170,2100 
Val44 130 84 1.5 25 0.032 780 510 
Leu44 184 96 1.9 36 0.016 2200 1200 
Gln44(E7) 230±17 190±25 1.2±0.2 32±4.7 0.05±0.03 590±100 490±110 WT 
His44 85 81 1.0 4.0 0.010 400 380 
Phe44 20 170 0.11 1.3 0.054 24 210 
Trp44 10,170 330,33 0.03, 5.2 5 0.035, 0.011 140,460 4600,89 
B.SwMb k'o2 ko2 Koz k'co kco Kco M 
Mutants JlM-1s·1 s·1 J.LM-1 JlM-1s·1 s-1 J.LM-1 (Kco/Koz) 
Ala64 53" 2300 0.02 4 0.061 69 3450 
Val64 110 10000 0.01 7 0.048 150 15000 
Leu64 98 4100 0.02 26 0.024 1100 55000 
His64(E7) 16::1:3 14::1:3 1.1::1:0.2 0.53 0.019 27 25 WT 
Gln64 23 130 0.18 1 0.012 82 455 
Phe64 75 10000 O.Dl 5 0.054 83 8300 
Trp64 6.2 87 0.07 0.023 28 400 
The standard deviations for the wild type CerHb values for k'02, ko2, and k'co were obtained from the 
analysis of 12 completely independent sets of experiments starting with the at least 7 different expressions 
and purifications of CerHb. The standard deviation for kco came from the analysis of 16 different 
determinations. The values of Ko2 and Kco were calculated from k'oz/koz and k'colkco and the standard 
deviations were calculated from standard propagation of error formula ( 7 4). 
"The SwMb rate constants were taken from (89, 91, 93). 
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Figure 5.2. Comparison of the effects of E7 mutations on the association, dissociation, and 
equilibrium constants for 0 2 binding to SwMb (36, 72) and CerHb. The wt amino acids are His64(E7) 
and Gln44(E7) in Mb and CerHb, respectively, and the effects are expressed as the logarithm of the ratio of 
the mutant parameter divided by the wild-type parameter. All rates were measured in 0.1 M phosphate, pH 
7, 20 °C. 0 2 binding to TrpE7 CerHb showed two phases of roughly equal amplitude. Wl was assigned to 
the slow component with reduced association and high dissociation rate constants and W2 to the faster 
reacting component with the low dissociation constant. In contrast SwMb TrpE7 showed only a single slow 
phase and its values are presented as Wl (74). 
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In contrast toMb, replacing Gln44(E7) with small apolar amino acids in CerHb results in 
decreases in the rates ofboth 02 association and dissociation and small increases in 0 2 
affinity (A,V, L black bars in Fig. 5.2). The decreases in k'02 and ko2 with decreasing size 
and polarity at the E7 position argue against this amino acid being part of the pathway for 
entry and exit because opposite effects, increases in k'02 and ko2 would be expected if the 
E7 channel were enlarged, made apolar, and the gate removed. As shown in Fig. 5.2A, 
there are significant decreases in the bimolecular rate constants for 0 2 binding when the 
size of the E7 amino acid is increased from Gin to His, Phe, and Trp. However, there are 
no large concomitant decreases in the 0 2 dissociation rate constant (Fig 5.2B), and as a 
result, there are significant 10 to 3-fold decreases in 0 2 affinity for the larger PheE7 and 
TrpE7 CerHb mutants (Fig 5.2C). These effects for the larger E7 amino acids appear to 
be due to direct steric and electrostatic interactions with the bound ligand and not 
necessarily alterations in the speed of entry and escape. 
The TrpE7 CerHb mutant shows two distinct and roughly equal phases for 02 
association, 0 2 dissociation, and CO dissociation (Table 5.1A). The slower phase for 02 
association shows a rate similar to that for binding to the PheE7 mutant, whereas the 
faster phase is similar to that of AlaE7 CerHb. The simplest interpretation is that the 
indole side chain can occupy an inward orientation that directly hinders binding to the Fe 
atom and an outward orientation that leaves the Fe more accessible, regardless of the 
pathway for ligand entry and exit. The low k'02 value would correspond to the inward 
conformer and the high k'02 value would correspond to the outward conformer. Similar 
effects of the PheE7 and TrpE7 mutants are observed in the a and 13 subunits ofHbA 
where inward conformations appear to restrict access to the Fe atom causing marked 
decreases in both CO and 0 2 affinities (73, 78). 
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Using this steric hindrance model, the high rate of 0 2 dissociation was assigned to 
the inward conformer, in which the large indole side chain sterically hinders bound 
ligands and enhances the rate ofFe-ligand bond breakage. For this model, the calculated 
02 affinity of the inward conformer would be 0.03 JlM-1, which is similar to that for the 
PheE7 CerHb mutant. The outward conformer would have Ko2 =- 5 JlM-1, which is 
similar to the affinity of the unhindered AlaE7 mutant. Although compelling, these 
assignments must be considered tentative in the absence of a crystal structure of the 
TrpE7 CerHb mutant and further examination. However, Birukou eta/. (78) did 
determine the crystal structure of TrpE7 deoxy a-chains, and the prediction of an inward 
conformation was verified for this subunit ofHbA. 
5.3 Geminate CO recombination in position 44(£7) CerHb mutants - Although 
the overall kinetic parameters in Table 5.1 indicate that GlnE7 is not acting as a gate for 
ligand entry and exit, the results are complex and difficult to interpret. To explore the role 
of this position more completely, time courses for geminate CO recombination in all six 
E7 CerHb mutants were measured (Fig. 5.3A). In this case, the results are definitive. 
Neither the rate nor the extent of geminate recombination vary widely with increasing 
size, from Ala to TrpE7, supporting the idea that the amino acid at the E7 position is not 
part of the gate for ligand movement into the active site ofCerHb. 
The largest fraction of geminate recombination is 0.19 (LeuE7) and the smallest is 
- 0.02 (PheE7), with wild-type (GlnE7) being 0.05. The rates of geminate recombination 
(kgem) do not vary greatly, 60 to- 100 JlS-1, and, because the extents of geminate 
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Figure 5.3. Time courses for geminate recombination in mutants of CerHb at 20°C, pH 7.0. A, geminate rebinding in position Gln44(E7) mutants of 
CerHbCO. B, CO geminate binding in position Ala55(El8) mutants. C, 0 2 geminate rebinding in position Ala55(E18) mutants (74). 
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recombination are small (:S 20%), the values ofkgem represent the rates of escape from the 
CerHb mutants (see Eqs. 5.1 and 5.2 below). Thus, it is clear that changes in the size of 
the E7 amino acid have little affect on ligand escape. In contrast, Scott et al. (36) 
observed systematic decreases in the fraction of 0 2 geminate rebinding with increasing 
size of the E7 position in SwMb, from- 0.12 for AlaE7 to 0.72 for TrpE7. 
5.4 02 and CO binding to position 55(El8) CerHb mutants- As shown in Fig. 
5.1, Ala55(El8) is located at the exit/entry point between the apolar channel and solvent 
between theE- and H- helices. To see if this entry and escape point could be blocked, 
AlaE18 was replaced with Val, Leu, Phe, and Trp, under the premise that the barrier to 
ligand uptake would increase with increasing size of the amino acid side chain. As shown 
in Fig. 5.4 and Table 5.2A, there are strong inverse correlations between amino acid size 
and the rates of 0 2 association and dissociation, with both k'02 and ko2 decreasing by > 3 
to 4-fold for the AlaE18 to Leu, Phe, Trp mutations and little change in Ko2. The 
concomitant decreases in k'02 and ko2 strongly suggest that the mutations are increasing 
the free energy barrier for entering the protein and only affecting this transition state. 
This pattern of effects at the E 18 position contrasts with the more complex behavior seen 
when the size of the amino acid at E7 is increased (Fig. 5.4C versus Fig. 5.2, 
respectively). 
As shown in Table 5.2, the affinity ofCerHb for 0 2 shows almost no dependence 
on the size ofthe amino acid at the E18 position particularly when considering the 
uncertainty in the measured value ofKo2 for wt CerHb02, which is represented by the 
standard deviation from~ 12 different independent determinations over six years. This 
observation argues strongly that the mutations only affect movement into the apolar 
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Table 5.2. Rate, equilibrium, and geminate constants for A, 0 2 and B, CO binding to position 55(E18) 
mutants of CerHb at pH 7, 20°C (74). 
A. 0 2 Binding at pH 7.0, 20 °C. 
Bimolecular binding parameters Observed Geminate parameters 
Mutant 
k'oz (llM·1s-1) koz (s-1) Koz (llM-1) kgem (j..Ls-1) Fgem• 
Ala55 WT 230±17 190±25 1.2±0.2 (-130) 0.39 
Val55 180 93 1.9 64 0.58 
Leu 55 72 40 1.8 54 0.83 
Phe55 61 51 1.2 55 0.86 
Trp55 63 66 0.95 55 0.86 
B. CO Binding at pH 7.0, 20 °C. 
Bimolecular binding parameters Observed Geminate parameters 
Mutant 
k'co (llM-1s-1) kco (s-1) Kco(j..LM-1) kgem (j..Ls-1) Fgem 
Ala55 WT 32±4.7 0.054±0.0053 590±100 80±40 0.05±0.03 
Val55 41 0.045 910 24 0.16 
Leu 55 17 0.016 1100 7.6 0.46 
Phe55 17 0.029 590 9.3 0.44 
Trp55 15 0.029 520 9.4 0.44 
"The fraction of geminate 0 2 rebinding to CerHb was estimated by assuming a "dead-time" of 9 ns for the 
laser light pulse. This adjustment partially compensates for the amount of geminate rebinding that occurs 
during the laser pulse, but is only an approximation. The standard deviations for the overall rate constants 
for wild-type CerHb are described in Table 5.1 and the relative errors - ± 10 % for 2:: 12 completely 
independent measurements are assumed to apply to the parameters for 55(E18) mutants. 
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tunnel. This interpretation is also supported by the much smaller effects observed for CO 
association and dissociation. In most globins, CO binding is limited by the internal rate of 
bond formation or bond breakage and not movement into and out of the protein ( 84, 96). 
As a result, the overall observed CO association and dissociation rate coefficients are 
little affected by mutations that only affect entry and exit into the protein as is observed 
for the position 55(E18) replacements shown in Table 5.2B. 
5.5 Effects of position 55(El8) CerHb mutants on geminate recombination-
Replacing Ala55(E18) with larger amino acids increases the fraction of geminate 
recombination, F gem, for both 02 and CO but slows the rate of this process, kgem, 
markedly (Figs. 5.3B and C, Table 5.2). In the case of CO geminate rebinding, Fgem 
increases almost 10-fold, from 0.05 to 0.44, whereas kgem decreases 10-fold from~ 80 to 
~ 9 J.lS-1• Similar increases in Fgem and decreases in kgem occur for internal 0 2 rebinding, 
but in this case the values are more difficult to assign since extensive geminate 
recombination is occurring during excitation and at speeds approaching the rate of decay 
of the laser pulse (Fig. 5.3C). However, the trends are identical to those seen for CO 
rebinding. The key observation is that the rate of geminate recombination decreases 
whereas the fraction of rebinding increases as the tunnel is blocked. These opposite 
trends can only occur if the rate of ligand escape is decreasing with little change in the 
rate of internal bond formation as the size ofthe position 55(E18) amino acid is 
increased. This interpretation is described quantitatively by Equation 5.1 (Section 5.8) 
5. 6 Association rate constants for NO binding to the position 55(E18) CerHb 
mutants - The bimolecular rate of NO binding to globins is determined solely by the rate 
of entry into the protein because, once captured in the distal pocket, virtually all the 
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internal ligands bind to the Fe atom before escaping due to the highly reactive free radical 
nature of nitric oxide. This high reactivity accounts for the large extent of picosecond 
geminate rebinding ofNO in photolysis experiments, the very low overall quantum yield 
ofNO complexes(~ 0.01), and the large bimolecular association rate coefficients, k'No 
(84). Scott eta!. (36) have shown that there is a 1:1 correlation between the bimolecular 
rate of ligand entry, k'enu-y, calculated from a combined analysis of geminate and overall 
02 rate constants and the values ofk'No determined for over 90 different SwMb mutants. 
Thus, the rates ofNO binding to the E18 mutants ofCerHb were measured to examine 
more directly if the larger amino acids are slowing the rate of ligand entry. As shown in 
Fig. 5.5 and Table 5.3, the rate ofNO binding decreases over 5-fold when Ala55 is 
replaced with Leu, Phe, and Trp, and the values ofk'No are similar to those for k'02 
implying that the rate limiting step for 0 2 binding is also movement into the protein and 
through the tunnel (see also Table 5.3). 
5. 7 Simple mechanism for ligand binding to CerHb to allow calculation of 
k'entry- The two-step mechanism shown in Fig. 5.6 was adopted to determine more 
quantitatively the effects of the E18 mutations on the rates ofligand entry and exit. Deng 
et al. (53) have shown that there are multiple geminate states in the distal pocket of 
CerHb, which interconvert with relatively small enthalpy barriers. These discrete 
intermediates are easily visualized in FTIR-TDS experiments at cryoscopic temperatures 
(3-160 K). However, in our experiments at room temperature, simple exponential 
geminate rebinding is observed, suggesting that only a single intermediate needs to be 
considered on I 0 to 2000 nanosecond time scales. 
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Figure 5.5. NO binding to 55(E18) mutants of CerHb at pH 7, 20 °C. CerHbCO (- 50 1-LM) was rapidly 
mixing with buffer equilibrated with 1 atm of NO and photolysis was initiated immediately after mixing to 
generate deoxyCerHb in - 0.5 1-LS. NO binding was followed at 436 nm. The offset is due to the difference in 
absorbance between the initial CerHbCO and final CerHbNO complexes. This experiment was repeated 
with four different NO concentrations and k'No was determined from the slope of plots ofkobs versus [NO]. 
Inset_ correlations between the calculated value of k'entry and the measured value of k'No for wt and the four 
55(E18) mutants (74). 
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Table 5.3. Bimolecular rate constants for NO binding and calculated rate parameters for entry, 
escape and internal bond formation for position 55(E18) mutants of CerHb using the simple two step 
mechanism shown in Fig. 5.6 and Equations 5.1 and 5.2 (74). 
A. Kinetic Parameters derived from NO and CO binding at pH 7.0, 20 oc 
Calculated rate parameters for two step mechanism 
CerHb k'No k'enny kescape Kenny kbond (!lM·1s-1) (!lM-1s·1) (fls-1) (!lM·1) (flS·1) 
AlaSS(WT) 230:t:30 640:t:400 76:t:40 8 4.0:t:3.0 
Val 55 140 260 20 13 3.8 
LeuSS 47 37 4 9 3.5 
Phe55 48 39 5 8 4.1 
TrpSS 45 34 5 6 4.1 
B. Kinetic Parameters derived from 0 2 Binding at pH 7.0, 20°C. 
Calculated rate parameters for two step mechanism 
CerHb k'No k'enny kescape Kenny kbond 
(!lM·1s·1) (!lM·1s-1) (fls·1) (!lM·1) (fls·1) 
AlaSS(WT) 230:t:30 620 79 8 51 
Val 55 140 310 27 12 37 
Leu 55 47 87 9 9 45 
PheSS 48 71 8 9 47 
TrpSS 45 73 8 10 47 
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At ambient temperatures, both geminate and overall ligand binding to CerHb can 
be analyzed in terms of three reactions: (I) photolysis to the intermediate state, where the 
ligand is in transient equilibrium between the C, B and tunnel positions, (2) rebinding 
to the Fe atom from this intermediate state at a rate equal to IQ,ond; and (3) escape from 
the intermediate state out through the tunnel past the Ala55(E 18) position at a rate equal 
to kescape (Fig. 5.6). The fraction and rate of geminate rebinding, Fgem and kgem, are then 
given by: 
F - kbond • k - k k 
gem - k + k ' gem - bond + escape 
bond escape 
Eq. 5.1 
These fractions and rates of internal recombination are obtained by fitting the observed 
geminate time courses to a single exponential expression, where the first order rate is 
kgem, and the normalized amplitude and offset are equal to Fgem and (1-Fgem) respectively 
(Fig 2.6 and(84)). These parameters can then be used to compute kbond and kescape as 
shown in Equation 5 .1. An expression for the overall bimolecular rate constant for ligand 
binding, k'x, where X is the ligand (02, CO, NO, etc), can be obtained by assuming a 
steady state approximation (d[I]/dt = 0) for the intermediate on J..I.S and ms time scales. 
Under these conditions, k'x is given by: 
' ' kbond k' F k' k~ 
kx = kentry = entry gem; entry = F 
k bond + k escape gem 
Eq. 5.2 
Equations 5.1 and 5.2 and the measured kinetic parameters for 02 and CO binding 
in Table 5.2 were used to compute estimates ofk'entry, kescape, and kbond for ligand binding 
to wt CerHb and the four position E18 mutants. The results are shown in Table 5.3 along 
with the k'No values. These parameters provide a self-consistent interpretation of both Oz 
Tyr11 (81 0) 
Leu86(G12) CerHb Gln44(E7) ~ Vai7(B6) 
~ B staty C state-{ 
Solvent oJ-.N'H _...0 O 0-0 ~---- Solvent 
\ 0 ' 
H H Thr48(E 11) - -
0 ,o HO~ ~ Apolar tunnel between 
A state 9 L the E and H helices 
~=::~~~~~~=:=:2 tE 
' Fe(ll) 
~ I 
0 N~ 
His(F8) t :,H 
hv or k-bond 
A or CerHb02 ~==========~~ 
kbond 
B,C, 'I" 
-50-500 ns 
geminate 
intermediate (I) 
I ~ 
multiple tunnel sites 
kescape 
k'entry 
--~ 0-0 
\ 
Ala55(E18) 
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Figure 5.6. Simple two-step mechanism for ligand binding to wild type and 55(E18) mutants of CerHb. Deng et al. (53) have shown that 
there are at least three distinct photodissociated states for CO at 3 to 100 K and made tentative assignments to specific cavities within the 
protein. The B state is close to the iron atom in cavity bounded by the porphyrin ring, Tyrll and PhelO. The C state appears to be located 
further into the protein underneath Va17. The D state (not shown) was reported to be in the distal pocket close to Gln44, Thr48, and Tyrll and 
thought to be on side path and that ligands either rebind from this state or move into the B to C to apolar pathway for escape (74). 
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and CO binding. The estimated value of kbond for 0 2 rebinding is, as expected, roughly 10 
times greater than that for CO,- 50 JJ.S-1 versus- 4 JJ.S-1• Both values ofkbond are 
independent of changes at the E 18 position, demonstrating that the amino acid at this 
remote location does not influence reaction at the Fe atom. In contrast, the values ofk'entry 
and kescape are roughly independent of ligand, but both rates decrease over 1 0-fold as the 
size of the position E18 amino acid is increased (Table 5.3). The correspondence of the 
absolute values ofk'entry and kescape calculated using the 0 2 and CO data is remarkably 
good, considering it is difficult to determine the exact values ofkgem and Fgem for 0 2• For 
this ligand, significant geminate rebinding is occurring during the laser excitation pulse 
and the fitted rate is approaching the rate of decay of the pulse light intensity. 
As described in the previous section, bimolecular rates of NO binding were 
measured to verify the computed values ofk'entry· NO is expected to show Fgem values 2::: 
0.95, and it was verified that CerHbNO has an extremely small quantum yield for 
complete photodissociation to solvent (data not shown). Thus k'No should be 
approximately equal to k'entry· As shown in Table 5.3 and the inset to Fig. 5.5, there is 
strong linear correlation between k'No and k'entry· However, the calculated values ofk'entry 
appear to be- 2-fold greater than k'No for wt and ValE18 CerHb. The cause of this 
discrepancy is probably the oversimplification inherent in the two-step model (Fig. 5.6). 
For wt and ValE 18 CerHb, the extent of geminate recombination is small; the rate of 
internal rebinding is large and difficult to define; and there are probably multiple steps 
that cannot be easily visualized using a 9 ns excitation pulse. In these proteins, the tunnel 
is open to solvent, and as a result the photodissociated ligands are not easily trapped in 
the intermediate state. Much more complex expressions define the overall rate constant 
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when contributions from the rates of interconversion of the B and C states are 
incorporated into the steady-state expression for k'entry· Evidence for these interior ligand 
transitions is seen in the kinetic data for mutations in the Band C sites (data not shown), 
complicating our larger mapping study of the entire pathway (see Chapters 6 and 7). In 
contrast, blocking the entrance to the apolar tunnel, simplifies the observed results 
leading to a single, well-defined geminate intermediate. As a result, there is a reasonably 
close correspondence between k'No and the calculated values of k'entry for the larger E 18 
mutants (Table 5.3). 
Perhaps the strongest argument in favor of the mechanism in Fig. 5.6 for 
interpreting the kinetic data is the independence of the estimated equilibrium constant, 
!<entry, for non-covalent capture ofligands in the intermediate state (i.e. in the tunnel and 
the space associated with state Band C) for all the E18 variants. The average computed 
value is- 9.1 ±2.0 M-1 for wt and the four E18 CerHb mutants, and does not vary with 
either ligand or the size of the residue at the entrance to the apolar tunnel (Table 5.3). The 
lack of dependence on the amino acid at the El8 position fits with the structures ofwt, 
Phe55(E18), and Trp55(E18), all of which show equivalent tunnel volumes of- 56 A3. 
The value for !<entry for ligand capture in wt SwMb is- 5.5 ±1.8 M-1, implying that the 
apolar tunnel in CerHb provides almost twice the volume for non-covalent ligand binding 
than the active site and Xe cavities in mammalian Mb (36). However, in wt SwMb a 
water molecule is present in the distal pocket reducing the effective volume for non-
covalent capture. When this water is removed by replacing His64(E7) with Leu, the value 
of Kentry for SwMb increases to -10 M-1, and similar values were estimated for ValE? and 
PheE7 Mb (36). Thus, when the water is removed, the functional volume in Mb, as 
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measured by the equilibrium constant for non-covalent ligand binding, is similar to that in 
the CerHb tunnel. 
5.8 Crystal structures ofPhe55(E18) and Trp55(El8) CerHb- The crystal 
structures ofthe Trp55(El8) and Phe55{E18) mutants were determined by Martino 
Bolognesi, Marco Nardini (University of Milan), and Alessandra Pesce (University of 
Genova) to visualize whether the large aromatic side chains do physically block the 
entrance to the apolar tunnel and to examine whether perturbations of the active site 
occur due to changes at the EF corner of the CerHb tertiary structure. The three-
dimensional structures ofPhe55{E18) and Trp55(E18) CerHb02 were refined to final R-
factor/R-free values of 18.8%/23.0% and 16.7%/21.3%, respectively, at 1.8 A and 1.6 A 
resolution, with good overall stereochemistry (for statistics and crystal parameters see 
Table 4 in Salter eta/. (74)). 
The overall tertiary structures of the mutant proteins are unaffected by the 
mutations at position E18 (Fig. 5.7A). The rmsd calculated between theCa atoms ofthe 
wt and mutated proteins is 0.15 A for both mutants, and only marginal readjustments are 
detected at the end of theE-helix and along the adjacent H-helical region (residues 97-
104) due to the larger aromatic side chains at position E18. When the two mutant 
structures are superimposed (overall rmsd of0.13 A), the phenyl ring ofPheE18 sits 
approximately in the center of mass ofthe indole ring ofTrpE18 (Fig. 5.7A). The Phe 
and Trp side chains make 19 and 26 favorable van der Waals contacts, respectively, with 
adjacent regions of the protein, and the TrpE18 indole Nb1 atom appears to form a weak 
hydrogen bond with the 062 atom of Asp104(H15). 
WT 
A Side view of CerHb02 B. Tunnels ~~~(t;~S'i' C. Back view of TrpSS CerHb02 D. Back view of PheSS CerHb02 
Figure 5.7. Protein matrix cavity in CerHb mutants. A, Superimposition ofwt (PDB ID: lkr7, gray), Phe55 (PDB ID: 2vyz, cyan) and Trp55 (PDB ID: 
2vyy, purple) crystal structures. Gln44(E7) and 55(El8) side chains are shown in ball-and-stick representation. B, Stereo view of the protein core cavities 
stretching from protein surface to the heme distal site for the wt (cyan ribbon), Ala55(E18)---7Phe mutant (green ribbon), and the Ala55(E18)---7Trp mutant 
(red ribbon). Protein cavities have been calculated with a 1.4 A radius probe using the program SURFNET (97), and represented as a net in brown color. 
Side-chains of the mutated residues at topological position E18 are shown in ball-and-stick representation. For comparison C, a back view of CerHb0
2 
Trp55 is displayed in spheres to demonstrate the blockade of the apolar tunnel by the indole ring designated by green spheres (74) and D , a back view of 
CerHb02 Phe55 where the phenyl ring is displayed in green spheres. 
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The PheE18 and TrpE18 side-chains fit into a surface cleft, located between the 
end of theE-helix and the beginning of the H-helix, bordered by surface residues 
His100(H11), Asp104(H15), and by main chain carbonyl groups ofthe 55-62 region (EF 
helical corner, Figs. 5.1 and 5.7). In wt CerHb this cleft is "open" and provides access to 
an elongated tunnel, lined by the hydrophobic residues Val7(B6), Phe10{B9), Ile52{E15), 
Ala55(E18), Leu86{G12), Leu98(H9), Ala101{H12), Ilel02(H13), Ilel05(H16), by 
hydrophilic residues Tyr11{B10), Thr48{E11), and Tyr51(E14), and by the heme B-
methyl and B-vinyl groups (See Figure 7.1B). The surface aperture ofthe cleft is 
bordered by residues Ala55(E18), Ala60(F1), Ala62(F2), and Asp104(H15) and has a 
diameter between 6.8- 7.7 A (Fig. 5.8). Thus, the major structural effect of the 
Ala55(E18) to Phe and Trp mutations is blocking access to the tunnel from the solvent 
phase {Fig. 5.7C). 
The blockage caused by the E18 mutations is shown in Fig. 5.7B, where protein 
cavities are shown as brown nets and were calculated using a 1.4 A radius probe and the 
program SURFNET (97). In wt CerHb, the apolar tunnel connects directly to the aperture 
between theE- and H- helices. In contrast, the entrance is almost fully blocked in by the 
aromatic rings of the PheE 18 and TrpE 18 side chains. The interior tunnel in the mutants 
appears as an isolated cavity of roughly the same size (57 A3) as that found in the wt 
protein (59 A3). In both mutants, the tunnel entrance hosts two water molecules hydrogen 
bonded to Ala101(Hl2) and Tyr51(E14), and to Asp104(H15) (Fig. 5.8). The presence of 
these water molecules suggest dynamic opening of the channel, even in the presence of 
the TrpE 18 indole side chain. This interpretation is supported by the observation that 
rates of 0 2 association and dissociation seem to reach a lower limit when the size of the 
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Figure 5.8. Surface aperture of the cleft in Trp55(E18) CerHb (PDB ID: 2vyy). Residues Ala55(El8), 
Ala60(Fl), Ala62(F2), and Asp104(H15) surround the opening of the apolar tunnel in CerHb. Structural 
representation of the TrpE18 CerHb mutant was chosen to demonstrate the presence of two water 
molecules (red spheres) hydrogen bonded (blue dashed lines) to residues AlalOl , Tyr51 , and Aspl04 in 
both Trp55(E18) and Phe55(El8) (PDB ID: 2vyz) mutant models. The carbon backbone of the protein is 
represented by gray sticks, key amino acid residues are represented by sticks, and the sticks of Trp55 
mutation have been reduced in radii so that residues behind this position may be visible from this back 
perspective. From this perspective, it can be easily imagined that Ala55 reveals an "open" cleft. Protein 
structure generated in MacPyMol. 
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side chain at E18 reaches that of Leu, and no significant additiona1lowering occurs for 
Phe or Trp (Table 5.2). In addition, the fractions of CO and 0 2 geminate recombination 
do not increase to 1.0 but limit off at values of- 0.5 and- 0.85, and imply either the 
presence of alternative routes or a reasonably high frequency of opening the tunnel, 
evenin the presence ofPheE18 and TrpE18 side chains (Table 5.2). 
5.9 Multiple conformations ofGln44(E7)- Even though there appear to be few, 
if any, changes in the positions ofthe Ca atoms in theN-terminal region ofthe E-helix 
and the CD corner (Fig. 5.7A), the amide side chain ofGln44(E7) is found in two 
conformations (each refined to 0.5 occupancy) in both the PheE18 and TrpE18 mutant 
structures (Fig. 5.9). The electron density clearly defines two positions of roughly equal 
occupancy, which will affect electrostatic fields in the active site and could potentially 
influence rates of02 binding and the FTIR spectra ofbound CO. This double 
conformation is particularly well defined in the TrpE 18 CerHb02 structure, perhaps due 
to the higher resolution X-ray diffraction data (1.6 A). The innermost Gln44(E7) 
conformer exactly matches the rotamer found in the oxygenated wt protein, and appears 
to form a hydrogen bond between the Gln44(E7) Ne2 atom and the 01 of the bound 
ligand (01-Ne2 distances of2.61 A and 2.66 A in the PheE18 and TrpE18 mutants, 
respectively). The Gln44(E7) Ne2 atom may also weakly interact with the Tyr11(B10) 
hydroxyl 0~ atom (distances of3.26 A and 3.28 A in PheE18 and TrpE18 mutants, 
respectively) and with the Thr48(E11) Oy1 atom (distances of3.36 A and 3.25 A in the 
PheE18 and TrpE18 mutants, respectively). 
In the second outermost conformation, the Gln44(E7) side-chain is rotated 
outward towards the solvent interface by - 45° about Ca-Cj3 and the amide NH2 and 0 
E-helix 
A. Trp55 CerHb02 
(electron density) 
B. Trp55 CerHb02 (conformations) 
B-helix 
C. Phe55 CerHb02 (conformations) 
B-helix 
Figure 5.9. The distal pockets of the Trp-55 (A and B) and the Phe-55 (C) mutants. Residues Phel0(B9), Tyrll(BIO), Phe25(CD1 ), Ala40(E3), 
Gln44(E7) (in double side-chain conformation), Lys 47(El0), and Thr48(Ell ), the dioxygen molecule (red), the heme group (red), and part of the 
polypeptide chain path are shown in ball-and-stick and ribbon representations. The proximal HisF8 residue and selected water molecules (see text) are 
also shown. Hydrogen bonds are drawn as dashed lines (blue for between protein atoms and green for interaction between protein atoms and water 
molecules). Weak electrostatic interactions may also occur between the innennost Gln44(E7) atom and the Tyr 11 (B 1 0) hydroxyl but are not shown 
(74) . 
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atoms have been modeled to switch positions by a 180° rotation about Cj3-Cy (Fig. 5.9B). 
As a consequence, polar interactions with the bound ligand, Tyrll(BlO), and Thr48(Ell) 
are lost. However, in the outer conformation ofTrpE18 CerHb02, the Gln44(E7) Ne2 
atom appears to be part of a hydrogen bonding network that connects the carbonyl of 
Ala40(E3) to theN~ ofLys47(E10) through well-defined water molecules, and there may 
also be electrostatic interactions with the heme propionates. This network is less well 
defined in the PheE18 structure. 
Note that in all the structures, the Thr48(Ell) Oyl atom is accepting a strong 
hydrogen bond from the hydroxyl proton ofTyrll(BlO) (2.48 A and 2.56 A in PheE18 
and TrpE18 CerHb02, respectively). Thus, bound ligands are experiencing a strong 
negative field from the non-bonded electrons ofthe 0~ atom ofTyrll(BlO), which 
accounts for the moderate 0 2 affinity (Table 5.2 and Fig. 4.5A) and high stretching 
frequency ofbound CO (~1980 cm-1 (53, 62)) for wt CerHb and all five position E18 
mutants. As described in Chapter 4, mutation of Thr48(E 11) to Val causes a dramatic ~ 
200 fold increase in 0 2 affinity and shift ofvc-o to~ 1930 cm-1 which signifies rotation 
of the Tyrll(BlO) proton back to the bound ligand, creating a strong and favorable 
positive electrostatic field (Fig. 4.5B). This key role ofThr48(Ell) in regulating 02 
binding in CerHb and a complete discussion of the associated electrostatic interactions is 
given in Chapter 4 and Pesce eta/. ( 62). 
The outward rotation of Gln44(E7) in the E 18 mutants is puzzling for two 
reasons. First, it is not clear how mutations at the end of theE-helix cause this 
conformational shift of the E7 side chain without causing a significant effect on the 
position E7 Ca atom. A simple interpretation would be that the larger Phe and TrpE18 
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side chains sterically clash with the adjacent H-helix, decreasing the angle of the E-F 
comer, pushing theE- helix slightly toward the distal surface of the heme, and forcing the 
GlnE7 side chain out of the active site. The inner surfaces of theE- and F- helices are 
slightly closer in the TrpE 18 structure, but the changes are very small and this idea 
remains speculative. However, as will be discussed in Chapter 6, similar multiple 
conformations ofGln44(E7) are observed in wt met CerHb and in Leu86(G12)Ala 
mutants containing bound Xe. 
Second, if the E7 residue served as a gate for ligand entry and exit, then the 
outward movement of the GlnE7 side chain would be expected to increase the rates of02 
association and dissociation and decrease the fraction of geminate recombination by 
enhancing the rate ofligand escape. However, the PheE18 and TrpE18 mutations cause 
the opposite effect, decreasing k'02 and ko2 and increasing the fraction of internal 
rebinding. In addition, the outer Gln44(E7) conformer does not create a significant 
opening to solvent, even though there is net movement away from the Fe atom {Fig. 5.9). 
In wt SwMb, protonation of the imidazole side chain ofHis64(E7) at low pH causes an 
upward and outward rotation into a truly "open" conformation, creating a direct channel 
from solvent to the Fe atom (98). A similar opening is created by the Phe46(CD4) to Val 
mutation in MbCO and deoxyMb (99). In contrast, access to the Fe atom is still blocked 
in the outer Gln44(E7) conformer ofTrp55{El8) CerHb (Fig. 5.9). 
The other remarkable result in Table 5.2 is that the 02 affinity of all the E 18 
mutants are, within the error limits(± 20%), virtually the same as that ofwt CerHb 
(Table 5.2), and the stretching frequency ofbound CO is unaffected by the PheE18 and 
TrpE18 substitutions (74). These results suggest that the exact conformation of 
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Gln44(E7) has little effect on either the rate or equilibrium constants for ligand binding. 
This conclusion is partially supported by the results for the position E7 mutants in Table 
5.1. The AlaE?, ValE?, and LeuE7 mutations have little affect on the rate and 
equilibrium constants for ligand association and, unexpectedly, cause small to moderate 
decreases in the rate of 02 dissociation. However, the PheE7 and TrpE7 mutations cause 
marked decreases in k'02 with little change in ko2• The simplest interpretation of the latter 
results is that the large aromatic side chains occupy the inner conformation and sterically 
hinder access to the Fe atom and the bound ligand. Further multiple mutations and 
structure determinations are needed to verify this interpretation; however, it is clear that 
the naturally occurring Gln44(E7) side chain does not appear to be part of the main 
pathway for ligand entry and escape. 
5.10 Conclusions- Taken together, the kinetic and structural data for the position 
El8 mutants suggest strongly that the major pathway for ligand entry and exit in CerHb 
is the apolar tunnel between theE- and H- helices, which is shown in Figs. 5.1, 5.6, 5.7, 
and 5.8. Increasing the size of the amino acid at this position increases the free energy 
barrier to ligand movement from the solvent interface into the apolar channel. Changing 
the size of the barrier only affects the rates of entry and exit and not the rate of Fe-ligand 
bond formation, the equilibrium constant for non-covalent ligand capture, nor the overall 
affinity ofCerHb for ligands. The lack of further decreases in either k'entry or kescape as the 
size of the E 18 amino acid is increased from Leu to Phe to Trp suggests that the small, 
limiting values of these parameters,~ 50 J.!M-1s·1 and~ 6 JlS-1, respectively (Table 5.3) 
may represent the rates of ligand movement through alternative pathways, including the 
E7 gate. These rates are remarkably similar to the values estimated for entry into and exit 
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from wt SwMb which uses the E7 channel where k'entry;::: 34±7 J.LM-1s-1 and kescape;::: 6.3±1 
J.LS-1 (36). 
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Chapter 6: Defining the Tunnel with Xe Binding and Internal Mutations 
*Much of the prose, figures, and references that appear in this chapter were taken from 
Pesce et al. (1 00). The use of quotation marks has been omitted from this section to avoid 
redundancy. 
6.1 Introduction -As highlighted by the previous structural and functional studies 
(42, 53, 62, 74), a wide elongated tunnel, about 10 A long, >100 A3 in volume as defined 
by a 1.4 A probe, crosses through the CerHb protein matrix. The tunnel is located 
between theE- and H-helices and directed from the solvent near residues Ala55(E18) and 
HislOO(H11) to the heme distal site where it is terminated by Val7(B6), Phe10(B9), and 
Thr48(E11) (Fig. 5.1). The tunnel is mainly lined by hydrophobic residues, with its inner 
part characterized by a diameter varying from a minimum of 5.5 A to a maximum of 6.9 
A, the narrowest segment corresponding to the site occupied by Leu86(G12) (42). 
Diatomic ligands could enter and exit CerHb through the apolar tunnel, whose access 
from the solvent space is facilitated by the absence of the A-helix, the wide tunnel cross-
section, and the short spans of some of the globin helices. As shown in the preceding 
chapter, obstructing the tunnel entrance by increasing the size of Ala55(E18) to Phe and 
Trp causes an- 4-fold decrease ofboth k'02 and k02, an increase in the fraction of 
geminate CO recombination, Fgem, from -Q.05 to 0.45, and a decrease ofthe rate of 
geminate CO recombination, kgem, from -80 ).lS-1 to -9 ).lS-1, as ligands are increasingly 
trapped in the tunnel and inhibited from escaping. Kinetic experiments on Gln44(E7) 
mutants indicated that a classical E7-gating mechanism for ligand entry and exit, as found 
in HbA (73, 78) and Mb (101), is unlikely to be operative in CerHb. 
Apolar cavities and tunnel systems have been suggested in selected families of 
heme-containing proteins, although, relative to CerHb, these are located at slightly 
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different positions within the overall globin fold topology (102-104). In this chapter the 
structural and kinetic features of CerHb that relate to ligand diffusion within the middle 
of the protein tunnel system is the point of focus. At Rice University, George Blouin and 
I obtained direct experimental evidence of access to the heme pocket via the internal 
tunnel by forcing Xe atoms into CerHb at high pressures and then determining the effects 
on CO binding. Alessandra Pesce and Martino Bolognesi in Italy then determined the 
crystal structure of a mutant containing bound Xe ( 1 00). These structural data were 
complemented by ligand-binding kinetics measured at Rice University for 
Leu86(G 12)Ala, Phe, and Trp mutants, where these substitutions modulate the shape and 
dimensions of the protein tunnel. In addition, the Bolognesi group determined crystal 
structures of the Xe-free oxygenated Leu86(G12)Ala mutant and the aquo-met wt CerHb 
species, which allowed an examination of the tunnel, rates of ligand binding, and changes 
in orientation of the GlnE7 side chain. Despite small conformational changes at the E7 
position, the Gin gate never opened and ligands seem to move primarily through the 
tunnel (1 00). 
6.2 Crystal structures of Ala86(Gl2) CerHb02 and its Xe derivative- To 
examine the accessibility of the internal regions of the apolar tunnel, mutants at position 
86(G 12) were constructed and sent to our collaborators in Italy for crystallization. 
Suspensions of crystals ofwt CerHb02 were equilibrated with high pressures of pure Xe 
gas. Xe has been used previously to identify cavities in a variety of other Mbs and Hbs 
(102, 103, 105-109). Unfortunately, wt CerHb02 crystals quickly lose diffraction power 
after exposure to Xe, even at low pressure and short times. This effect could be due to Xe 
binding at intermolecular crystal contacts, causing disruption ofthe crystal lattice, or to 
Xe binding within the apolar channel, expanding the protein and indirectly disrupting 
intermolecular contacts. 
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To solve this problem, the Leu86(G12)Ala CerHb02 mutant was crystallized and 
its structure determined (2xkg). In this mutant the constriction near the center of the 
tunnel is relieved by removal of three side chain carbon atoms at the G 12 helical position. 
When crystals of AlaG 12 CerHb02 were exposed to high pressures of Xe, diffraction 
persisted after incubation with ~ 10 atm of Xe, and a full data set was successfully 
collected at 2.3 A resolution (2xkh, Fig. 6.1). The resulting structure was refined to a 
final R-factor of 19.4% and R-free of26.6 %, respectively, and compared to the 
independently determined structure of the Xe-free L86A CerHb02 mutant, for which a 
full data-set was collected to 1.6 A resolution and a model refined to final R-factor and R-
free values of 15.4% and 18.6 %, respectively (Fig. 6.1, (100)). 
The backbone structure of Xe-free A1aG 12 CerHb02 is virtually identical to that 
ofwt CerHb02, with an rms deviation of0.15 A calculated for all109 Ca atom pairs. 
Other than the replacement of the iso-butyl group at position G12 with a methyl carbon, 
the only significant structural differences between the mutant and wt structures are small 
rotations of the side chains ofLeu98(H9) and Ile101(H13). The net result of these 
changes and the Ala replacement is an increase in the tunnel inner diameter and volume 
by ~ 1.9 A and 36 %, respectively. This increase either promotes preferential Xe binding 
in the channel versus binding to external sites that disrupt the crystal lattice or facilitates 
internal Xe binding without requiring expansion of the protein structure and subsequent 
alterations in intermolecular packing. 
Ala86 CerHb02 + 1 0 bar Xe 
lle105 
A. Side View B. Back View C. Back View, Electron density 
Figure 6.1 Effects of 10 atm Xe on the structure of L86A CerHb02 (PDB code 2xkh). A, Side view looking through the heme propionates into the 
protein interior. B, Back view looking between theE and H helices through the apolar tunnel. The empty space in the tunnel is highlighted in gray. The 
heme group, proximal His, and Gln44(E7) are shown as sticks with 0 atoms in red, N atoms in blue, and C atoms in white. The Xe atoms are shown as 
green spheres at half their van der Waal radii to indicate partial occupancy and designated as Xel and Xe2. The Ala86(Gl2) and Ala55(El8) methyl 
side chains are shown as green sticks. C, Electron density maps of the amino acids and Xe atoms lining the tunnel using the same orientation as in panel 
B. Amino acid side chains are shown as ball and stick models and the Xe atoms drawn as green spheres. The electron densities (2Fo-Fc map contoured 
at Is) are shown in magenta for the side chains and in blue for the Xe atoms (100) . 
102 
103 
The heme cavity ofXe-free AlaG12 CerHb02 is virtually identical to that ofwt 
CerHb02 (Table 6.1). The general conservation ofheme distal site structure and ligand-
stabilizing interactions in wt CerHb02 and in the Xe-free AlaG12 mutant is supported by 
their similar kinetic parameters for diatomic ligand binding (Tables 6.2-6.4) and ensures 
that this mutant is a reliable model for studying ligand diffusion through the apolar 
tunnel. The structure of the AlaG12 mutant containing bound Xe is also vecy similar to 
that ofwt CerHb02, with an rms deviation of0.19 A for alll09 Ca atom pairs. 
Inspection of the residual difference electron density, after the initial refinement of the 
Xe-bound mutant, indicated the presence of two Xe atoms (Xel and Xe2) at refined 
occupancies of ~65% and temperature factors of36 A2 and 22 A2, respectively (Fig. 
6.1). The Xel-site is directly adjacent to Ala86(Gl2) and surrounded by the ring B vinyl 
carbon atoms of the heme, the terminal side chain atoms ofPhelO(B9) and Ile52(El5). 
The Xe2 site is adjacent to the Xel site, surrounded by the ring B methyl group of the 
heme, Tyr51(E14), Leu98(H9), Alal0l(Hl2). and Ilel02(H13) and is near Ala55(El8) 
and the exit to solvent. Together both atoms fill the empty space located in the protein 
interior (transparent gray net in Fig. 6.1) and help define the apolar channel. Both Xe 
atoms appear to be stabilized by favorable van der Waals contacts with the apolar carbon 
atoms ofVal7(B6), Phe10(B9), Thr48(Ell), Tyr5l(El4), Ile52(El5), Ala55(El8), 
Ala86(Gl2), Leu98(H9), Alal0l(Hl2). and Ilel02(H13). 
Unexpectedly, Xe binding to the AlaG12 mutant induces small, but readily 
detectable changes in the position of the Gln44(E7) side chain, which alter the hydrogen 
bonding lattice near bound 0 2 and the heme propionates (Fig. 6.2). The model for Xe-
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Table 6.1. Distances between polar atoms in the distal pockets of L86A CerHb02, wild type 
CerHb02, and wt aquomet CerHb. The in and out conformation of the Gln44(E7) side-chain are 
indicated by the superscript "i" and "o" letters (100). 
wt Xe-free Xe-bound wtaquomet 
CerHbOz L86A L86A CerHb 
(1kr7)a CerHbOz CerHbOz (2xki) 
(2xkg) (2xkh) 
Fe---02 (A) 1.94 1.97 1.90 
Fe---wat(Fe3•) (A) 2.14 
Fe-01-02 angle (A) 103 110 -105 
Tyrll(B10) OH---02 (A) 2.57 2.47 2.46 
Tyrll(B10) OH---water(Fe3•) (A) 2.87 
Gln44(E7) NE2---01 (A) 2.60 2.96 
Gln44(E7) NE2---02 (A) 2.651,0 
Gln44(E7) NE2---water(Fe3•) (A) 2.721, 7.13° 
Tyrll(B10) OH---Thr48(Ell) OG1 (A) 2.59 2.62 2.75 2.68 
Tyrll(B10) OH---Gln44(E7) NE2 (A) 3.24 3.33 3.41', 7.97° 3.59 
Gln44(E7) NE2---Thr48(Ell) OG1 (A) 3.53 3.34 3.48', 7.50° 3.34 
Gln44(E7) NE2-solvent water (A) 2.72° 2.83° 
Solvent water---Ala40(E3) 0 (A) 2.59° 2.73° 
3 Structure reported in Pesce et a!. ( 60). 
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C. CerHb(Feiii)OH2 
B.ED Map, L86A + Xe CerHb02 D. ED Map, CerHb(Feiii)OH2 
Figure 6.2. Multiple conformations of Gln44(E7) in various structures of CerHb. A, Xe-bound L86A 
CerHb02 (2xkh, cyan color) showing the distal pocket, E helix, multiple conformations of Gln44(E7), and 
bound 0 2. B, The electron density maps, ED (2Fo-Fc map contoured at ls) for Xe-bound L86A CerHb02 is 
shown in magenta for the double conformation of Gln44(E7), the heme group, and the oxygen molecule 
coordinated to the iron atom for the Gln44(E7) chain refined in two (in and out) conformations. C, wt 
aquomet CerHb (2xki, green color) showing the heme pocket, E-helix, in and out conformers of Gln44(E7), 
and coordinated water. D, Electron density maps (2Fo-Fc map contoured at ls) for wt aquomet CerHb are 
shown in magenta for the heme group, the heme-coordinated water molecule and for the Gln44(E7) side 
chain refined in two (in and out) conformations. In the upper panels A and C, the Gln44(E7) side chain 
conformer from wild-type CerHb02 (1 kr7) is superimposed as white sticks. The position of bound 0 2 in wt 
CerHb02 is also shown in panel A as white sticks. Residues Tyrll(BlO), Gln44(E7), Lys47(El0), and 
Thr48(Ell) are represented as sticks; heme-bound 0 2 and coordinated H20 are represented as red sticks; 
the heme group is displayed as sticks with the C atoms either light blue (panel A) or green (panel C), the Fe 
atom orange, and N and 0 atoms blue and red, respectively; external water molecules are displayed as red 
spheres; and hydrogen bonds are drawn as dashed black lines (1 00). 
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bound AlaG 12 CerHb02 indicates that the second bound 0 atom rotates outward toward 
the solvent interface and closer to the terminal 0 or N atom of Gln44(E7) (Fig. 6.2A). 
The B factors for the 02 molecule (Boo)= 35 A2, Bo(2) = 38 A2) show a higher degree of 
mobility relative to that in wt CerHb (Bo{I) = 23 A2, Bo{2) = 28 A2). This difference in 
mobility and orientation ofbound 02 is coupled to conformational heterogeneity of the 
Gln44(E7) side chain. 
The innermost Gln44(E7) conformer is close enough to stabilize the ligand by 
hydrogen bonding if the Ne atom is close to the second bound oxygen atom. The 
Tyr11(B10) hydroxyl H atom is still hydrogen bonded to the Thr48(E11) hydroxyl 0 
atom, and the non-bonded electrons of the Tyr11(B10) hydroxyl 0 atom are still close 
enough to bound 02 to destabilize it. Thus, the 0 2 dissociation rate constant is expected 
to be large, as is observed for both AlaG 12 and wt CerHb02. However, in the Xe bound 
structure of the AlaG 12 mutant, Gln44(E7) is too far away to interact electrostatically 
with Tyr 11 (B 1 0) and Thr48(E 11) in either of its conformations (Fig. 6.2A and Table 
6.1). 
In the outermost conformation ofGln44(E7) in Xe-bound L86A CerHb02, the Ne 
atom is postulated to move out toward solvent by an -180 o rotation about the Ca-Cy 
bond. A smaller -30 o rotation about the Ca-C(3 bond moves the entire GlnE7 side chain 
away from the Fe atom. In this conformation, the GlnE7 side chain has lost contact with 
the ligand and, instead, is stabilized by a hydrogen bonded network linking the Ne atom 
to the carbonyl oxygen of Ala40(E3) and the heme A propionate carboxyl groups through 
two well defmed water molecules (Table 6.1 and Fig. 6.2A). 
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Similar in and out conformations for Gln44(E7) occur in the structure of the wt 
aquomet CerHb (Fig. 6.2B). The terminal amide side chain atoms in the innermost 
conformation appear to be interacting with bound water, whereas in the outer 
conformation the amide side chain has moved away from the coordinated ligand and is 
again fixed in position by a hydrogen bonding water network involving the carbonyl of 
Ala40(E3). In both the in and out conformers of met CerHb, there is an electrostatic 
interaction between Lys47(E10) and the heme-7-propionate. In the out conformers of 
both Xe bound L86A CerHb02 and wt met CerHb, the Gln44(E7) amide side chain still 
blocks access to the Fe atom by filling the outer portion of the channel between theN-
terminal region of theE-helix and the heme propionates. This position contrasts with the 
truly out position ofHisE7 in SwMbCO when it is protonated at low pH or when 
Phe46(CD4) is mutated to Val (98, 99). 
6.3 Effects of Xe binding on geminate CO recombination - The location of 
bound Xe in the middle of the apolar channel suggests that escape of photolyzed ligands 
should be inhibited when samples are equilibrated with high pressures of the gas, and this 
prediction was confirmed experimentally. As shown in Fig. 6.3, the fraction of geminate 
recombination (F gem) for both wt and AlaG 12 CerHbCO increases almost linearly with 
increasing Xe pressure, from~ 0.1 at 0 atm to~ 0.35 at 15 atm (Table 6.2). Equilibration 
with 15 atm ofN2 had no effect on F gem for wt CerHbCO, ruling out a non-specific 
pressure effect (Fig. 6.3A). As observed previously for geminate 02 rebinding (36), there 
is no effect of 15 atm of Xe on the fraction of CO rebinding in Mb, which remains close 
to zero (expected value is 0.05, Fig. 6.3B). The linear dependence ofF gem on Xe pressure 
indicates weak binding of the gas to CerHbCO in solution, with a Pso > 15 atm. The 
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Figure 6.3. Effect of Xe on CO geminate recombination in wild type and L86A CerHbCO at pH 7.0, 
20 °C. The smooth solid black lines represent fits to single or double exponential functions with an offset. 
The gas pressure above each solution is marked next to each time course. There was no effect of 15 atm of 
Xe on geminate rebinding in wild type sperm whale Mb (WT MbCO, B) nor was there an effect of 15 atm 
ofN2 on geminate recombination in wild-type CerHbCO (A) (100). 
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Table 6.2. Rate constants for bimolecular and geminate recombination of CO with wild type and 
L86A CerHb at pH 7, 20 °C (100). 
CerHb /(co kgem,CO Fgem.CO /(en~, co J.!M-1s-1 JlS-1 l:!M- s-1 
Leu86(wtt 32±5 80±40 0.05±0.03 640±400 
Leu86(wt) + Xe (15 atm) 26 63±10 0.29±0.5 90 
Ala86 30 ;:::150, 15 0.13 190 
Ala86 + Xe (15 atm) 27 ;:::150, 28 0.34 80 
• The numbers for wt CerHb are based on the average of all determinations for the past 6 years (2: I 0 
separate preparations, see (5, 8, 9)). The error in k'entry is very large because Fgem is close to 0.0, poorly 
defined, and has an error of± 60 %. When Fgem is 2: 0.1, the error in k'entry diminishes greatly to-± 20 %. 
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fractional occupancy estimated from the crystal structure at 10 atm ofXe was~ 0.65 
indicating a somewhat high affinity under the crystallization conditions. Assuming a 
lower estimate of 15 atm for the P50 of both Xe sites, the extent of geminate 
recombination at full occupancy of sites 1 and 2 is predicted to be~ 0.7 compared to~ 
0.1 when the channel is completely open. Thus, Xe binding in the channel reduces the 
extent of CO escape at least 7-fold, strongly supporting the view that the apolar channel 
is the major pathway for ligand escape. 
6.4 Effects of Leu86(Gl2) CerHb mutants on bimolecular and geminate 
recombination- The Xe1 and Xe2 sites are located near to side chains at the G12 and 
E18 helical positions in the apolar tunnel (Fig. 6.1 ). The effects of increasing the size of 
the amino acid at the Ala55(E18) position have already been examined and it was found 
that Leu, Phe, and Trp substitutions trap CO in the tunnel after laser photolysis, increase 
Fgem to~ 0.50 (Table 5.2B), and decrease the bimolecular rate constant for ligand entry 
roughly 10-fold from ~500 JlM-1s-1 to ~50 JlM-1s-1 (Table 5.3B). To examine the Xe1 site, 
ligand binding to AlaG12, PheG12, and TrpG12 mutants was measured (Figs. 6.4 and 6.5 
and Tables 6.3 and 6.4). 
The PheG 12 and TrpG 12 CerHbCO mutants show progressive increases in 
geminate recombination, with F gem for the TrpG 12 mutant being roughly the same as that 
for the TrpE18 variant. However, for the G 12 mutants, the rates of geminate 
recombination remain very large, 2: 100 J..lS-1 compared to that for the TrpE18 mutant, 
which is 10-fold smaller, ~10 J..lS-1 (Fig. 6.4 and Table 6.5). The simplest interpretation is 
that TrpG12 keeps the photodissociated ligand closer to the Fe atom, facilitating its 
111 
1.1 
E 1.0 c 
Hb/ T CD (\') 0.9 "¢ (I) 0.8 C) 
Fgem c ro 
.c 0.7 u 
(I) 0.6 u c 
ro 
.0 0.5 .... 
0 (/) 
.0 0.4 <( 
"'0 0.3 (I) 
.!:::! 
-a; 0.2 hv CO geminate rebinding 1~ E .... 0 0.1 z 
0.0 
-0.1 0.0 0.1 0.2 0.3 0.4 0.5 
Time IJS 
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Figure 6.5. NO binding to position 86(Gl2) mutants of CerHb at pH 7.0, 20 °C. Time courses for NO 
binding after photolysis of 86A(L86A), 86F(L86F), 86W (L86W), and wt CerHbCO complexes at low 
[CO] and high [NO] are represented by black lines. The smooth gray lines represent fits to a single 
exponential function with an offset. The Inset shows the linear dependence of kobs (s-1) on [NO] with a y-
intercept of zero (1 00). 
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rebinding and lowering the en tropic barrier to bond reformation. In the TrpE 18 mutant, 
the entire tunnel is available to dissociated ligands because only the exit to solvent is 
blocked, and, as a result, both rebinding to the heme Fe and escape from the tunnel are 
slower. 
The rates of02 and CO binding to the position G12 mutants are compared to 
those for wt and TrpE18 CerHb in Table 6.3, and a summary ofNO association and 
calculated bimolecular rates ofligand entry are presented in Fig. 6.5 and Table 6.4. Both 
the association and dissociation rate constants for 0 2 binding decrease 2 to 3-fold when 
LeuG 12 is replaced with Trp, demonstrating that the indole ring limits both diatomic gas 
escape and entry into the active site, but has little effect on overall affinity. A similar- 3-
fold decrease in the rate of NO binding is observed, and, as shown in the inset to Fig. 6.5, 
the observed rates are linearly dependent on ligand concentration. 
Estimates ofk' entry based on bimolecular association rate constants and Fgem 
values for CO binding to wt and mutant CerHb are given in Table 6.4. (Note k' entry,CO = 
k' coiF gem, see Equation 5.2.) Equilibrating AlaG 12 CerHb with 15 atm ofXe causes a 2:: 
2-fold decrease in the estimated value ofk' entry (Table 6.2). Assuming that the two Xe 
sites are :S 50 % occupied, this result suggests that filling the Xe I and Xe2 pockets would 
probably decrease k' entry at least 4 to 5-fold. Similarly, the TrpG 12 mutation decreases the 
calculated k' entry value- 6 fold compared to the computed value for AlaG12 CerHb 
(Table 6.4). The magnitude of this decrease is similar to that observed for the TrpE18 
mutation, either calculated from CO binding data or estimated from k'No values. Thus, 
both geminate recombination and overall ligand binding data, demonstrate 
Table 6.3. Rate and equilibrium constants for 0 2 and CO binding to position 86(G12) and 55(E18) mutants of 
CerHb at ~H 7.0, 20 °C (100). 
CerHb k'02 k02 K02 k'co kco Kco Kco!Koz M-1 -1 s-1 M-1 M-1 -1 s-1 M-1 1:!: s 1:!: 1:!: s 1:!: 
Ala55/Leu86 230±17 190±25 1.2±0.2 32±5 0.054±0.005 590±100 490±110 (wtt 
Ala86 230 153 1.5 30 0.053 570 380 
Phe86 120 71 1.7 24 0.024 710 600 
Trp86 97 60 1.6 16 0.014 1100 700 
Trp55 63 66 0.95 15 0.029 500 520 
a The numbers for wt CerHb are based on the average of all determinations for the past 6 years (~ 10 separate 
preparations, see Table 6.1 ). 
Table 6.4 Observed bimolecular rate constants for NO association and calculated rate parameters for ligand 
entry int()_ 86{G12) and 55(E18) mutants ofCerHb at pH 7.0, 20 °C (100). 
CerHb k'No kgem, CO Fgem. CO k'entry, CO I!M-1s-1 J!S-1 J.l,M-Is-1 
AlaS 5/Leu86( wtt 230±30 80±40 0.05±0.03 640±400 
Ala86 200 ~150, 15 0.13 190 
Phe86 110 ~150,53 0.17 140 
Trp86 67 ~80 0.52 31 
Trp55 45 9.4 0.44 33 
a The numbers for wt CerHb are based on the average of all determinations for the past 6 years (~ 10 separate 
preparations, see Table 6.1). 
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unambiguously that the dominant pathway for ligand entry and escape is the apolar 
tunnel, which is defined by the Xe binding sites. 
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6.5 The size and accessibility ofthe apolar channel- The crystal structure of 
AlaG 12 CerHb02 equilibrated with ~ 10 atm of Xe demonstrates that the apolar cavity 
between theE- and H- helices is readily accessible to apolar gases (Fig. 6.1). Xe binding 
to both wt and AlaG12 CerHbCO causes a significant increase in Fgem (Fig. 6.3), 
demonstrating experimentally that occupancy of the apolar cavity blocks ligand escape. 
Assuming a partial pressure of 15-20 atm for 50% saturation of the Xe sites, the 
predicted extent of CO trapping inside the protein could be as large as 75 % when both 
Xe sites are filled. 
The kinetic results in Fig. 6.3 show that in solution Xe binds within the apolar 
channel to roughly the same extent in wt and in AlaG 12 CerHb, but only the crystals of 
the AlaG12 variant were stable under high pressures ofXe gas. In general, wt and 
AlaG 12 CerHb have almost identical ligand binding properties and crystal structures, 
implying that the LeuG 12 side chain has only a small effect on the functional properties 
of the protein. However, wt crystals become disordered in response to Xe binding, 
presumably because expansion of the channel near the Leu86( G 12) position leads to 
disruption of intermolecular packing. 
As in the case of Xe binding, the extent of geminate recombination increases 
significantly, to ~50%, when the size ofthe Leu86(G12) side chain is increased (Fig. 
6.4). The PheG 12 and TrpG 12 mutations also cause significant decreases in both k' 02 and 
k02, with little change in affinity as would be expected if the pathway for ligand entry and 
exit were blocked (Table 6.3). The magnitude of this TrpG 12 effect is similar to that 
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observed when exit from the tunnel into solvent is blocked by the TrpE18 mutation (Fig. 
6.4 and Table 6.3). In contrast to 02 binding, there is little change in k' co because the 
major rate limiting step for CO binding is internal bond formation with the Fe atom, 
which is little affected by mutations in the tunnel that are 8 to 12 A away from the active 
site. In contrast, the tunnel mutations cause large decreases (4-5 fold) of the rate constant 
for bimolecular NO binding, which is limited only by movement into the protein {Table 
6.4). Similar decreases are obtained for the bimolecular rate constant ofligand entry, 
k' entry, calculated using k' co, Fgem, and Equation 5.2 {Table 6.4). 
6. 6 Pathway for ligand binding - The results in this chapter show unambiguously 
that filling the apolar cavity, with either Xe atoms or large aromatic amino acids at 
position 86(G 12), markedly inhibits ligand entry and exit and increases both the rate and 
extent of geminate recombination. The simplest interpretation of these results is shown in 
Fig. 5.6 in the previous chapter, which was first proposed by Deng eta/. (53) and refined 
by Salter eta/. (74). The apolar tunnel containing the Xe binding sites is assumed to be 
the major pathway for ligand entry and escape. Laser excitation photodissociates the Fe-
ligand bond, generating an initial intermediate with ligand remaining in the distal pocket 
(state B). From there the ligand can either rebind or move into the apolar tunnel, both of 
which are rapid processes. However, once inside the tunnel, the ligand can occupy 
multiple locations in the large space between the distal pocket and the solvent aperture. 
This larger space slows return to the Fe atom and geminate recombination, allowing most 
of the ligands to escape into solvent. 
When Xe atoms or the indole ring of TrpG 12 block the initial portion of the 
tunnel, ligands are trapped in or very near to the distal pocket and rapidly rebind to the Fe 
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atom, and large values ofkgem and Fgem are observed (Fig. 6.4, Tables 6.2 and 6.4). The 
ligand molecules that move past the bound Xe atoms or the TrpG 12 side chain rapidly 
escape because return to the distal pocket from the exterior portion of the tunnel is 
blocked. When the tunnel exit is blocked by the TrpE18 mutation, Fgem also increases. 
However, in this case, the rate of internal rebinding decreases markedly because the 
trapped ligand molecules can access the entire apolar tunnel, making return to the Fe and 
net escape much slower (Fig. 6.4 and Table 6.4). 
This mechanism also explains the results for the AlaG 12 mutation. In wt 
CerHbCO, the LeuG 12 side chain does partially sequester ligands close to the distal 
pocket. Even though this barrier is small, it does separate the two Xe binding sites (Fig. 
6.1) and causes the small amount of observed geminate rebinding to be fast in wt 
CerHbCO. At the same time, the LeuG12 restriction decreases Fgem by inhibiting ligand 
return to the distal pocket from the more exterior portions of the tunnel. When Ala 
replaces Leu at this position, movement back to the heme distal pocket from the interior 
of the tunnel occurs more readily. As a result, geminate recombination is biphasic in the 
AlaG 12 mutant. The observed time course shows a small rapid phase with F gem and kgem 
values= 0.05 and :::::100 1..1.s-1, respectively, which are similar to those for wt CerHbCO, 
and a second, slow phase with Fgem ~ 0.05 and kgem ~ 15 I..I.S-1• The latter slower phase 
represents ligand return from the exterior portion of the tunnel, presumably the Xe2 site, 
at a rate similar to that seen for geminate recombination in the TrpE18 mutant where exit 
to solvent is blocked. 
6. 7 Conformational flexibility of Gln44 and the role of the E7 channel- In the 
crystal structure ofwt CerHb02, the amide side chain ofGln44(E7) appears to be fixed in 
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position by multiple hydrogen bonding interactions with the bound ligand and the 
hydroxyl groups ofTyr11{B10) and Thr48{E11). This observation, the existence ofthe 
large apolar tunnel between theE- and H- helices, and the effects of mutagenesis led us 
to propose that ligands enter and exit CerHb through the interior tunnel rather than the 
more direct E7 gate as in mammalian Mbs and Hbs (Chapter 5). However, when the 
structure ofTrpE18 CerHb02 was examined in detail, two conformations for the 
Gln44(E7) side chain were observed and differed primarily by rotation about the Cj3-Cy 
bond. In the in conformation, the amide Ne atom donates a hydrogen bond to the bound 
ligand, whereas in the more out orientation, the amide side chain interacts with the 
carbonyl of Ala40(E3) and the heme propionates through well defined crystallographic 
water molecules (Fig. 5.7). As shown in Fig. 6.2, two similar Gln44(E7) conformations 
occur in the Xe bound AlaG12 CerHb02 and wt met CerHb structures. Taken together, 
these structures suggest that the Gln44(E7) side chain is not rigidly held in place but may 
fluctuate between positions in which the amide side chain is either interacting 
electrostatically with internal polar side chains and bound ligand when the amide Ne is 
pointing inward or with Lys47(E10), the carbonyl 0 atom of Ala40(E3), the heme 
propionates, and water molecules at the solvent interface when the amide Ne is pointing 
outward. 
When Gln44(E7) is replaced with small amino acid side chains there is no change 
in the rates of 0 2, CO, and NO binding or in the fraction of either 02 or CO geminate 
recombination (Chapter 5). The PheE7 and TrpE7 mutations do cause 10-fold decreases 
in the rates of ligand association but the rates of dissociation stay the same or increase 2-
fold. As a result, these mutations cause marked 10-fold decreases in ligand affinity. The 
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decreases in the association rate constants appear to be due to direct steric hindrance of 
internal Fe-ligand bond formation by the large aromatic side chains and not to a change 
in the rate of ligand entry and escape. This conclusion is supported by the lack of an 
increase in F gem when the size of the amino acid at position 44(E7) is increased 
progressively from Ala to Trp. Fgem remains at 0.05 to 0.1 for all the Gln44(E7) mutants 
(Fig. 5.3). 
In contrast, increasing the size of the amino acids at positions 86(G 12) and 
55(El8) in the middle and end of the apolar tunnel causes large, progressive, and equal 
decreases in the rate constants for 0 2 association and dissociation. The TrpG 12 and 
TrpE 18 mutations and Xe binding within the apolar channel also cause large increases in 
the fraction of geminate CO recombination (Figs. 6.3-6.5). These effects are 
unambiguous, indicate that the apolar tunnel is the major pathway for ligand movement 
into the protein, and demonstrate that the side chains at positions 86(G12) and 55(E18) 
line the major pathway for ligand entry and exit. 
However, the tryptophan tunnel mutations do not completely inhibit ligand 
binding. Although 4- 5 fold-less than that for wt CerHb, the observed bimolecular rate 
constants for ligand entry into the TrpG12 and TrpE18 mutants are still large, ~30 to 60 
JlM-1s-1 (k'No and k' entry values, Table 6.5) and similar to the values for both wt and 
GlnE7 mutants ofSwMb (36) and the a and~ subunits of human HbA (73). Thus, 20-
25% of the ligand molecules could be entering the active site ofCerHb through the E7 
channel. The small motions of the Gln44(E7) side chain shown in Fig. 6.2 are very 
similar to those expected during partial opening of the HisE7 gate in mammalian Mbs 
and Hbs (98, 99). In addition, the barrier heights for ligand entry through the E7 channel 
in all three proteins are similar, as reflected in the absolute values ofk' entty for native 
human Hb subunits, native SwMb, and CerHb mutants in which the apolar channel is 
blocked with aromatic amino acid residues or Xe (i.e. 20 to 80 JlM-1s-1). 
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Chapter 7: Summary: Apolar Tunnels Versus Polar Gates 
7.1 Introduction: mutagenesis mapping versus molecular dynamics simulations -
In 1990 E1ber and Karplus ( 11 0) carried out locally enhanced simulations of ligand 
movement in SwMb and observed multiple trajectories with no specific pathway for 
ligand movement out of the protein. Even the most recent computations still describe 
multiple pathways in animal Mbs and Hbs with the gated E7 channel always being a 
minor route ( 111-119). In 1994 Huang and Boxer ( 120) used an elegant random 
mutagenesis protocol to create and screen a library of -1,500 single point mutants. 
Mutations were identified from colonies that produced lysates containing Mbs with 
kinetic parameters significantly different(- ±50%) from those of the wt control. 
Roughly 10 % of the mutants examined showed differences, and a structural model of 
Mb was constructed with the positions of the sequenced mutants highlighted. In addition 
to positions near the heme bound ligand, other regions were highlighted, including 
interior positions near the Xe cavities and the C-terminal portion of the H-helix, which 
were interpreted to mean that multiple pathways for CO and 0 2 entry and exit do exist, 
supporting the initial MD simulations (120). 
Seven years later, building on Huang and Boxer's strategy, Scott et al. (36) 
explored the E7 gate and Xe cavity pathways in SwMb by the rational mutagenesis 
mapping strategy described in chapters 3, 5, and 6, in which small (G or A) and large (F 
or W) mutations were constructed in ligand accessible cavities, along the major 
trajectories specified by the MD simulations, and at some of the positions found in the 
random mutagenesis screen. Each of 90 different mutants was produced in milligram 
quantities; the kinetics of ligand binding were characterized with pure proteins; and, in 
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many cases, crystal structures were determined (32, 91, 99, 121-123). The mutagenesis 
mapping results indicated strongly that the major pathway(~ 75 %) for ligand entry and 
exit is the short channel that opens by outward movement ofHisE7. The discrepancy 
between the mutagenesis map initiated by Scott et al. (36) and that of Huang and Boxer 
(1 20) is not as great as it first appears. The largest changes in their random mutagenesis 
map are observed at or near the E7 gate, and most of the effects observed at remote 
positions can be rationalized as false positives, due to mutations that destabilize Mb 
leading to lysates containing partially unfolded protein. The discrepancy between the 
calculated multiple trajectories for ligand migration obtained in molecular dynamics 
simulations and the dominant E7 gate pathway determined experimentally in SwMb is 
harder to reconcile and implies that internal pathways cannot be "found" with a rational 
mutagenesis mapping strategy. Elber (39) has summarized this dichotomy in a recent 
review on computational methods for finding ligand trajectories. 
As described in Chapters 5 and 6 (74, 100), it has been shown that the mini-
hemoglobin from the sea worm Cerebratulus lacteus has an apolar tunnel leading from 
the distal pocket to solvent, with an exit point between theE- and H-helices created by 
the loss of theN-terminal A-helix, and our initial mutagenesis and Xe binding studies 
suggest strongly that this internal tunnel is the major ligand pathway. However, Orlowski 
and Nowak (1 17) carried out simulations with CerHb and, as with Mb, obtained multiple 
trajectories with the apolar tunnel being only one of them. To resolve this discrepancy 
and determine whether the experimental mutagenesis mapping strategy used for SwMb 
by Scott et al. ( 3 6) can identify internal pathways, 120 different mutants of CerHb were 
constructed and the 0 2, CO, and NO ligand binding properties were examined. Rates of 
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ligand entry and exit for this library of CerHb variants were compared to the results for 
an expanded library of SwMb mutants, extending the initial results of Scott eta/. (36) to 
regions near the ends of theE- and H-helices. The results of these comparisons are 
provided in this chapter, which summarizes our views on ligand pathways in globins in 
general, using SwMb and CerHb as model systems, and on the validity of the 
mutagenesis mapping strategy to find them. 
7.2 Mechanisms for ligand binding to SwMb and CerHb and estimations of 
k'entry and kescape- A comparison ofthe distal pockets ofCerHb and SwMb is shown in 
Fig. 7 .1. Key amino acid side chains near the E7 gate ( Gln44 in CerHb, His64 in Mb ), at 
the Xe binding sites, and along the apolar tunnel in CerHb between the E- and H-helices 
are shown as sticks and labeled. From these side views, it is clear that the equivalent 
apolar tunnel in SwMb is blocked both by the A-helix and by larger amino acid side 
chains located along the interiors of theE-, G-, and H-helices. To define the actual 
pathway in CerHb, a series of replacements with large (For W) to small (A) amino acids 
at positions in or along the E7 channel (Chapter 5), the apolar tunnel (Chapters 5 and 6), 
and other regions reported to be important based on previous simulations and 
experimental work with recombinant Mbs and Hbs has been constructed. The overall rate 
constants for 0 2, CO, and NO binding were measured using rapid mixing, laser 
photolysis methods with 0 2/CO mixtures, and flow-flash techniques as described in 
Chapter 2 (Section 2.5). Internal CO recombination within each mutant was also 
measured using a 7 ns Y AG laser, and the rate of geminate recombination, kgem, the 
fraction of recombination, F gem, and the overall bimolecular rate constant for CO binding 
B. CerHb02 
Figure 7.1. Structural representation ofXe-bound WT CerHb02 and SwMb showing side view of the molecules. In both globins the molecules are 
oriented from the side with the heme propionates facing left and portions of the protein matrix slabbed away so an interior view is clear. Xe atoms are 
depicted as violet spheres; key amino acids and the heme prosthetic group are indicated by gray sticks with oxygen in red and nitrogen in blue; the 
remainder of the protein matrices are represented as yellow spheres. A, The two Xe atoms in CerHb are oriented as in the Leu86Ala structure (PDB ID: 
2xkh). Key distal pocket and apolar tunnel residues include Val7(B6), Tyrll(BlO), Gln44(E7), Thr48(El1), Ala55(El8), Ala82(G8), Leu86(G12), 
Leu98(H9), HislOO(Hll). B, Xel and Xe4 of SwMb are included in this depiction to indicate proposed ligand cavities within the protein matrix. Key 
distal pocket residues include Leu29(B 1 0), His64(E7), Val68(E 11 ), and Phe43(CD 1 ). Additional mutants constructed in this study include mutations 
made at residues Arg45(CD3), Leu6l(E4), Leu69(E12), Ile75(E18), and Leul35(H12). Protein structures generated with MacPyMol. 
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were used as described below to estimate the first order rate constant for ligand escape 
and the bimolecular rate for ligand re-entry from solvent. All of these kinetic parameters 
are listed in Appendix A {Tables A.l-A.6). 
In Scott eta/. (36) bimolecular and geminate 0 2 binding to SwMb were analyzed 
in terms of the three-step, side path model shown in Fig. 7.2. The rate constants for 
intramolecular rebinding, escape, and movement through the protein between sites B and 
C were obtained by fitting sets of time courses to this model using numerical integration 
algorithms described in Scott and Gibson (79). The geminate rebinding time courses for 
wt and many of the mutant Mbs can also be fitted well by the sum of two exponential 
processes and an offset reflecting the amount of escape to solvent (Fig. 2.6). The side 
path scheme in Fig. 7.2 was chosen because both Xe binding and mutations that fill the 
Xe 1 and Xe4 cavities collapse the time courses to a single rapid phase with little or no 
change in the total fraction of geminate rebinding (36, 79). Similar results were obtained 
for geminate ligand rebinding to wt Scapharca inaequivalvis Hbl, where again Xe 
binding and Phe and Trp replacements in internal cavities caused little change in the total 
fraction of geminate recombination (Chapter 3 and (81)). In the case ofHbA subunits, 
single geminate phases for CO rebinding are observed at room temperature on ns time 
scales and indicate that there are no side path C states, and the E7 channel also appears to 
be the major path{> 90%) for ligand entry and escape (73, 78). Thus, the side path 
scheme appears to apply to most vertebrate hemoglobins with a tertiary and distal pocket 
structure similar to that of SwMb. 
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Figure 7.2. Side path ligand binding scheme for SwMb. Ligand enters from the solvent (left) into the 
distal pocket where it temporarily resides until bond formation (A state) and stabilization occur. Following 
photolysis, ligand resides in the geminate state (B state) and/or travels to aXe pocket (CorD state). Ligand 
must first return to the geminate state from the C and D states in order to escape the protein via the HisE7 
gate. Figure taken from (36). The figure was generated in ChemDraw. 
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It is important to note that the experimental values of Fgern are model independent 
and depend only on an accurate definition of absorbance change for the total amount of 
geminate recombination. Thus, Equations 5.1 and 5.2 can also be used empirically to 
estimate the rate of entry into any globin, including CerHb, where, in this case, the two-
step binding scheme involves a linear sequential set ofligand movements (Fig. 5.6). As 
discussed by Scott et al. (36), the steady state expression for k'x using a linear scheme is 
still k'x = k'entry Fgem, where k'entry represents the bimolecular rate of entry into the first 
discrete site in the protein, which, in the case of CerHb, would be the apolar tunnel. 
However, if the barriers along the tunnel and from the tunnel into the distal pocket are 
small compared to bond formation, the mechanism for CerHb reduces to a two-step 
process with a single geminate intermediate. Under these conditions, Fgem can be 
approximated as kbondl'(kbond + kescape). 
In the case of CO binding to CerHb, there is evidence of a barrier between the 
tunnel and the distal pocket implying a linear three-step scheme. However, this extra 
complexity is only evident at room temperature when restrictions in the tunnel are 
completely removed as is observed in the Leu86(G12)Ala mutation (100) or at low 
temperatures (53). When movement into and through the tunnel is restricted by 
mutagenesis, the geminate time courses become single exponentials and are readily 
analyzed as a simple two-step scheme where Equation 5.1 describes the geminate 
parameters. Expressions in Equations 5.1 and 5.2 were used to estimate values ofk'entry. 
kescape. and kbond for CO binding to all of the mutants ofCerHb listed in Tables A.l- A.6 
(see Appendix A). These estimations were felt, although empirical, to be the simplest and 
closest to the observed experimental data, making the maps shown in Fig. 7.4 (see 
Section 7 .4) experimentally defined and not model dependent. 
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7.3 Validity of using k'entry and kescape- In principle, k'entry and kescape values should 
be used to map the ligand pathways quantitatively because these parameters factor out the 
differences in reactivity (kbond values) between the 02, CO, and NO. The values of these 
rate constants should be the same for all three diatomic gases because of their similar 
sizes and diffusion constants at room temperature. In the case of CO binding to wt 
CerHb, the relative errors in these calculated parameters are very large because the extent 
of CO geminate recombination is very small ~ 0.05 and has a absolute error of~± 0.03 
which is roughly the same for all values ofF gem measured. To reassure ourselves that the 
calculated k'entry values are valid for the CerHb mutants, the correlations between k'entry, 
k'No, and k'02 were examined. As shown in Fig. 7.3, there is a linear correlation between 
k'entry, calculated using k'co and Fgem,co, and the experimentally measured value ofk'No 
for a series ofVal7(B6), Gln44(E7), Thr48(Ell), Ala55(El8), and Leu86(Gl2) mutants 
(Table A.2, Appendix A). Because the fraction of geminate NO recombination is 2: 0.99 
due to its high reactivity with Fe, the rate limiting step for its binding is the bimolecular 
rate ofNO entry into the protein, which should equal the calculated value ofk'entry· As 
shown, the error in k'entry is very large for those mutants with large k'co and very small 
Fgem,co values, making it hard to determine the slope of the correlation between k'entry and 
k'co. However, even with these errors, there does appear to be a systematic 
overestimation ofk'entry for the CerHb variants with Fgem,co < 0.1 (Fig. 7.3A). However, 
the correlation is strong for mutants where F gem is larger when the tunnel is partially 
blocked. Similar linear correlations between k'entry and k'No were observed for all of the 
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Figure 7.3. Correlation of calculated rates of ligand entry, k'No, and k'02 in CerHb. A, k'entry vs. k'No, B, k'02 vs. k'No. and C, k'entry vs. k'02 for 
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SwMb mutants reported in Scott eta/. (36), verifying the k'entry values for myoglobin. 
As shown in Fig. 7 .3B, there is a 1: 1 correlation between k'No and k'02 for the single 
mutants located in the tunnel implying that 0 2 binding is also primarily limited by the 
bimolecular rate of entry into the protein. The only exceptions are the Thr48(E11)Val 
mutation, which releases the TyrB 10 to sterically inhibit bond formation, and the 
Gln44(E7)Phe mutation, where the larger PheE7 side chain directly inhibits 0 2 binding at 
the Fe atom. For these mutants, overall Oz binding is slowed because bond formation is 
markedly inhibited and kbond becomes similar to kescape causing a decrease in k'oz due to a 
decrease in Fgem and not the rate of entry (Equations 5.1 and 5.2). In the case of NO, its 
high reactivity with the Fe atom is still much greater than that for ligand escape, keeping 
ligand entry as the rate-limiting step even for the Thr48(E11)Val and Gln44(E7)Phe 
mutants. 
Fig. 7.3C shows the correspondence between the calculated ligand entry rate 
using overall and geminate CO binding data with the bimolecular rate constant for 0 2 
binding. In this case, there is a 1: 1 correspondence with all the mutants examined even 
though the scatter is fairly large. These results, the data in Fig. 7 .3A, and correlations 
between NO binding rates and k'entry values for the SwMb mutants (36) support the use of 
calculated k'entry and kescape values to map ligand pathways and demonstrate that similar 
conclusions would be obtained ifk'No or k'02 values were used in the mapping analysis. 
7.4 Mutagenesis mapping strategy- The underlying premise of our mutagenesis 
approach is that larger and smaller amino acid side chains should impose larger or 
smaller kinetic barriers, respectively, for ligand entry and escape if they are located along 
the primary pathway for ligand binding (Chapters 3, 5, and 6; (36, 74)). Thus, the overall 
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bimolecular rate constant for ligand entry into a mutant with a small amino acid, 
k'entry,smaiJ, should be significantly larger than the entry rate constant for a mutant with a 
large amino acid, k'entry,Jarge, at the same on-pathway position. Similar relationships should 
occur for the rate constants for ligand escape from the same mutants. To quantify these 
effects, overall effects of large to small mutations on these rate enhancements were 
computed as (36): 
R = l ( k~ntry,smallll ( kescape,smalll enhance og ' + og 
kentry,large kescape,la:rge 
Eq. 7.1 
Large to small mutations at positions on the major pathway increase both k'entry and kescape 
leading to positive values for both logarithmic terms in Equation 7.1, which, when added 
together, generate large Renhance values. In contrast, mutations at positions distant from the 
ligand trajectory have little or no effect. Mutations near the bound ligand often have large 
effects on overall ligand binding parameters due to either direct steric hindrance or 
electrostatic stabilization of the bound ligand, but in many cases, there are only small or 
compensating effects on entry and escape. 
To complement some of the new helical positions examined in CerHb, I 
constructed and characterized eight additional SwMb mutants: Arg45(CD3)Trp, 
Leu61(E4)Trp, Leu69(E12)Ala, Leu69(E12)Trp, Ile75(E18)Ala, Ile75(E18)Trp, 
Leu135(H12)Ala, and Leu135(H12)Trp (Table A6, Appendix A). Estimates of the rates 
of entry and escape were measured using 0 2 geminate recombination as described in 
Scott eta/. (36). The Fe atom in Mb is less reactive due to an eclipsed geometry between 
the edges of the coordinated imidazole ring of HisF8 and the pyrrole N atoms of the heme 
ring. A similar geometry occurs and reduces the reactivity of ScHbi with ligands in its T 
quaternary state, as mentioned in Chapter 1 (Fig. 1.7 A). As a result of this geometry, very 
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little internal CO recombination for MbCO is observed at room temperature in ordinary 
buffers. Fortunately, wt Mb shows~ 50% geminate 02 recombination, due to the higher 
reactivity of the ligand molecules, and the rate is slow enough (kgem ~ 10-20 J..lS-1, tv2 2: 
30-60 ns) to be measured readily using a 7 ns Y AO laser excitation pulse. In the case of 
CerHb, 02 geminate recombination is too fast to measure accurately in the wt and most of 
the mutant proteins (kgem 2: 130 J..lS-1, t112::::; 5 ns) (Chapter 5; (74)). 
Bar graphs of the rate enhancements caused by large to small mutations, Renhance, 
versus sequence position are shown in Fig. 7.4 for both SwMb and CerHb. In both 
proteins, significant effects are observed at the active site positions where the amino acid 
side chains interact directly with bound ligands (B 10, CD 1, E7 and E 11, bars labeled 
with blue diamonds in Fig. 7.4). However, beyond those regions the differences between 
Mb and CerHb are dramatic. In the case of Mb, large rate enhancements are only 
observed at or near the E7 channel or in the back of the distal pocket where ligands are 
initially captured before binding to the Fe atom, i.e. positions 28(B9), 29{Bl0), 32(B13), 
43(CD1), 46{CD4), 64(E7), and 68(E11). No significant enhancements ofthe rates of 
entry and escape are observed at positions around the Xe1 cavity, in regions equivalent to 
the apolar tunnel in CerHb (i.e. between theE-, 0-, and H-helices), or at other locations 
suggested from MD simulations. In contrast, large rate enhancements for entry into and 
escape from CerHb are observed for replacements lining the apolar tunnel, including 
positions near the C-terminal ends of theE-, 0-, and H-helices and at position Val7(B6) 
where the distal pocket connects to the apolar tunnel (bars labeled with green asterisks, 
Fig. 7.4B). 
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7.5 Rate enhancement maps for SwMb and CerHb - The magnitudes of the 
Renhance parameters are mapped onto the three dimensional crystal structures ofwt SwMb 
and CerHb in Fig. 7.5 (see (36)). The color coding of the key side chain positions is as 
follows: red spheres, Reooance?: 1.5 (?: 30-fold rate increases); orange spheres, 1.5 > 
Reooance?: 1.0 (30 tolO-fold increases); yellow spheres, 1.0 > Renbance?: 0.5 (10 to 3-fold 
increases); white or gray sticks 0.5 > Reooance (no significant effect,< 3-fold). The results 
are quite clear for both proteins. Only positions near the E7 gate or in the distal heme 
pocket are highlighted in Mb, and no rate enhancements are observed along alternative 
pathways, including the Xe pockets or other interior apolar regions. In contrast, our 
mutagenesis mapping approach clearly highlights the internal tunnel in CerHb, proving 
experimentally that ligands enter and exit this globin through this pathway. This 
conclusion is particularly evident in Fig. 7 .SF in which the tunnel between the E- and H-
helices is clearly seen and circumscribed by red, orange, and yellow side chains. The 
same view for Mb (Fig. 7 .5E) shows that this pathway is completely blocked by the A-
helix. 
7.6 Experimental tests of apolar tunnel pathway in CerHb - Three further tests 
of the apolar pathway in CerHb were performed. First, the polar imidazole side chain of 
HislOO(Hll) is extended out into solvent in the wt CerHb02 structures (Figs. 7.1A, 
7.5B,D,F; (74)). As shown in Table 7.1, removing the imidazole at the Hll position by a 
His - Ala mutation has little affect on ligand binding, whereas both the Phe and Trp 
mutations cause- 3-fold decreases in both k'02 and ko2 with little change in affinity. 
These same aromatic amino acid mutations cause large increases in the fraction of CO 
geminate recombination, from- 0.05 for wt CerHbCO to- 0.34 for TrpHll (see Fig. 
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Figure 7.5. Maps of the effects of small to large mutations on the rate of Entry and Escape in SwMb 
(PDB: 2mgk) and CerHb (PDB: lkr7). The protein backbones are represented as silver ribbons, the heme 
group is shown as blue sticks. A, Side view of SwMb. B, Side view of CerHb. C, Top view of SwMb. D, 
Top view of CerHb. E, Back view of SwMb. F , Tunnel/back view of CerHb. Red spheres signify a 
SUMmutation :2: 1.5, orange spheres signify 1.5 :2: SUMmutation :2: 1.0, yellow spheres signify 1.0 :2: SUMmutation :2: 
0.5, and gray sticks signify a 0.5 :2: SUMmutation (numerical values can be gathered from Figure 7.4 and Scott 
et a/. (36)) . The figure was generated in MacPyMol. 
7.5) and a marked decrease in kgem,co due to an 8-fold decrease in kescape· All of these 
effects suggest that the large aromatic side chains rotate back to the protein surface to 
partially cover the exit aperture of the ligand tunnel (Fig. 7.1, Tables 7.1 and A1, 
Appendix A and (74)). 
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Second, Pesce eta/. (42, 124) have argued that extensive polar interactions 
between Tyrll(BlO), Gln44(E7), Lys47(El0) and Thr48(Ell) limit opening ofthe E7 
gate, causing ligands to use the apolar tunnel for entry and exit. To test this idea, ligand 
binding to a triple CerHb mutant with a completely apolar active site containing 
PheBIO/LeuE7NalE11 mutations were examined. As shown in Table 7.1, Fig. 7.6B and 
Table AS in Appendix A, rates of 0 2 binding to and release from this triple mutant 
increase only about 50%, and there is little change in the computed value ofk'entry 
compared to wt CerHb even though the extent of geminate recombination increases to ~ 
0.40 due to a marked~ 7-fold increase in the rate of internal bond formation compared to 
wt CerHb. However, when the Ala55(E18)Trp mutation is added to this triple mutant to 
block exit from the apolar tunnel, there are marked~ 5-fold decreases in k'02 and k02, the 
fraction of geminate CO rebinding increases to 0.85, and the calculated value ofk'entry 
decreases from~ 400 to~ 30 J.lM-1s-1 (Table 7.1 and Table AS in Appendix A and Fig. 
7.6B). Thus, even when the distal pocket is made apolar, ligands still move into and out 
of the protein through the apolar tunnel. 
Third, to close the apolar tunnel completely, Phe and Trp mutations were 
constructed at: (1) the connection between the distal pocket and the interior of the tunnel, 
Val7(B6) (53); (2) in the middle ofthe tunnel at the Xe binding sites, Leu86(G12) 
(Chapter 6 and (100)); and (3) at the exit aperture, Ala55(E18) (Chapter 5 and (74)). The 
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Table 7.1. Rate and equilibrium parameters for 0 2 CO, and NO binding to wt and selected mutants 
of CerHb at pH 7, 20°C. The values in parentheses in the last column are the values for k'No, the 
bimolecular association rate constant for NO binding, which should equal the computed rate of ligand 
en 'k'en . 
CerHb Variant k'o2 ko2 Ko2 k'co Fgem,CO k' entry 
J.!M-1s-1 s-1 J.!M-1 J.!M-1s-1 (k'No) 
M-1s-1 
Wt 230±17 190±25 1.2±0.2 32±5 0.05±0.03 640±400 (270) 
H100A 210 230 0.93 30 0.05 570 
H100F 
H100W 77 92 0.84 17 0.34 50 
Y11F/Q44L/T48V 340 270 1.6 165 0.40 410 
Y11F/Q44L/T48V/ 70 50 1.4 27 0.85 30 A55W 
Wt 230±17 190±25 1.2±0.2 32±5 0.05±0.03 640±400 (270) 
V7A/L86A 240 190 1.3 35 0.14 255 
V7F 110 115 0.97 22 0.16 135 (110) 
L86F 120 71 1.7 24 0.17 140 (110) 
A55F 61 51 1.2 17 0.44 38 (48) 
V7F IL86F I A55F 42 17 2.5 17 0.79 20 
V7WIL86W/A55W 23 3.0 7.6 7.2 0.93 8 
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Figure 7.6. Time courses for geminate recombination in HislOO(Hll) and apolar distal pocket 
mutants of CerHbCO at 20 °C, pH 7.0. A, CO geminate rebinding to HlOOA, F, and W mutants. The 
fraction of geminate recombination increases 6-fold upon mutating a polar His to a large nonpolar Trp. B, 
CO geminate rebinding in CerHb multiple mutants with an apolar distal pocket containing 
Yl1F/Q44L/T48V mutations and Trp replacements at the Val7(B6) and Ala55(E18) tunnel positions. 
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Figure 7.7. Time courses for geminate recombination in multiple tunnel mutants of CerHb at 20 o C, pH 7.0. A, CO geminate rebinding in position 
Val-7(B6) mutants of CerHb. B, CO geminate rebinding in single, double, and triple Phe mutants in positions Val-7(B6), Ala-55(El8), and Leu-86(G 12) 
mutants ofCerHbCO. C, CO geminate rebinding in single, double, and trip Trp mutants in positions Val-7(B6), Ala-55(El8), and Leu-86(Gl2) mutants 
ofCerHbCO. 
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AlaB6/ AlaG 12 double mutant, which has Ala at all three positions, has kinetic 
parameters very similar to those of wt CerHb. In contrast, the PheB6/PheE 18/PheG 12 
and TrpB6/TrpE18/TrpG12 triple mutants show dramatic 2: 10-fold decreases in k'02, k02, 
and k'entry and 2:10-fold increases in Fgem,co, from- 0.05 for wt CerHb to 0.80 to 0.93 for 
the triple Phe and Trp mutants, respectively (Table 7.1 and Table A4 in Appendix A and 
Fig. 7. 7). These data show that the apolar tunnel can be closed by mutagenesis, reducing 
the measured bimolecular rate constants for 0 2 and NO binding and the calculated rate 
for ligand entry to less than 10% of the wt values. 
7. 7 Single versus multiple pathways - The experimental mutagenesis results in 
Figs. 7.3-7.7 and in Table 7.1 and A1-A5, Appendix A are very clear. Ligands enter and 
exit CerHb through the apolar tunnel as suggested originally by Pesce eta!. ( 42). When 
three Phe or Trp replacements are used to fill the entire tunnel, the bimolecular rate of 
ligand entry decreases dramatically. An estimate of the rate of ligand entry when the 
apolar channel is closed was calculated from the average of the k'entry, k'No, and k'02 
values for the PheB6/PheE 18/PheG 12 and TrpB6/TrpE 18/TrpG 12 mutants (Tables 7.1, 
AI, and A5, Appendix A) and is 25 ± 12 JJ.M-1s-1• An estimate ofthe value for ligand 
entry into CerHb with an open tunnel was computed from the k'entry, k'No, and k'02 values 
for wt CerHb and the AlaB6, AlaG 12, and AlaB6/AlaG 12 mutants and is equal to 300 ± 
130 J!M-1s-1. If the triple aromatic mutations at B6, E18, and G12 completely close the 
tunnel, the residual bimolecular rate of 25 JJ.M-1s-1 applies to ligand binding through 
alternative routes. This value suggests that in wt CerHb 2: 92 % of the ligand molecules 
enter through the apolar tunnel, and only 8% by alternative routes. Interestingly, the 
value ofk'entry when the tunnel is completely blocked is only slightly smaller than the 
141 
estimated rates of ligand entry into wt and His64(E7)Gln SwMb, which are 34 and ~ 60 
J.!M-1s-I, respectively. Thus, it seems likely that the limiting value of25 J.!M-1s-1 for the 
triple aromatic CerHb mutants represents ligand movement through the GlnE7 gate. 
At first analysis, the mapping results for SwMb seem less clear because all the 
positions that regulate entry and escape are located in the distal pocket or at the heme 
propionate solvent interface (Figs. 7.4 and 7 .5). However as pointed out by Scott et al. 
(36) and Olson et al. (32), when the effects ofXe binding and selected mutations are 
examined individually, the mutagenesis results demonstrate ligand movement through the 
E7 gate. There are little or no changes in the fraction of geminate 02 recombination or in 
the bimolecular rate constants for ligand entry, 0 2, and CO binding to wt SwMb when the 
protein solution is pressurized with 5-10 atm ofXe (79). Similarly, when Trp 
substitutions are made in the Xe1 and Xe4 sites there are little or no changes in k'entry, 
kescape and Fgem (32, 36). The E7 gate pathway in Mb is also supported strongly and 
independently by time-resolved X-ray crystallography measurements. The life times of 
CO in the Xe1 pockets ofwt, PheB10, and TrpB10 Mb are~ 2-10 JlS (37), 100-300 JlS 
(31, 35), and 1-2 ms (34), respectively, and the double mutant TyrB10/GlnE7 Mb shows 
intermediate behavior (125). Ifligand molecules moved directly to solvent from the Xe1 
site, the size of the amino acid at the B 10 position should have had no effect on ligand 
escape from this position. Instead, ligands appear to move back to the distal pocket, pass 
between the BlO side chain and the plane of the heme, and exit through the E7 channel. 
When HisE7 is replaced with Trp in Mb, the calculated bimolecular rate of entry 
decreases from 34 J.!M-1 to 7 J.!M-1s-I, implying that up to 75% of the ligand molecules 
move through the E7 gate to the active site (36). However, this calculation assumes that 
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the TrpE7 substitution completely blocks the E7 channel. Recently, Birukou et al. (78) 
have shown that the indole side chain in the crystal structure ofTrpE7 deoxyMb does not 
enter the E7 channel but only partially blocks the entrance, occupying a position between 
the heme propionates. A similar "blocked" conformation is observed in the crystal 
structure ofTrpE7j3 human HbCO subunits (78). In contrast, the E7 indole side chain in 
the crystal structure of TrpE7 deoxy-a human Hb subunits is located in the distal pocket, 
completely blocking the E7 channel and sterically restricting access to the heme Fe (78). 
In this completely "closed" conformation, the a TrpE7 side chain causes 2: 100-fold 
decreases in both k'No and the calculated value of k'entry for isolated mutant a subunits 
(73, 78). Thus, it is possible that the percentage of ligand molecules entering through the 
E7 channel in Mb is significantly larger than 7 5 %, which was estimated from the rate of 
entry for TrpE7 Mb02 where the E7 channel is not completely closed. 
7.8 Discrepancies with MD simulations- The kinetic results in Fig. 7.5 are not in 
agreement with either past or recent molecular dynamics simulations, all of which 
suggest multiple (2: 4) pathways. The latest theoretical work for both CerHb and Mb 
suggest 3 to 5 pathways with roughly equal probabilities, one of which is the E7 channel 
in Mb and one of which is the apolar tunnel in CerHb. Thus, the calculations do predict 
that~ 20 to 33% of the ligands enter and exit through the paths identified experimentally 
by mutagenesis. These- 4-fold differences compared to the experimental percentages 
(i.e. -20 versus 2: 80%) indicate that small inaccuracies in representing structural barriers 
in the computations could easily alter the number of plausible trajectories. 
One key problem is representing the barrier to apolar ligand movement through 
clathrate-like water clusters that cover apolar patches at the protein surface. For example, 
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well-defined crystallographic water molecules surround the highly conserved Leu89(F4) 
side chain in Mb, which is apolar and protects the Fe-His93(F8) bond from being 
hydrated ( 121). Liong et a!. ( 121) mutated this amino acid to Gly to open a hole into the 
Xe1 cavity, and observed that a string of3 to 4 water molecules entered this site and were 
connected to well-defined surface waters, forming an extended chain of "ice-like" 
structures. The rates of bimolecular ligand binding and unimolecular release were 
relatively unaffected by this mutation, and there was little or no effect on the net extent of 
02 geminate recombination, even though the Xe 1 cavity was completely open to solvent. 
The only major change was the loss of the slow phase of geminate rebinding, which 
reflects movement into and then back from the Xe1 cavity (36). These results show that 
water entered to the exposed Xel cavity and formed a barrier that prevented diatomic 
apolar ligands from entering this site. Another example ofhow the hydrophobic effect 
can influence ligand binding is the effect ofthe His100(H11) to Phe and Trp mutations 
on ligand binding to CerHb. In most published structures ofwt and mutant CerHb, the 
imidazole side chain ofHisHll is pointing directly out into solvent (see Figs. 7.1 and 
7.5). However, when this polar amino acid is replaced by Phe and Trp, the hydrophobic 
effect appears to push the more apolar phenyl and indole rings back on the surface of the 
protein, partially blocking the tunnel entrance and decreasing both lC entry and kescape and 
causing marked increases in F gem,co by trapping ligands within the CerHb tunnel. 
A key test of the accuracy of the theoretical algorithms would be to examine the 
effects ofthe Leu89(F4)Gly Mb and HislOO(Hll)Trp CerHb mutations on simulated 
structures, starting from the wt protein, and on ligand trajectories, carefully looking at 
water structure in and around the Mb Xel cavity and the exit aperture of the CerHb 
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tunnel. Other valuable tests would be simulations of the effects of the ValCD4 Mb 
mutation on movement of the HisE7 side chain and of the motions of the indole side 
chain in TrpE7 Mb. The ValCD4 mutation accelerates ligand entry and release in Mb and 
causes outward movement of the distal histidine (99). The TrpE7 mutation slows ligand 
entry~ 4-fold, even though only the entrance to the E7 channel is blocked (36, 78). The 
effects of all four of these mutations are clear experimentally and should be replicated in 
any molecular dynamics simulation. Ironically, the fastest rates ofligand uptake and 
release are observed when the longer, apolar tunnel trajectory is used rather than the 
much shorter E7 gate channel. The rates of ligand binding to CerHb are close to diffusion 
controlled and very similar to model heme compounds with no distal steric hindrance or 
to Mb and Hb mutants in which the distal histidine is replaced by Gly or Ala, creating a 
short, completely opened channel between solvent and the heme Fe. 
7. 9 Final conclusions - In our view, the experimental mutagenesis mapping results 
shown in Fig. 7.4 are unambiguous. Ligands enter and exit CerHb through the interior 
apolar tunnel at least~ 90% of the time, whereas ligands enter Mb from the opposite 
direction, ~ 80 % of the time through the E7 gate. The same HisE7 gate pathway appears 
to occur in both subunits of human HbA (73, 78) and in the Scapharca inaequivalvis Hbi 
dimer (Chapter 3 and (81)). The significance of these results is three-fold. (1) Our 
rational mutagenesis mapping strategy is robust and can identify interior apolar pathways. 
{2) The Mb and CerHb results provide experimental benchmarks for testing the validity 
of molecular dynamics trajectories, one with a short pathway between the heme 
propionates that is gated by a polar residue and another internal route to an external 
opening at the opposite end of the protein. (3) Globins have evolved different routes for 
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ligand entry and, the longer but more open apolar pathways allow more rapid rates of 
entry and exit. The HisE7 gate pathway appears to be ubiquitous in all vertebrate red cell 
Hbs and muscle Mbs, and probably most animal and plant Hbs with a distal histidine but 
otherwise apolar distal pocket (36, 73, 78, 126). The apolar tunnel route occurs more 
rarely, perhaps in response to the need for very rapid 0 2 release and uptake ( 43, 54, 1 03). 
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Appendix A 
Table Al. Bimolecular, geminate, and calculated rate parameters for CerHb mutants located throughout the apolar tunnel measured at pH 7.0, 20 °C. 
0 bserved Geminate 
Calculated rate parameters Bimolecular binding parameters parameters 
Mutants k' k x02 k'co kco Kco kgem F a kbond kescape k'entry 
02 02 1 1 1 1 gem -1 -1 M-1 -1 l-!M-1s-1 s-I l-!M-1 gM-1s- s- gM- gs- gs gs l=l s 
WT 
Trp3(B2) 
Ala3 
Leu3 
Phe3 
Tyr3 
Va17(B6) 
Ala7 
Phe7 
Trp7 
Tyr51(E14) 
Ala51 
Leu51 
Phe51 
Trp51 
Ile52(E15) 
Ala52 
Phe52 
Trp52 
Ala55(E18) 
Val55 
Leu55 
Phe55 
Trp55 
230±17 190±25 32±4.7 0.054±0.0053 590± 1 0 80±40 0.05±0.03 4.0±3.0 76±40 640±400 
(12) (12) 1.2±0·2 (12) (15) 0 (8) (8) 
220 
260 
260 
230 
250 
110 
33 
260 
370 
270 
130 
130 
67 
47 
180 
72 
61 
63 
140 
190 
180 
160 
270 
110 
14 
150 
500 
280 
89 
75 
74 
25 
93 
40 
51 
66 
1.6 
1.4 
1.4 
1.4 
0.93 
1.0 
2.4 
1.7 
0.74 
0.96 
1.5 
1.7 
0.91 
1.9 
1.9 
1.8 
1.2 
0.95 
33 
22 
25 
26 
36 
22 
13 
38 
39 
37 
38 
31 
19 
11 
41 
17 
17 
15 
0.060 
0.056 
0.047 
0.060 
0.033 
0.027 
0.0042 
0.015 (26%) 
0.17 (74%) 
0.039 
0.041 
0.020 
0.036 
0.022 
0.016 
0.045 
0.016 
0.029 
0.029 
550 
390 
530 
430 
1,100 
820 
3,100 
2,500 
230 
1,000 
900 
1,900 
860 
860 
690 
910 
1,100 
590 
520 
140 
54 
92 
52 
33 
64 
70 
200 
15 
30 
96 
50 
12 
87 
59 
24 
7.6 
9.3 
9.4 
0.068 
0.040 
0.069 
0.040 
0.080 
0.16 
0.82 
0.16 
0.16 
0.087 
0.26 
0.28 
0.30 
0.41 
0.16 
0.46 
0.44 
0.44 
9.5 
2.2 
6.3 
2.1 
2.6 
10 
57 
32 
2.4 
4.8 
8.4 
13 
3.4 
26 
24 
3.8 
3.5 
4.1 
4.1 
130 
52 
86 
50 
30 
54 
13 
90b 
25 
88 
37 
9.0 
61 
35 
20 
4.0 
5.0 
5.0 
490 
550 
360 
650 
450 
140 
16 
240 
240 
430 
150 
110 
63 
27 
260 
37 
39 
34 
159 
160 
Table Al (cont'd). Bimolecular, geminate, and calculated rate parameters for CerHb mutants located throughout the apolar tunnel measured at pH 7.0, 20 oc. 
. . . Observed Geminate 
Bimolecular bmdmg parameters t Calculated rate parameters parame ers 
Mutants k' k K k' k K k k k , 
02 02 02 CO CO CO gem p a bond escape k entry 
WT 
Ile56(E19) 
Ala56 
Phe56 
Trp56 
Leu86(G12) 
Ala86 
Phe86 
Trp86 
Leu98(H9) 
Ala98 
Phe98 
Trp98 
His100(H11) 
Ala100 
Phe100 
Trp100 
Ala101(H12) 
Phe101 
Trp 101 
M -1 -1 -1 M-1 M-ls-1 s-1 !lM-1 !lS-1 gem -1 -1 M-1 -1 !l S S !l !l !lS !lS )l S 
230±17 190±25 1 2±0 2 32±4.7 0.054±0.0053 590±1 0 80±40 0.05±0.03 4 0 3 0 76 40 
(12) (12) . . (12) (15) 0 (8) (8) . ± . ± 640±400 
180 
200 
170 
230 
120 
97 
150 
120 
61 
210 
99 
77 
77 
100 
94 
130 
110 
150 
71 
60 
160 
74 
62 
230 
110 
92 
68 
65 
1.9 
1.5 
1.5 
1.5 
1.7 
1.6 
0.93 
1.6 
0.98 
0.91 
0.90 
0.84 
1.1 
1.5 
17 
35 
33 
25 
24 
16 
18 
23 
15 
30 
17 
17 
16 
23 
0.056 
0.055 
0.073 
0.053 
0.024 
0.014 
0.059 
0.038 
0.032 
0.056 
0.032 
0.00030 
0.036 
0.027 
0.035 
300 
640 
450 
470 
1,000 
1,100 
300 
600 
470 
540 
530 
57,000 
470 
590 
660 
40 
58 
46 
23 
92 
78 
200 
61 
31 
80 
20 
11 
8.1 
11 
0.15 
0.11 
0.13 
0.10 
0.16 
0.54 
0.15 
0.11 
0.30 
0.10 
0.29 
0.34 
0.38 
0.28 
6.0 
6.4 
6.0 
2.3 
15 
42 
30 
6.7 
9.3 
8.0 
5.8 
3.7 
3.1 
3.1 
34 
52 
40 
21 
77 
36 
170 
54 
22 
72 
14 
7.0 
5.0 
8.0 
110 
320 
250 
250 
150 
30 
120 
210 
50 
300 
59 
50 
42 
82 
161 
Table Al (cont'd). Bimolecular, geminate, and calculated rate parameters for CerHb mutants located throughout the apolar tunnel measured at pH 7.0, 20 oc. 
Observed Geminate Bimolecular binding parameters 
M ta t parameters 
u n s k'02 k02 K02 k'co kco Kco kgem F a kbond kescape k'entry 
Calculated rate parameters 
WT 
Ilel 02(H13) 
Ala102 
Phe102 
Trp102 
Asp104(H15) 
Val104 
Leu104 
Ilel 05(H16) 
Ala105 
Phe105 
Trp105 
M -1 -1 -1 M-1 M-1 -1 -1 M-1 -1 gem -1 ~~ 1 1 J.1 S S J.1 J.1 S S J.1 J.lS J.lS J.lS J.lM- s· 
230±17 190±25 1 2±0 2 32±4.7 0.054±0.0053 590±10 80±40 0.05±0.03 4 0 3 0 
(12) (12) 0 0 (12) (15) 0 (8) (8) 0 ± 0 76±40 640±400 
270 
190 
120 
230 
270 
290 
230 
160 
190 
120 
60 
170 
200 
98 
260 
64 
1.4 
1.6 
2.0 
1.4 
1.4 
3.0 
0.88 
2.5 
35 
23 
24 
36 
52 
80 
22 
32 
0.036 
0.040 
0.054 (60%) 
0.0069 (40%) 
0.063 
0.050 
0.026 
0.025 
0.00030 
0.014 
0.0020 
970 
580 
440 
3,500 
570 
1,000 
3,100 
880 
73,000 
2,300 
16,000 
19 
25 
32 
35 
44 
39 
100 
73 
0.12 
0.060 
0.19 
0.072 
0.15 
0.23 
0.15 
0.30 
2.3 
1.5 
6.1 
2.5 
6.6 
9.0 
15 
22 
17 
24 
26 
32 
37 
30 
85 
51 
290 
380 
130 
500 
350 
350 
150 
110 
The standard deviations for the wt values for k'02, k02, and k'co were obtained from the analysis of 12 completely independent sets of experiments starting with at 
least 7 different expressions and purifications of CerHb. The standard deviation for kco came from the analysis of 16 different determinations. The values of K02 
and Kco were calculated from k'02/k02 and k'cc/kco, and their standard deviations were calculated from the standard propagation of error formula. 
a The fraction of geminate CO rebinding was measured using a 7 ns Y AG laser light pulse. 
b ke.cape calculated from 50 % of each kgem value. 
Table A2. Rate constants displaying correlations between calculated rates of ligand entry, k'No, and k'02 in CerHb 
mutants measured at EH 7.0, 20 °C. 
k'No k'02 k'entry, CO Mutants !lM-'s· !lM-' I !lM-'s·' 
WT 230±30 230±1 640±40 7 0 
Val7(B6) 
Ala? 240 250 450 
Val? 110 110 140 
Trp7 30 33 16 
Gln44(E7) 
Phe44 110 20 26 
Thr48(E11) 
Val48 80 30 27 
Ala55(E18) 
Val55 140 180 260 
Leu55 47 72 37 
Phe55 48 61 39 
Trp55 45 63 34 
Leu86(G12) 
Ala86 200 230 250 
Phe86 110 120 150 
Trp86 68 97 30 
Phe7!Phe55!Phe86 32 42 22 
The numbers for wt CerHb are based on the average of all determinations for the past 6 years (:!:10 separate 
preparations). The error in k'entry is very large because Fgem is close to 0.0, poorly defined, and has an error of± 60%. 
When Fgem is <!:0.1, the error in k'entry diminishes greatly to-± 20%. 
a The fraction of geminate 0 2 rebinding was measured using a 7 ns YAG laser light pulse. 
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Table 3. Bimolecular, geminate, and calculated rate parameters for CerHb mutants located in the heme pocket measured at pH 7.0, 20 °C. 
Observed Geminate 
Calculated rate parameters Bimolecular binding parameters parameters 
Mutants k' k Ko2 k'co kco Kco kgem F. a kbo~f k.,.c~ k'.,ry_1 02 ?2 -I -I -I -I l.l.M-1 J.lS-1 gem J.lS J.lS !lM s J.lM-Is-I s I J.lM J.lM s s 
WT 
Phe10(B9) 
Ala10 
VallO 
Leu10 
lso10 
Trp10 
230±17 190±25 1 2±0 2 32±4.7 0.054±0.005 590±10 80±40 0.05±0.03 
(12) (12) . . (12) (15) 0 (8) (8) 4.0±3.0 76±40 
70 40 
94 210 
130 160 
140 290 
65 8.5 
6.8 (55%) 
2.2 (35%) 
1.8 10% 
0.45 
0.81 
0.48 
7.6 
slower 
phases 
6.4 
12 (81%) 
2.6 (13%) 
6% slower 
phases 
13 
12 (89%) 
2.6 (11%) 
0.020 
0.040 
0.0070 
0.040 
0.049 
0.010 
0.0080 
340 
160 
910 
300 
270 
1,300 
1,500 
22 
160 
54 
80 
(84%) 
13 
(16%) 
0.10 
0.70 
0.16 
0.61 
2.2 20 
110 48 
8.6 45 
42 27 
640±400 
50 
15 
81 
18 
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TableA3 (cont'd). Bimolecular, geminate, and calculated rate parameters for CerHb mutants located in the heme pocket measured at pH 7.0, 20 °C. 
Observed Geminate 
Calculated rate parameters Bimolecular binding parameters Mutants parameters 
k'?2 _ k?2 Ko: k'~o _ k~o Kc? kgem F a kbond kescape k'en(ry 
WT 
Tyrl1(B10) 
Ala11 
Val11 
Leull 
Isoll 
Phe11 
Trp11 
gM 's I s I gM I gM Is I s I gM I gs-1 gem gs-1 gs-1 gM-Is-1 
230±17 190±25 1 2±0 2 32±4.7 0.054±0.005 590±1 0 80±40 0.05±0.03 
(12) (12) . . (12) (15) 0 (8) (8) 4.0±3.0 76±40 
120b 400b 0.30b 
150 640 0.23 
52 610 0.085 
120 750 0.16 
140b 460b 0.30b 
1.3 270 0.0048 
33b 
40 
22 
33 
34 
0.050 
0.015 2,200 
0.021 1,900 
0.00010 400,000 
0.011 2,000 
0.019 
0.0010 
0.0081 
0.0080 
0.0010 
1,700 
33,000 
4,200 
6.3 
50 
2.8 
(42%) 
19 
(58%) 
1.2 
(23%) 
14 
(77%) 
24 
1.3 
(14%) 
17 
(86%) 
44 
5.1 
(20%) 
170 
(80%) 
0.28 
0.40 
0.66 
0.44 
0.31 
0.12 
3.4 8.8 
4.4 6.6 
16 8.2 
6.5 8.3 
14 30 
16 120 
640±400 
120 
100 
33 
75 
110 
0.42 
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Table A3 (cont'd). Bimolecular, geminate, and calculated rate parameters for CerHb mutants located in the heme pocket mea§ured at pH 7.0, 20 oc. 
Observed Geminate Bimolecular binding parameters 
M tants parameters 
U k'02 k02 K02 k'co kco Kco kgem F a kbond kescape k'entn• 
Calculated rate parameters 
WT 
Phe25(CD1) 
Val25 
Trp25 
Phe27(CD3) 
Ala27 
Val27 
Trp27 
Gln44(E7) 
Ala44 
Val44 
Leu44 
Phe44 
Trp44 
His44 
M·l ·I ·I M"l M"l ·I ·I M"l ·I gem ·I ·I {' I J.l. S S J.l. J.l. S S J.l. J.l.S J.l.S J.!S gM· s· 
230±17 190±25 1 2 0 2 32±4.7 0.054±0.005 590±10 80±40 0.05±0.03 
(12) (12) . ± . (12) (15) 0 (8) (8) 4.0±3.0 76±40 
180 
35 
190 
180 
130 
160 
130 
180 
20 
10 
170 
85 
200 
99 
240 
330 
83 
33 
84 
96 
170 
33 
330 
81 
0.90 
0.35 
0.79 
0.55 
1.6 
4.8 
1.5 
1.9 
0.12 
0.30 
0.52 
1.0 
70 
3.2 
30 
27 
45 
41 
25 
36 
1.3 
5.0 
4.0 
0.015 
0.17 
0.063 
0.057 
0.070 
0.050 
0.0040 
0.032 
0.016 
0.054 
0.035 
0.011 
0.010 
6,200 
3,200 
19 
480 
470 
640 
820 
10,000 
780 
2,300 
24 
140 
460 
400 
52 
200° 
120 
76 
50 
81 
96 
58 
80 
65 
150 
0.26 
0.050 
0.10 
0.13 
0.050 
0.090 
0.14 
0.19 
0.050 
0.11 
0.08 
14 
10 
12 
9.9 
2.5 
7.3 
14 
11 
4.0 
7.2 
12 
38 
190 
110 
66 
48 
74 
83 
47 
76 
58 
140 
640±400 
270 
64 
300 
210 
900 
460 
180 
190 
26 
45 
50 
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TableA3 (cont'd). Bimolecular, geminate, and calculated rate parameters for CerHb mutants located in the heme pocket measured at pH 7.0, 20 oc. 
Observed Geminate 
Calculated rate parameters Bimolecular binding parameters parameters 
Mutants k' k K k'co kco Kco kgem F a kbond kescape k'entry 
02 02 02 ' '1 -1 -1 gem -1 -1 M-1 -1 gM-1s-1 s·1 gM·1 gM-1s·1 s· gM gs gs gs 11 s 
WT 
Lys47(E10) 
Ala47 
Leu47 
Asn47 
Asp47 
Phe47 
Trp47b 
Thr48(E11) 
Ala48 
Val48 
Leu48 
Iso48 
Phe48 
Trp48 
Ala82(G8) 
Leu82 
Phe82 
Trp82 
230±17 190±25 32±4.7 0.054±0.005 590±100 80±40 0.05±0.03 4.0±3.0 76±40 640±400 
(12) (12) 1.2±0·2 (12) (15) (8) (8) 
180 
210 
150 
180 
190 
180 
41b 
30b 
16 
43 
6.2 
4.3 
49 
240 
63 
350 0.51 
270 0.78 
270 0.56 
250 0.72 
260 0.73 
180 1.0 
0.26b 160b 
0.18b 170b 
0.15 110 
0.40 110 
0.020 310 
0.025 170 
56 
18 
11 
0.88 
13 
5.7 
20 
33 
16 
24 
26 
27 
2.6 
3.0b 
3.1 
5.1 
0.99 
1.4 
7.8 
94 
8.1 
0.050 
0.053 
0.067 
0.063 
0.065 
0.080 
0.0065 
0.0070b 
0.0030 
0.0050 
0.00070 
0.0035 
0.031 (75%) 
0.0030 (25%) 
0.0020 
0.0030 (50%) 
0.00060 (50%) 
400 
620 
240 
380 
400 
340 
400 
430b 
1,000 
1,000 
1,400 
400 
250 
2,600 
47,000 
2,700 
14,000 
140 
44 
100 
49 
25 
96 
67 
70 
110 
46 
13 
(30%) 
66 
(70%) 
200 
74 
200 
0.090 
0.12 
0.052 
0.067 
0.065 
0.088 
s 0.025 
0.11 
0.11 
0.11 
0.73 
0.72 
0.064 
0.32 
0.087 
13 
5.3 
5.2 
3.3 
1.6 
8.4 
7.4 
7.7 
12 
34 
36 
13 
24 
17 
130 
39 
95 
46 
23 
88 
60 
62 
98 
12 
14 
190 
50 
180 
220 
280 
310 
360 
400 
310 
27 
28 
46 
1.4 
1.9 
120 
290 
93 
The standard deviations for the wt values for k'02, k02, and k'co were obtained from the analysis of 12 completely independent sets of experiments starting 
with at least 7 different expressions and purifications of CerHb. The standard deviation for kco came from the analysis of 16 different determinations. The 
values of K02 and Kco were calculated from k'o/k02 and k'cclkco, and their standard deviations were calculated from the standard propagation of error 
formula. 
a The fraction of geminate CO rebinding was measured using a 7 ns Y AG laser light pulse. 
b Binding parameters reported in {Pesce, 2004 #2}. 
cMost of the amplitude change occurs during the light pulse. This kgem value is an estimate. 
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Table A4. Bimolecular, geminate, and calculated rate parameters for CerHb multiple mutants located throughout the apolar tunnel measured at pH 7.0, 20 
oc. 
Bimolecular binding parameters Observed Geminate Calculated rate parameters 
Mutants 
parameters 
k'02 k02 K02 k'co kco Kco kg em Fgem a kbond kescape k'entry llM.1s·1 s·l llM-1 llM-Is-1 s·l llM-1 !lS-I !lS-I !lS-I llM-Is-1 
WT 230±17 190±25 1.2±0.2 32±4.7 0.054±0.0053 590±100 80±40 0.05±0.03 4.0±3.0 (12) (12) (12) (15) (8) (8) 76±40 640±400 
V7A/L86A 240 190 1.3 35 0.034 1,030 8.5 0.14 1.2 7.3 250 
V7A/A55F 68 87 0.78 16 O.o18 890 7.3 0.48 3.5 3.8 33 
V7F/A55F 63 58 1.1 15 0.013 1,200 42 0.40 17 25 38 
V7F/A55W 45 37 1.2 11 0.0080 1,400 40 0.54 22 18 20 
V7F/A55F/L86F 42 17 2.5 17 0.0010 17,000 39 0.79 31 8.2 22 
V7W/A55F 33 9.3 3.6 12 0.0010 12,000 59 0.82 48 11 15 
V7W/L86F 34 5.0 6.8 15 0.00090 17,000 86 0.92 79 0.00020 75,000 6.9 16 
V7W/A55F/L86F 19 2.5 7.6 5.8 0.00026 22,000 76 0.91 69 6.8 6.4 
V7W/A55W 26 10 2.6 10 0.0012 8,300 54 0.85 46 8.1 12 
V7W/L86W 30 2.3 13 12 0.00030 40,000 99 0.93 92 6.9 13 
V7W/A55W/L86W 23 3.0 7.6 7.2 0.00070 10,300 59 0.93 55 4.1 0.00010 72,000 7.7 
The standard deviations for the wt values for k'02, k02, and k'co were obtained from the analysis of 12 completely independent sets of experiments starting 
with at least 7 different expressions and purifications of CerHb. The standard deviation for kco came from the analysis of 16 different determinations. The 
values of K02 and Kco were calculated from k'0 /k02 and k'colkco, and their standard deviations were calculated from the standard propagation of error 
formula. 
• The fraction of geminate CO rebinding was measured using a 7 ns Y AG laser light pulse. 
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Table AS. Bimolecular, geminate, and calculated rate Earameters for CerHb multiEle mutants located throughout the heme Eocket measured at EH 7.0, 20 °C. 
Bimolecular binding parameters Observed Geminate Calculated rate parameters parameters Mutants k'02 k02 K02 k'co kco Kco kg em kbond kescape k'entry Fgem a J.LM.'s·' s·' M·' J.LM·'s·' s·' J.LM·' j.LS·l j.LS·l j.LS.J J.LM.'s·' !:! 
WT 230±17 190±25 1.2±0.2 32±4.7 0.054±0.0053 590±100 80±40 0.05±0.03 4.0±3.0 (12) (12) (12) (15) (8) (8) 76±40 640±400 
0.0040 31,000 
Y11F/Q44L 290 490 0.60 120 0.00020 610,000 65 0.39 25 40 310 
Y11F/Q44H 14 16 0.88 0.84 0.016 53 54 0.16 8.6 45 0.0020 420 5.3 
Y11F/T48V 230 62 3.7 75 0.0040 19,000 65 0.33 21 44 230 
Q44LIT48V 55 4.2 13 7.1 0.036 200 95 0.16 15 80 0.0069 1,030 44 
Q44H/T48V 120 11 11 50, 10, 0.010 - 120 0.36 43 77 1.0, 
0.20 
Q44T/T48Q 63 360 0.17 4.0 0.040 100 14 0.019 0.27 14 52 1.2 210 
Y11F/Q44LIT48V 340 270 1.6 170 0.0030 55,000 73 0.40 29 44 430 
3.9 0.036 
Y11F/Q44H/T48V 29 2.9 10 1.2 0.0050 - 36 0.081 2.9 33 48 
15 
V7WN11F/Q44LIT48V 82 54 1.5 40 0.00018 220,000 95 0.77 73 22 52 
Y11F/Q44LIT48V/A55W 70 50 1.4 27 0.00036 75,000 50 0.85 43 7.5 32 
The standard deviations for the wt values for k'02, k02, and k'co were obtained from the analysis of 12 completely independent sets of experiments starting with at 
least 7 different expressions and purifications of CerHb. The standard deviation for kco came from the analysis of 16 different determinations. The values of K02 
and Kco were calculated from k'0 /k02 and k'colkc0 , and their standard deviations were calculated from the standard propagation of error formula. 
• The fraction of geminate CO rebinding was measured using a 7 ns Y AG laser light pulse. 
Table A.6 Bimolecular, geminate, and calculated rate parameters for Mb mutants located throughout the protein matrix measured at pH 7.0, 20 °C. 
Observed Geminate Calculated rate parameters Bimolecular binding parameters t M parame ers 
utants k'02 k02 K02 kgem F a kbond kescape k'entry 
M ·l -1 s·l IlM-I IlS-I gem, 02 -1 -1 M-1 -1 1! S r r !!S I.LS !l S 
WT 16±3b 14±3 1.1±0.2 12±3 0.47±0.09 5.7±1.0 6.3±1.0 34±7 
Arg45(CD3) 
Ala45 
Trp45 
Leu6I(E4) 
Ala6I 
Trp6I 
Leu69(El2) 
Aia69 
Trp69 
Ile75(EI8) 
Aia75 
Trp75 
Leu135(HI2) 
7.7 
6.2 
11 
8.8 
28 
13 
22 
I6 
30 
2I 
26 
II 
13 
5.2 
8.5 
8.8 
0.26 
0.30 
0.43 
0.80 
2.2 
2.5 
2.6 
1.8 
5.8 
IO 
19 
I5 
22 
32 
16 
I6 
0.31 
0.13 
0.33 
0.24 
0.46 
0.6I 
0.35 
0.43 
1.8 
1.3 
6.6 
3.6 
IO 
20 
5.6 
6.9 
4.0 
8.7 
12 
II 
I2 
13 
IO 
9.I 
25 
48 
33 
37 
6I 
2I 
63 
37 
Vai135 2I 8.1 2.6 20 0.40 8.0 I2 53 
Trpi35 23 6.5 3.5 I8 0.33 5.9 I2 70 
The value of K02 were calculated from k'0 /k02, and its standard deviation was calculated from the standard propagation of error 
formula. When fitting the 0 2 geminate data, single and double exponential fits were examined. In the case of kgem values, 
estimates from 1 exponential fits were used as final values. In the case of F gem values, 2 exponential fits were used to estimate 
total F gem,02· 
a The fraction of geminate 0 2 rebinding was measured using a 7 ns Y AG laser light pulse. 
b Rate constants in bold are taken from {Scott, 2001 # 14}. 
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